En ImmSumm 2013

IMMUNIZATION SUMMARY
A statistical reference containing

data through 2011
(The 2013 edition)
DISCLAIMER: The data in this
edition supersede all historical
data previously published by
UNICEF and WHO.
Version en franais sur CD-ROM
Versin en espaol en CD-ROM
CD-ROM
inside
IMMUNIZATION SUMMARY
A statistical reference containing

data through 2011
See inside back cover

for CD-ROM
CONTENTS
Introduction................................................................... iv
Annual updates............................................................ vii
Indicative prices....................................................... viii
Trends: Regional progress....................................... xi
Maps: Global indicators........................................... xv
Notes on indicators and data................................. xix
Countries and territories.......................................... xxiii
Afghanistan...............1
Albania......................2
Algeria.......................3
Andorra.....................4
Angola.......................5
Antigua and
Barbuda.................6
Argentina...................7
Armenia.....................8
Australia....................9
Austria.....................10
Azerbaijan...............11
Bahamas..................12
Bahrain....................13
Bangladesh.............14
Barbados.................15
Belarus.....................16
Belgium...................17
Belize ......................18
Benin........................19
Bhutan.....................20
Bolivia......................21
Bosnia and
Herzegovina........22
Botswana.................23
Brazil........................24
Brunei
Darussalam.........25
Bulgaria...................26
Burkina Faso...........27
Burundi....................28
Cambodia................29
Cameroon................30
Canada.....................31
Cape Verde..............32
Central African
Republic..............33
ii
Chad.........................34
Chile.........................35
China........................36
Colombia.................37
Comoros..................38
Congo......................39
Congo, Democratic
Republic of the...40
Cook Islands............41
Costa Rica...............42
Cte dIvoire............43
Croatia.....................44
Cuba.........................45
Cyprus.....................46
Czech Republic.......47
Denmark..................48
Djibouti....................49
Dominica.................50
Dominican
Republic..............51
Ecuador...................52
Egypt........................53
El Salvador..............54
Equatorial Guinea...55
Eritrea......................56
Estonia.....................57
Ethiopia...................58
Fiji............................59
Finland.....................60
France......................61
Gabon......................62
Gambia....................63
Georgia....................64
Germany..................65
Ghana......................66
Greece.....................67
Grenada...................68
Guatemala...............69
Guinea.....................70
Guinea-Bissau.........71
Guyana....................72
Haiti..........................73
Honduras.................74
Hungary...................75
Iceland.....................76
India.........................77
Indonesia.................78
Iran (Islamic
Republic of)........79
Iraq...........................80
Ireland......................81
Israel........................82
Italy..........................83
Jamaica...................84
Japan.......................85
Jordan.....................86
Kazakhstan..............87
Kenya.......................88
Kiribati.....................89
Korea, Democratic
Peoples Republic
of..........................90
Korea, Republic
of..........................91
Kuwait......................92
Kyrgyzstan...............93
Lao Peoples
Democratic
Republic..............94
Latvia.......................95
Lebanon...................96
Lesotho....................97
Liberia......................98
Libya........................99
Lithuania................100
Luxembourg..........101
Madagascar...........102
Malawi...................103
Malaysia................104
Maldives................105
Mali........................106
Malta......................107
Marshall Islands...108
Mauritania.............109
Mauritius...............110
Mexico...................111
Micronesia
(Federated
States of)...........112
Moldova................113
Monaco..................114
Mongolia...............115
Montenegro..........116
Morocco................117
Mozambique.........118
Myanmar...............119
Namibia.................120
Nauru.....................121
Nepal.....................122
Netherlands...........123
New Zealand.........124
Nicaragua..............125
Niger......................126
Nigeria...................127
Niue.......................128
Norway..................129
occupied Palestinian
territory.............130
Oman.....................131
Pakistan.................132
Palau......................133
Panama..................134
Papua New
Guinea...............135
Paraguay...............136
Peru........................137
Philippines.............138
Poland....................139
Portugal.................140
Qatar......................141
Romania................142
Russian
Federation.........143
Rwanda..................144
Saint Kitts and
Nevis.................145
Saint Lucia............146
Saint Vincent
and the
Grenadines.......147
Samoa...................148
San Marino...........149
Sao Tome and
Principe.............150
Saudi Arabia.........151
Senegal..................152
Serbia....................153
Seychelles.............154
Sierra Leone..........155
Singapore..............156
Slovakia.................157
Slovenia.................158
Solomon Islands...159
Somalia.................160
South Africa..........161
South Sudan.........162
Spain......................163
Sri Lanka...............164
Sudan....................165
Suriname...............166
Swaziland..............167
Sweden..................168
Switzerland...........169
Syrian Arab
Republic............170
Tajikistan...............171
Tanzania, United
Republic of........172
Thailand.................173
The former
Yugoslav
Republic of
Macedonia........174
Timor-Leste...........175
Togo.......................176
Tonga.....................177
Trinidad and
Tobago..............178
Tunisia...................179
Turkey....................180
Turkmenistan........181
Tuvalu....................182
Uganda..................183
Ukraine..................184
United Arab
Emirates............185
United Kingdom...186
United States........187
Uruguay.................188
Uzbekistan.............189
Vanuatu.................190
Venezuela
(Bolivarian
Republic of)......191
Viet Nam...............192
Yemen...................193
Zambia...................194
Zimbabwe.............195
Glossary of acronyms............................................... 196
iii
INTRODUCTION
Tracking, evaluating and sharing information provides a vital tool for understanding immunization
coverage. Statistics on levels and trends are used
to monitor the performance of services at local,
national and international levels. They guide campaigns to eradicate polio, control measles and
eliminate neonatal tetanus. They identify areas of
weak system performance and reveal areas where
focused attention and extra resources may be
required. And, when deciding whether to introduce
a vaccine, immunization levels and trends are one
important consideration.
The numbers for a single vaccine can provide vital
information for national and global action. Coverage
levels for the diphtheria and tetanus toxoid with pertussis vaccine (DTP), for example, are considered to
be good indicators of health system performance.
In addition, some funding agencies, such as the
GAVI Alliance, often consider immunization coverage levels when reviewing applications for financial
and technical support, although coverage estimates
alone are insufficient to constitute a sole criterion for
determining whether a national immunization programme has achieved certain performance levels.
This reference book, jointly produced by the United
Nations Childrens Fund (UNICEF) and the World
Health Organization (WHO), presents detailed statistics on the performance of national and district-level
immunization systems in 195 countries and territories. It provides an overview of key aspects, including:
Basic indicators from WHO and UNICEF, the
United Nations Population Division and the World
Bank for each country or territory.
Trends in national and territorial coverage for
eight major antigens.
District-level performance in achieving coverage
with DTP and measles vaccines.
iv
Measles control activities, including coverage

achieved through routine services and information on national measles campaigns.
The most current immunization schedule reported
by each country or territory.
A copy of the most recent data collection form can
be found on the CD-ROM on the inside back cover
of this booklet. Background documentation and data
can also be downloaded, along with further information and electronic copies of this book, from the
following websites:
UNICEF: http://www.childinfo.org/immunization.html
WHO: http://www.who.int/immunization_monitoring/
data/en/
ANNUAL UPDATES
Table 1: Indicative budget prices for

major antigens, 2013
The prices listed in the table below are subject to change.
UNICEF Supply Division provides this information for
preliminary budget planning only. Full names of these
vaccines appear in the Glossary of Acronyms, p. 196.
Vaccine (doses per vial)
BCG
DT
DTP
DTPHepHib
DTPHib
HepB
Hib
Influenza
MCV
MenAC
MMR
MR
OPV
bOPV
mOPV
Pneumococcal
Rotavirus
Td
TT
Yellow fever
BCG-20
DT-10
DTP-10
DTP-HepB-Hib-1 (Liquid) non-GAVI
DTP-HepB+Hib-2 (Liquid + Lyophilized) non-GAVI
DTP-HepB-Hib-1 (Liquid) GAVI
DTP-HepB-Hib-10 (Liquid) GAVI
DTP-HepB+Hib-2 (Liquid + Lyophilized) GAVI
DTP+Hib-1 (Lyophilized) non-GAVI
DTP+Hib-10 (Lyophilized) non-GAVI
HepB-1
HepB-10
HepB-1 adult (1 ml)
HepB-10 adult (10 ml)
Hib-1 (Lyophilized)
Influenza-10
Influenza-20
Mea-10
Meningitis AC PS-10
MMR-1 (L-Zagreb strain)
MMR-1 (Urabe strain)
MMR-10 (Urabe strain)
MR-10
OPV-10
OPV-20
bOPV-20
mOPV1-20
Pneumococcal-1* GAVI (13-val)
Pneumococcal-2* GAVI (10-val)
Pneumococcal-1 non-GAVI (13-val)
Pneumococcal-1 non-GAVI (10-val)
RV 1-1** GAVI
RV 1-1 non-GAVI
RV 5-1** GAVI
RV 5-1 non-GAVI
Td-10
TT-10
TT-20
YF-5
YF-10
* The price of RV1-1 vaccines contracted with supplier is EUR 1.88 per dose. Therefore,
the price in US$ will fluctuate throughout the year. The price indicated in this table is
based on the UN rate of exchange as of 1 August 2012.
** Vaccine prices to suppliers are initially US$7; however, AMC donors will assume a
portion of the price so that in 2012, countries pay a maximum of US$3.50.
viii
Recommended budget price, 2013

(US$ per vial)
(US$ per dose)
2.74
1.18
1.97
3.00
7.00
2.60
18.00
5.90
3.50
34.00
0.38
1.73
0.37
1.90
3.40
5.50
45.00
2.40
12.20
2.05
3.70
4.95
18.00
9.76
5.24
2.05
3.00
3.00
2.90
3.50
7.00
20.00
20.00
2.31
6.74
5.00
8.00
1.13
0.95
1.16
3.40
10.78
0.1370
0.1175
0.1970
3.0000
3.5000
2.6000
1.8000
2.9500
3.5000
3.4000
0.3800
0.1730
0.3700
0.1900
3.4000
5.5000
4.5000
0.2400
1.2200
2.0500
3.7000
0.9900
1.8000
0.9760
0.5240
0.2050
0.1500
0.1500
0.1450
3.5000
3.5000
20.0000
20.0000
2.3100
6.7400
5.0000
8.0000
0.1130
0.0950
0.0580
0.6800
1.0780
ix
Table 2: Indicative budget price for

immunization devices, 2013
These prices are subject to change. UNICEF Supply Division
provides this information for preliminary budget planning only.
Device (box of 100,

unless otherwise stated)
BCG autodisable syringe, 0.05 ml
5.50
BCG autodisable syringe, 0.1 ml
5.29
Autodisable syringe, 0.5 ml
4.65
Reconstitution syringe, 2 ml, with needle
2.84
Re-use prevention feature syringe, 2 ml,

with fixed needle
5.10
3.50
Re-use prevention feature syringe, 5 ml,

with fixed needle
5.60
Re-use prevention feature syringe with SIP,

5 ml, with fixed needle
Recommended budget
price, 2013 (US$ per box)
18.00
5.75
Re-use prevention feature syringe with SIP, 10

ml, with fixed needle
20.00
Safety box, 5 l (box of 25)
14.50
TRENDS: REGIONAL
PROGRESS TOWARDS
MDG4, 1980 - 2011
Note: The list of countries and territories in MDG regions appears

online at the United Nations Statistics Division website Millennium
Development Goals Indicators <http://mdgs.un.org/unsd/mdg/
Host.aspx?Content=Data/regionalGroupings>
xii
Global
MDG regions
Caucasus and Central Asia
Developed countries
Eastern Asia
Latin America
Caribbean
Northern Africa
Oceania
South-eastern Asia
Southern Asia
Sub-Saharan Africa
Western Asia
UNICEF regions
Central and Eastern Europe and CIS
East Asia and Pacific
Eastern and Southern Africa
Industrialised Countries
Latin America and the Caribbean
Middle East and North Africa
South Asia
West and Central Africa
WHO regions
African
American
Eastern Mediterranean
European
South East Asian
Western Pacific
MCV coverage
94
92
99
94
76
96
59
90
77
75
86
93
95
79
92
93
90
77
71
75
92
84
93
79
96
95
92
99
94
76
96
64
89
77
74
86
94
95
79
92
93
90
77
69
75
92
83
94
79
96
2011
85
2010
84
2009
73
94
80
94
79
96
94
95
76
93
94
89
76
69
92
93
99
96
76
95
59
88
76
73
87
84
2008
69
94
82
95
78
95
96
93
73
93
94
88
77
63
93
93
97
96
76
92
58
88
77
68
86
83
2007
66
93
81
95
78
92
96
91
72
93
94
87
76
59
93
94
94
95
75
96
63
86
77
66
83
82
2006
64
93
80
94
75
92
96
90
69
93
94
86
73
59
93
94
93
95
76
96
68
86
74
64
83
80
2005
61
93
80
93
70
88
93
86
65
93
93
86
68
56
94
93
87
94
77
95
66
84
69
61
84
77
2004
59
94
76
92
67
88
90
86
65
92
94
86
64
52
94
93
87
95
78
93
63
85
65
59
82
76
2003
57
94
74
91
64
86
89
84
64
92
95
85
60
49
94
92
86
96
77
93
66
82
62
56
79
74
2002
54
93
74
91
61
86
90
83
64
91
93
85
58
44
91
92
86
94
78
93
65
80
59
54
82
72
2001
54
93
73
92
62
86
92
83
63
91
94
85
58
43
93
91
85
95
78
94
61
80
59
53
86
72
2000
54
92
72
91
61
85
91
83
60
91
93
86
57
45
93
91
84
94
76
93
66
80
58
53
86
72
1999
51
92
71
90
61
84
89
83
60
90
92
85
56
40
91
91
84
93
75
92
67
81
58
50
85
71
1998
53
91
70
88
59
84
88
82
64
89
90
85
54
41
91
89
82
91
76
93
64
82
56
52
84
71
1997
54
90
68
88
61
83
87
82
66
90
89
83
57
40
91
89
82
90
74
92
56
82
58
53
78
71
1996
54
86
69
86
69
84
83
83
67
90
84
84
64
41
89
89
83
85
75
92
39
82
65
53
76
73
1995
55
86
66
84
72
81
80
78
64
88
85
81
69
44
86
87
80
86
74
89
52
75
70
54
73
73
1994
56
84
67
83
69
77
79
75
66
86
82
80
66
44
77
85
76
83
73
89
47
75
67
54
74
71
1993
52
83
67
83
63
80
81
79
60
82
82
80
59
41
81
83
82
83
70
88
42
74
61
50
74
70
1992
51
83
67
81
56
85
80
82
57
81
83
79
53
41
77
81
87
84
67
87
73
72
55
49
72
69
1991
54
82
66
79
50
89
83
85
58
82
80
78
47
47
...
83
92
81
68
87
73
71
48
52
73
68
1990
58
80
66
80
59
94
85
89
61
83
76
79
56
50
...
84
98
77
64
84
70
70
57
56
77
72
1985
35
68
47
62
6
78
89
67
42
72
60
55
6
24
...
80
87
61
51
66
36
26
9
32
54
47
6
51
15
31
0
5
73
1
8
52
42
20
0
4
...
63
1
43
20
22
4
0
2
6
17
16
1980
xiii
Global
MDG regions
Caucasus and Central Asia
Developed countries
Eastern Asia
Latin America
Caribbean
Northern Africa
Oceania
South-eastern Asia
Southern Asia
Sub-Saharan Africa
Western Asia
UNICEF regions
Central and Eastern Europe and CIS
East Asia and Pacific
Eastern and Southern Africa
Industrialised Countries
Latin America and the Caribbean
Middle East and North Africa
South Asia
West and Central Africa
WHO regions
African
American
Eastern Mediterranean
European
South East Asian
Western Pacific
DTP3 coverage
94
94
99
94
79
97
62
79
77
74
88
92
91
77
96
93
92
76
70
74
93
87
94
75
96
95
94
99
93
78
97
67
80
76
71
87
92
91
79
96
92
92
75
62
71
92
85
94
75
96
2011
84
2010
83
2009
73
93
83
95
75
97
94
91
74
96
93
91
75
70
94
95
99
94
78
97
67
80
76
72
88
83
2008
70
92
80
96
74
95
95
90
74
96
91
90
74
64
93
96
97
92
78
97
58
79
75
70
86
82
2007
67
93
84
96
75
92
95
89
72
96
92
89
75
61
92
96
93
93
79
97
65
83
76
67
84
81
2006
65
93
82
96
71
92
94
89
70
96
92
88
71
58
92
96
93
93
79
97
66
83
72
64
82
80
2005
63
94
82
95
72
88
92
85
69
96
93
88
71
55
93
95
87
94
78
96
66
82
72
62
84
79
2004
60
93
77
94
70
88
90
85
67
96
92
87
67
51
91
95
87
93
75
95
67
82
68
59
82
77
2003
56
93
76
92
67
87
85
84
64
96
92
86
64
46
92
95
86
94
71
94
72
81
65
55
76
75
2002
53
92
75
93
64
85
89
82
63
95
91
85
62
43
93
94
86
92
77
94
66
76
63
53
80
73
2001
53
91
75
94
65
86
91
83
63
94
90
87
63
41
93
94
86
91
73
96
61
79
64
52
85
73
2000
52
92
73
93
67
85
90
83
60
92
91
87
64
43
93
92
85
92
73
95
65
79
65
52
84
73
1999
50
91
71
93
67
84
89
82
59
93
89
85
64
39
93
93
84
90
73
93
66
79
65
49
82
73
1998
51
88
69
92
69
83
88
82
62
92
86
83
65
38
93
91
83
87
71
91
65
80
66
50
82
73
1997
50
86
67
91
67
83
86
82
66
91
83
82
62
32
91
90
83
84
70
90
53
81
63
49
77
71
1996
51
85
66
89
69
83
83
81
66
94
82
83
64
34
90
92
83
82
68
91
63
79
65
50
76
72
1995
54
86
69
87
71
80
80
79
67
91
83
81
68
38
87
89
80
84
70
89
68
76
69
52
74
73
1994
55
84
60
88
70
84
83
82
66
91
80
79
64
41
73
90
85
81
71
86
67
76
65
53
79
73
1993
50
81
62
81
64
86
73
83
61
87
78
81
59
36
60
86
88
79
70
85
65
74
60
48
78
70
1992
50
79
63
85
60
88
78
85
56
88
77
80
55
40
81
85
91
78
68
84
65
73
57
48
75
70
1991
49
80
65
87
61
92
79
87
57
89
78
78
57
37
...
86
94
78
68
81
73
74
59
48
74
71
1990
57
74
71
87
70
94
75
89
62
89
68
84
67
49
...
83
96
68
68
87
73
75
68
55
84
75
1985
32
64
46
72
20
73
81
65
40
80
56
57
19
20
...
82
78
56
50
73
45
38
20
29
55
49
5
50
18
45
7
8
76
6
9
62
37
24
5
1
...
69
1
37
32
29
36
15
7
5
28
20
1980
MAPS: GLOBAL INDICATORS
xvi
Source: WHO/UNICEF coverage estimates,

1980-2011, July 2012
>
_ 90% (123 countries or 63%)
80-89% (29 countries or 15%)
50-79% (38 countries or 20%)
<50% (4 countries or 2%)
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of UNICEF or the World Health Organization concerning the legal status of any country, territory, city
or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent
approximate border lines for which there may not yet be full agreement.
Map 1: Immunization coverage with measles-containing vaccines in infants, 2011
xvii
*156 developing countries and economies

in transition per UN World Economic &
Social Survey, 2011 classification.
Source: WHO/UNICEF coverage estimates,

1980-2011, July 2012
Not applicable (38 countries)
(DTP3 estimated coverage for 2011

17 countries 90%; 5 countries <90%)
No data (22 countries or 15%)
No (97 countries or 62%)
Yes (36 countries or 23%)
The boundaries and names shown and the designations used on this map do not imply the expression of any
opinion whatsoever on the part of UNICEF or the World Health Organization concerning the legal status of any
country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.
Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.
Map 2: Developing and transition countries and territories* with all districts achieving at least 80% DTP3
coverage, 2011
NOTES ON INDICATORS
AND DATA
Basic indicators
Births The number of children born each year.
Surviving infants The number of children who have survived beyond
their first year of life.
For both births and surviving infants, figures are rounded to the nearest thousand. Where populations are small and birth rates are low,
the figure shown is 0. In countries or territories where the numbers
of births and surviving infants are very close, rounding to the nearest
thousand may cause the figures to appear equal. In places where the
birth rate is declining, it is possible for the number of surviving infants
to exceed births because the former were born in the previous year.
Infant mortality rate The probability of dying between birth and
exactly one year of age. The infant mortality rate is expressed as the
number of infant deaths per 1,000 live births.
Under-five mortality rate The probability of dying between birth and
exactly five years of age. The under-five mortality rate is expressed as
the number of deaths of children under age five per 1,000 live births.
Gross national income per capita (PPP, US) Gross national income
(GNI) is the sum of value added by all resident producers, plus any
product taxes (less subsidies) not included in the valuation of output,
plus net receipts of primary income (compensation of employees
and property income) from abroad. GNI per capita is gross national
income divided by mid-year population. GNI per capita in US dollars
is converted using the World Bank Atlas method. Purchasing power
parity (PPP) is a criterion for an appropriate exchange rate between
currencies. It indicates that a representative basket of goods in one
country would cost the same as in another country if the currencies
are exchanged at that rate. Actual exchange rates vary from the PPP
levels for such reasons as the demand for imports or investments
between countries.
Percentage of routine EPI vaccines financed by government The
immunizations in the Expanded Programme on Immunization (EPI)
include those against tuberculosis, diphtheria, tetanus and pertussis
(DTP), polio and measles, as well as protecting newborn children and
their mothers against tetanus by vaccination of pregnant women. In
some countries, other vaccines (e.g., against hepatitis B, Haemophilus
influenzae type B or yellow fever) may be included.
National coverage rates (WHO/UNICEF estimates)

UNICEF and WHO conduct an annual review of national or territorial
immunization reports to determine the most accurate levels of coverage. The resulting estimates are based on reported (administrative) data,
household surveys and government estimates as reported annually in
the WHO/UNICEF Joint Reporting Form on Immunization, as well as
data from the scientific and technical literature. As an essential part of
this review, UNICEF and WHO consult and collaborate with national and
territorial authorities. Prior to public release, the draft estimates are sent
to the authorities of each country or territory for their review and subsequent revisions as necessary. The vaccines included in this section are:
xx
BCG bacille Calmette-Gurin (vaccine against tuberculosis)

DTP1 first dose of diphtheria and tetanus toxoid with pertussis vaccine
DTP3 third dose of diphtheria and tetanus toxoid with pertussis vaccine
HepB3 third dose of hepatitis B vaccine
Hib3 third dose of Haemophilus influenza type B vaccine
MCV measles-containing vaccine
Pol3 third dose of polio vaccine
PAB protection at birth against tetanus
Coverage for DTP1 should be at least as high as DTP3. Cases where
DTP1 coverage is less than DTP3 coverage reflect deficiencies in data
collection and reporting. UNICEF and WHO are working with national
systems to eliminate these discrepancies. Because DTP and Hib vaccines are dispensed on the same schedule, the coverage levels for
DTP3 and Hib3 should be similar. More information on the estimation
method can be found on the following websites:
UNICEF: http://www.childinfo.org/Immunization.html
WHO: http://www.who.int/immunization_monitoring/routine/
immunization_coverage/en/index4.html
District coverage (as reported)

The disaggregation of immunization statistics to the district level
assists efforts to ensure an equitable distribution of immunization for
all children. The data shown in this section reflect reported (administrative) coverage levels and give an indication of district-level performance. The data are reported through the annual WHO/UNICEF Joint
Reporting Form on Immunization.
Number of districts in country The total number of districts in a
country or territory; this figure may vary from year to year.
Percentage of districts reporting The proportion of districts that
report data through the annual WHO/UNICEF Joint Reporting Form on
Immunization.
DTP3 The proportion of districts achieving each of three coverage
ranges for DTP3. In some cases, not all districts are able to report
coverage levels; consequently, the sum of the three categories may
not be 100 per cent.
MCV The proportion of districts achieving coverage of 90 per cent or
higher for measles-containing vaccine.
DTP1-DTP3 drop-out rate The percentage of children who do not
receive all three doses of DTP after receiving an initial dose, compared
with all children who receive the initial dose of DTP. When a given
districts drop-out rate is less than 10 per cent, children who receive
an initial DTP dose are highly likely to receive all three required doses,
indicating a high level of health-care assistance and performance.
The key indicator given in this reference is the proportion of districts
categorized as high-performing, i.e., those with drop-out rates of less
than 10 per cent.
xxi
Measles control activities (as reported)

Measures such as introducing two rather than one dose of the measles vaccine into the national immunization schedule and conducting
supplementary immunization activities to fill in the gaps in routine
vaccination delivery systems are necessary to prevent measles outbreaks. This section presents data on:
MCV2 routine coverage in 2011: the level of coverage by the second
dose of the measles-containing vaccine, as reported in the annual
WHO/UNICEF Joint Reporting Form on Immunization.
Most recent national measles campaign: the year, target age group
and coverage level of the most recent national measles campaign (as
opposed to a rollover campaign, implemented in several subnational
stages over a period of time).
Immunization schedule
Updated immunization schedules are submitted through the annual
WHO/UNICEF Joint Reporting Form on Immunization. The notations
used in each table may vary slightly because there is no standard format for reporting immunization schedules.
Note: In all instances, an ellipsis indicates that data are not available.
DATA SOURCES
Births, surviving infants, total population: United Nations
Population Division.
Infant mortality rate, under-five mortality rate: The State of the
Worlds Children 2012, UNICEF, New York, 2011.
Gross national income per capita: The World Bank.
National coverage: WHO/UNICEF Review of National Immunization
Coverage 1980-2011, July 2012.
Percentage of routine EPI vaccines financed by government,
district coverage, measles control activities and immunization
schedules: WHO/UNICEF Joint Reporting Form on Immunization,
data collected in 2012.
xxii
COUNTRIES AND
TERRITORIES
Afghanistan
2011
Births............................................................................................................................... 1,408
Surviving infants........................................................................................................... 1,227
Total population.......................................................................................................... 32,358
Infant mortality rate (per 1,000 live births)...................................................................... 73
Under-five mortality rate (per 1,000 live births)............................................................ 101
Gross national income per capita (PPP, US$)............................................................... 910
Percentage of routine EPI vaccines financed by government......................................... ...
National coverage rates (%) (WHO/UNICEF estimates, 2011)

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
68
68
64
66
60
60
57
30
31
30
...
DTP1
86
86
84
85
84
81
80
48
44
50
22
DTP3
66
66
63
64
63
58
58
24
20
25
HepB3
66
66
63
64
63
...
...
...
...
...
...
Hib3
66
66
63
...
...
...
...
...
...
...
...
MCV
62
62
60
59
55
53
50
27
41
20
11
Pol3
66
66
63
64
63
58
58
24
20
25
...
PAB
60
79
89
83
84
95
96
32
13
13

2011 2010
Number of districts in country

Percentage of districts reporting

below 50%
329
329
98
98
11
11
DTP3: proportion of districts with coverage (%) between 50-79%
29
29
57
58
MCV: proportion of districts with coverage at 90% or above (%)
38
34
DTP1DTP3 drop-out rate: proportion of districts that

have achieved a rate of less than 10% (%)
59
50
at 80% or above

MCV2 routine coverage in 2011 (%)
48
year
2011
Most recent national measles campaign
target age group
coverage (%)
9 m-10 y
96
BCG birth
OPV
DTwPHibHep
TT

Measles
6, 10, 14 weeks
9, 18 months
birth; 6, 10, 14 weeks; 9 months

CBAW and 1st contact;
+1, +6 months; +1, +1 year
Albania
2011
Births.................................................................................................................................... 41
Surviving infants................................................................................................................ 40
Total population............................................................................................................ 3,216
Under-five mortality rate (per 1,000 live births).............................................................. 14
Gross national income per capita (PPP, US$)............................................................. 8,900

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
97
99
98
97
98
93
97
94
93
DTP1
99
99
99
99
98
98
99
98
98
97
97
DTP3
99
99
98
99
98
97
98
97
97
94
94
HepB3
99
99
98
99
98
98
98
96
88
...
...
Hib3
99
99
98
...
...
...
...
...
...
...
...
MCV
99
99
97
98
97
95
97
95
91
88
90
Pol3
99
99
98
99
99
97
97
97
98
89
92
PAB
87
87
87
87
87
87
86
86
90
30
...

2011 2010
...
36
...
100
below 50%
...
...
...
100
...
100

...
100
at 80% or above

...

year
2000
target age group
coverage (%)
12 m-14 y
98
BCG birth
MMR
DT
6 years
OPV
DTwP
2 years
Pneumo_conj
2, 4, 6 months
(subnational)
DTwPHibHep
2, 4, 6 months
HepB birth
1, 5 years
2, 4, 6 months; 2, 6 years
Td
14 years
TT
1st contact; +1 month
Algeria
2011
Births.................................................................................................................................. 712
Surviving infants.............................................................................................................. 696

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
99
99
99
99
98
97
93
99
...
DTP1
99
99
98
97
98
98
94
95
96
96
...
DTP3
95
95
95
93
95
95
88
86
88
89
...
HepB3
95
95
94
91
90
80
83
...
...
...
...
Hib3
95
95
95
93
...
...
...
...
...
...
...
MCV
95
95
92
88
92
91
83
80
89
83
...
Pol3
95
95
94
92
95
95
88
86
88
89
...
PAB
90
90
71
71
70
70
69
64
44
75
...

2011 2010


below 50%
271
271
...
77
16
71
50

...
94

at 80% or above

...
year
2007
target age group
coverage (%)
unknown
90
BCG birth
Influenza
DT
Measles
6 years
DTwPHib
3, 4, 5, 18 months
OPV
HepB
birth; 1, 5 months
Td
high-risk groups
9 months; 6 years
birth; 3, 4, 5, 18 months; 6 years

11-13, 16-18 years
Andorra
2011
Births.................................................................................................................................... ...
Surviving infants................................................................................................................ ...
Total population................................................................................................................. ...
Infant mortality rate (per 1,000 live births)........................................................................ 3
Under-five mortality rate (per 1,000 live births)................................................................ 3
Gross national income per capita (PPP, US$).................................................................. ...

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
DTP1
99
99
99
99
98
97
99
99
...
...
...
DTP3
99
99
99
99
96
93
98
98
...
...
...
HepB3
99
96
96
94
91
84
79
84
...
...
...
Hib3
99
98
97
98
95
93
97
90
...
...
...
MCV
99
99
98
98
94
91
94
97
...
...
...
Pol3
99
99
99
99
96
93
98
95
...
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
...
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above

...
year
...
target age group
...
coverage (%)
...
DTaP
DTaPHibHepIPV
DTaPHibIPV
5, 15 years
2, 6 months
4, 18 months
HepB birth
MenC_conj
MMR
Pneumo_conj
2, 4, 18 months
15 months; 5 years
3, 5, 15 months
Angola
2011
Births.................................................................................................................................. 803

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
88
93
83
87
88
65
61
56
60
48
...
DTP1
99
99
93
99
83
66
62
44
48
48
...
DTP3
86
91
73
81
83
44
47
31
24
24
...
HepB3
86
91
73
81
83
...
...
...
...
...
...
Hib3
86
91
73
81
83
...
...
...
...
...
...
MCV
88
93
77
79
88
48
45
41
46
38
...
Pol3
85
92
73
75
83
44
46
33
28
23
...
PAB
70
75
88
79
78
77
75
60
48
34
...

2011 2010
164
164
100
100
below 50%
14
16
27
23
59
60
48
53

38
29
at 80% or above

...
year
2011
target age group
coverage (%)
9-59 m
85
BCG birth
Rotavirus 2, 4, 6 months (subnational)
DTwPHibHep
TT

Measles
OPV
Pneumo_conj

2, 4, 6 months
9 months
birth; 2, 4, 6 months
2, 4, 6 months
(subnational)
1st contact pregnancy;

+1, +6 months; +1, +1 year
Vitamin A
Yellow fever
6, 9 months
9 months
Antigua and Barbuda

2011
Births.................................................................................................................................... ...
Gross national income per capita (PPP, US$)........................................................... 15,670

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
DTP1
99
99
99
99
99
99
99
98
99
99
77
DTP3
99
98
99
99
99
99
99
95
99
99
54
HepB3
99
98
98
98
97
99
99
...
...
...
...
Hib3
99
98
94
97
99
99
99
...
...
...
...
MCV
99
98
99
99
99
99
99
95
93
89
...
Pol3
99
99
98
99
98
99
98
96
99
99
36
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010


below 50%

at 80% or above

100
100
100
100
100
100
...
...

89

year
...
target age group
...
coverage (%)
...
DT
DTwP
DTwPHibHep
Influenza
5 years
18 months
2, 4, 6 months
6-35 months; adults
MMR
OPV
1, 5, 15 years
2, 4, 6, 18 months; 5, 15 years
Td 1st contact; + 6 weeks; +6 months;

+every 10 years
Argentina
2011
Births.................................................................................................................................. 693

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
99
99
99
99
99
99
99
99
62
DTP1
98
96
94
97
98
98
98
96
95
95
69
DTP3
93
94
87
92
96
94
94
83
85
87
44
HepB3
93
94
92
89
92
90
85
...
...
...
...
Hib3
93
94
87
92
96
94
94
83
...
...
...
MCV
93
99
99
97
98
97
99
91
99
93
61
Pol3
95
96
96
94
94
94
95
88
90
90
33
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
511
511
100
100
below 50%
23
29
74
68
62
64

91
...
at 80% or above

88
year
2009
target age group
1-4 y
coverage (%)
98
BCG birth
DTwP
6 years
DTwPHib
18 months
DTwPHibHep
2, 4, 6 months
HepA
1 year; health workers
HepB
birth; health workers
Hib
high-risk groups
HPV
11 years (3 doses)
Influenza
<2 years; 65 years
IPV
high-risk groups
MenACWY
management of outbreaks
MMR
1, 6 years; post-partum
MR post-partum
OPV
2, 4, 6, 18 months; 6 years
Pneumo_conj
high-risk groups
Pneumo_ps
high-risk groups
Td
16 years; +every 10 years
TdaP
11 years
Varicella
high-risk groups
Yellow fever
1 year
Armenia
2011
Births.................................................................................................................................... 47

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
96
95
99
98
94
91
94
97
84
...
...
DTP1
98
98
97
96
96
95
96
97
98
...
...
DTP3
95
94
93
89
88
87
90
93
98
...
...
HepB3
95
94
93
89
85
78
91
55
...
...
...
Hib3
95
48
...
...
...
...
...
...
...
...
...
MCV
97
97
96
94
92
92
94
92
96
...
...
Pol3
96
96
94
91
90
87
92
96
93
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010

51
51
100
100
100
100
100
100

100
96
below 50%

at 80% or above

98

year
2009
target age group
coverage (%)
28-45 y
67
BCG birth
MMR
DTwP
OPV

DTwPHibHep
18 months
6, 10, 14 weeks
HepB birth
Td
1, 6 years
6, 10, 14 weeks; 18 months;
6 years
6, 16, 26, 36, 46, 56 years
Australia
2011
Births.................................................................................................................................. 307

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
97
97
97
96
95
98
58
92
92
92
90
86
95
33
94
95
95
...
...
...
...
94
95
94
90
...
...
...
94
94
94
94
91
87
86
...
92
92
92
92
92
90
86
72
17
...
...
...
...
...
...
...
...
...
92
97
97
DTP3
92
92
92
92
HepB3
92
92
92
94
Hib3
92
92
92
94
MCV
94
94
94
Pol3
92
92
PAB
...
...
DTP1
97

2011 2010


below 50%

at 80% or above

100
100
100
100
100
100
...
...

90
year
target age group
coverage (%)
2009
28-45 y
67
DTaP
2, 4, 6 months; 4 years (subnational)
DTaPHepIPV
2, 4, 6 months; 4 years

(subnational)
DTaPHibHepIPV 2, 4, 6 months (subnational)
HepA 12-24 weeks, 18-24 months (subnational)
HepB
birth; 2, 4, 6, 12 months; 10-13 years
(subnational)
HepBHib
2, 4, 12 months (subnational)
Hib
2, 4, 6, 12 months (subnational)
HPV
12-13 years (3 doses)
Influenza
high-risk groups
IPV
2, 4, 6 months; 4 years (subnational)
MenC_conj
1 year
MMR
1, 4 years
Pneumo_conj
2, 4, 6, 12 months
Pneumo_ps
18-24 months; 15-49 years;

50 years (high-risk groups; subnational)
Rotavirus
TdaP
15-17 years
Varicella
18 months, 10-13 years
Austria
2011
Births.................................................................................................................................... 74

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
...
...
...
...
...
...
...
...
...
...
90
DTP1
93
93
93
97
99
99
99
99
96
96
96
DTP3
83
83
83
83
85
83
86
81
90
90
90
HepB3
83
83
83
83
85
83
86
33
...
...
...
Hib3
83
83
83
83
85
83
86
72
...
...
...
MCV
76
76
76
83
79
80
75
75
60
60
...
Pol3
83
83
83
83
85
83
86
71
90
90
90
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
...
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above
121

...
year
...
target age group
...
coverage (%)
...
Pneumo_conj

0-1 year (3 doses);

1-2 years
DTaPHibHepIPV

HepB
HPV
MMR
10
0-1 year (3 doses);

1-2 years
12-13 years
9 years (3 doses)
1-2 years (2 doses)
Rotavirus

7 weeks - 6 months
(2 or 3 doses)
Azerbaijan
2011
Births.................................................................................................................................. 184
Percentage of routine EPI vaccines financed by government......................................... 78

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
82
81
81
81
81
82
81
81
76
...
...
DTP1
79
80
79
80
80
80
78
82
79
...
...
DTP3
74
72
73
74
74
74
72
75
74
...
...
HepB3
48
49
49
49
49
45
48
...
...
...
...
Hib3
38
...
...
...
...
...
...
...
...
...
...
MCV
67
67
67
66
66
65
67
67
64
...
...
Pol3
80
78
78
80
79
79
79
76
71
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
64
64
98
100
below 50%
98
100
94
95

...
100

at 80% or above

98
year
2006
target age group
coverage (%)
23-35 y
94
BCG
DT
DTwP
DTwPHibHep
4-7 days
6 years
18 months
2, 3, 4 months
HepB birth
MMR
OPV
Vitamin A
1, 6 years
4-7 days; 2, 3, 4, 18 months
12, 18 months; 6 years
11
Bahamas
2011
Births...................................................................................................................................... 5
Surviving infants.................................................................................................................. 5
Total population............................................................................................................... 347

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
99
99
99
99
98
95
99
99
95
95
61
DTP3
98
99
96
93
95
95
93
99
87
86
36
HepB3
95
98
95
90
93
96
93
...
...
...
...
Hib3
98
98
96
94
95
95
93
90
...
...
...
MCV
90
94
98
90
96
88
85
93
90
86
...
Pol3
97
97
97
93
95
94
93
91
86
82
35
PAB
92
90
90
90
90
92
90
85
79
71
...

2011 2010
...
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above
31

79

year
2007
target age group
coverage (%)
4-40 y
2
DT
4-5 years
IPV
DTaPHepIPV
2, 4, 6 months
MMR
DTaPHibHepIPV
2, 4, 6 months
OPV
DTaPHibIPV
2, 4, 6 months
Pneumo_conj
DTwP
2, 4, 6 months
Rotavirus
DTwPHep
2, 4, 6 months
Td
DTwPHib
15 months
Influenza
high-risk groups
12
2, 4, 6 months; 4-5 years

2, 4, 6 months
2, 4 months
2, 4, 6 months
2, 4 months
10 years
Varicella
1, 4 years
Yellow fever
travellers
Bahrain
2011
Births.................................................................................................................................... 23
Percentage of routine EPI vaccines financed by government....................................... 100

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
99
99
98
98
97
99
99
98
98
97
89
DTP3
99
99
98
98
97
98
98
97
95
94
72
HepB3
99
99
98
98
97
98
98
97
95
...
...
Hib3
99
99
97
97
97
97
98
97
...
...
...
MCV
99
99
99
99
99
99
99
98
95
87
45
Pol3
99
99
97
97
97
98
98
97
95
94
72
PAB
94
94
94
99
96
93
97
84
59
48

2011 2010


below 50%
100
100
100
100
100
100

100
100

at 80% or above

96
year
...
target age group
...
coverage (%)
...
BCG birth
DT
2, 4, 6, 18 months (pertussis contraindication)
DTaP
5 years
DTapHibHep
4, 6, 18 months
DTaPHibHepIPV
2 months
HepA
18 months; 2 years (catch up)
HepB
birth; 1 month
Hib
high-risk groups
Influenza
6 months; 50 years

(high risk groups; pilgrims)
IPV

(immunocompromised)
MenACWY 2 years; 65 years (travellers; pilgrims)

MMR
1, 5 years
OPV
Pneumo_conj
2, 4, 6 months; 1 year
Pneumo_ps
65 years (high-risk groups)
Rotavirus
2, 4 months
Td
>10 years (post-trauma; pregnancy; pilgrims)
TdaP
13 years
Typhoid travellers
Varicella
high-risk groups
Yellow fever
travellers
13
Bangladesh
2011
Births............................................................................................................................... 3,016
Total population........................................................................................................ 150,494

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
95
94
94
90
92
96
97
95
93
86
...
DTP1
99
98
97
95
97
95
96
88
87
86
...
DTP3
96
95
96
95
95
93
96
83
69
69
...
HepB3
96
95
96
95
95
94
45
...
...
...
...
Hib3
96
95
96
...
...
...
...
...
...
...
...
MCV
96
94
98
96
95
92
94
72
79
65
...
Pol3
96
95
96
95
95
93
96
84
69
69
...
PAB
94
93
93
91
91
92
89
89
85
70

2011 2010

64
64
100
100
20
20
80
80
55
52
100
100
below 50%
at 80% or above


...

year
target age group
coverage (%)
2010
9-59 m
100
BCG birth
OPV
DTwPHibHep
TT 15 years; +1, +6 months; +1, +1 year
Measles
14
6, 10, 14 weeks
38 weeks
Vitamin A
6, 10, 14, 38 weeks
38 weeks
Barbados
2011
Births...................................................................................................................................... 3

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
93
93
93
85
93
94
97
93
97
97
82
DTP3
91
86
93
85
93
84
92
93
93
91
60
HepB3
91
86
93
85
93
84
92
...
...
...
...
Hib3
91
86
93
85
93
84
92
...
...
..
...
MCV
93
85
94
94
75
92
93
94
92
87
41
Pol3
91
90
93
85
93
85
91
86
93
90
99
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
100
...
...
...
...
...
...
...
...

...
...

below 50%
at 80% or above

94
year
...
target age group
...
coverage (%)
...
BCG
5 years
DTwP
18 months; 4.5 years
DTwPHibHep
2, 4, 6 months
HepB adults
Influenza

IPV

6-23 months
(high-risk groups)
2, 4, 6, 18 months;
4.5, 10-11 years (HIV-exposed)
MMR
OPV

Pneumo_conj
Td
Varicella
Yellow fever
1, 3-5 years
2, 4, 6, 18 months;
4.5, 10-11 years
2, 4, 6 months
10-11 years
18 years
1 year; travellers
15
Belarus
2011
Births.................................................................................................................................. 107

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
98
98
98
99
99
99
96
...
...
DTP1
99
99
98
98
99
99
99
99
98
...
...
DTP3
98
98
96
97
95
99
99
99
96
...
...
HepB3
98
96
98
98
91
98
99
70
...
...
...
Hib3
21
19
...
...
...
...
...
...
...
MCV
99
99
99
99
99
97
99
98
93
...
...
Pol3
98
99
98
98
90
97
98
99
96
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
130
130
100
100
below 50%

at 80% or above

100
100
100
100
...
100

99

year
...
target age group
...
coverage (%)
...
BCG
DT
3-5 days; 7, 14 years

6 years
IPV
MMR
3, 4, 5 months
1, 6 years
DTwP
3, 4, 5, 18 months
OPV
HepB
birth; 1, 5 months
Td
16 years
3, 4, 16 months;
<5 years (subnational)
TT
manage outbreaks
Hib

Influenza
16
high-risk groups
Yellow fever
high-risk groups
Belgium
2011
Births.................................................................................................................................. 123

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
99
99
99
99
99
99
98
97
97
97
98
DTP3
98
99
99
99
99
99
97
95
94
93
95
HepB3
97
97
97
98
94
94
77
60
...
...
...
Hib3
98
98
98
98
98
98
95
86
13
...
...
MCV
95
95
95
93
92
92
88
82
85
85
...
Pol3
98
99
99
99
99
99
97
96
92
95
99
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
43
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above
43

...
year
...
target age group
...
coverage (%)
...
DTaPHibHepIPV

DTaPIPV
HPV

MenC_conj
8, 12, 16 weeks;
15 months
5-7 years

10-13 years
MMR
1, 10-13 years
Pneumo_conj
2, 4, 12, 15 months
Rotavirus 2, 3, 4 months; 1, 10-13 years

TdaP
8, 16 weeks; 1, 14-16 years
15 months; 5-7 years
17
Belize
2011
Births...................................................................................................................................... 8

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
98
98
99
98
99
97
96
96
92
93
71
DTP1
98
99
99
98
98
98
98
96
94
97
72
DTP3
95
96
97
94
96
98
96
91
83
91
47
HepB3
95
96
97
94
96
98
96
76
...
...
...
Hib3
95
96
97
94
96
98
96
...
...
...
...
MCV
98
98
97
96
96
99
95
96
83
86
21
Pol3
95
96
98
94
97
98
96
91
83
86
44
PAB
88
88
88
88
87
85
87
85
87
88
...

2011 2010

100
100
100
100
100
67

100
100
below 50%

at 80% or above

97

year
2010
target age group
coverage (%)
12-24 m
95
BCG birth
DT

DTwP
DTwPHibHep

(pertussis contraindication)
4-5 years
2, 4, 6 months
HepB 2, 4, 6 months; 4-5 years (pertusisis

contraindication); high-risk groups
HPV subnational
Influenza 6-36 months (2 doses); >65 years;

health workers; high-risk groups
IPV 2, 4, 6 months; 4-5 years (HIV-exposed)
MMR
OPV
Rabies
Td

Vitamin A
18
1, 2 years
0, 3, 7, 14, 21, 28 days
10-14 years (school-age
children); pregnancy
6, 12, 18, 24, 30, 36 months
Benin
2011
Births.................................................................................................................................. 356

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
97
97
97
97
97
93
88
92
85
92
...
DTP1
94
94
94
94
94
89
84
89
82
86
...
DTP3
85
83
83
78
82
74
70
78
67
74
...
HepB3
85
83
83
78
82
74
70
...
...
...
...
Hib3
85
83
83
78
82
74
35
...
...
...
...
MCV
72
69
72
66
70
66
61
70
65
79
...
Pol3
85
83
83
79
82
76
73
78
68
74
...
PAB
92
92
92
92
93
95
95
87
82
48
...

2011 2010


below 50%
77
77
100
100
94
91
36
65

52
69

at 80% or above

...
year
2011
target age group
coverage (%)
9-59 m
104
BCG birth
DTwPHibHep
Measles
OPV
Pneumo_conj
6, 10, 14 weeks
9 months
birth; 6, 10, 14 weeks
TT


+1, +6 months; +1, +1 year
Vitamin A
6 months
Yellow fever
9 months
6, 10, 14 weeks
19
Bhutan
2011
Births.................................................................................................................................... 15
Percentage of routine EPI vaccines financed by government........................................... 4

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
95
96
94
99
94
92
92
97
98
99
43
DTP1
98
94
97
97
98
97
97
96
95
98
25
DTP3
95
91
93
96
95
95
95
92
87
96
HepB3
95
91
93
96
95
95
95
98
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
95
95
94
99
95
90
93
78
85
93
21
Pol3
95
92
93
96
93
96
95
98
86
96
PAB
89
89
89
89
84
85
85
85
78
63
...

2011 2010

20
20
100
100
10
95
90
70
75

95
100
below 50%

at 80% or above

88

year
2006
target age group
coverage (%)
9 m-44 y
98
BCG birth
MR
DT
OPV
2 years
9, 24 months
DTwPHep birth
TT
HPV

Vitamin A 6, 12, 18, 24, 30, 36 months
20
12 years; +2, +6 months;

12-18 (females)
1st contact pregnancy; +1 month
Bolivia
2011
Births.................................................................................................................................. 264

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
90
90
88
86
86
87
88
92
87
65
30
DTP1
90
87
87
87
85
87
93
92
84
66
32
DTP3
82
80
85
83
82
83
85
75
64
41
11
HepB3
82
80
85
83
82
83
85
77
...
...
...
Hib3
82
80
85
83
82
83
85
77
...
...
...
MCV
84
79
86
87
83
88
89
84
58
53
13
Pol3
82
80
84
82
82
82
84
74
64
50
14
PAB
74
74
74
74
71
71
70
67
57
23
...

2011 2010
337
337
100
100
below 50%
14
13
39
41
47
46
36
30

44
81
at 80% or above

...
year
2007
target age group
coverage (%)
2-15 y
96
BCG birth
OPV
DTwPHep
Rotavirus
Influenza

MMR
MR
2, 4, 6 months
6-23 months (2 doses);
65 years
12-23 months
2-5 years
Td

2, 4, 6 months
2, 4 months
1st contact; +1, +6 months;
+1, +1 year
Vitamin A
Yellow fever
6-11 months
12-23 months
21
Bosnia and Herzegovina

2011
Births.................................................................................................................................... 32

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
94
96
97
96
98
97
95
93
64
...
...
DTP1
94
95
95
95
96
94
95
90
78
...
...
DTP3
88
89
90
91
95
87
93
85
55
...
...
HepB3
88
89
90
88
94
90
93
...
...
...
...
Hib3
85
83
80
83
83
82
50
...
...
...
...
MCV
89
91
93
84
96
85
90
80
53
...
...
Pol3
89
90
90
92
95
91
95
87
69
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010

18
18
100
100
11
94
89
72
72

89
89
below 50%

at 80% or above

88

year
...
target age group
...
coverage (%)
...
BCG birth
DT
6 years (subnational)
DTaP

3, 4, 6 months;
DTaPIPV

2, 4, 6 months;
DTPHibIPV 3, 4, 5 months (subnational)

HepB birth; 1-2, 6 months (subnational)
22
Hib

2-3, 3-5, 18 months;

MMR 18 months; 2 years (subnational)

OPV

3 ,4 .5-6, 18-24 months;

5-7, 14 years (subnational)
Td
TT
Botswana
2011
Births.................................................................................................................................... 47

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
99
99
99
99
99
99
96
93
92
DTP1
98
98
98
98
98
98
98
98
98
99
89
DTP3
96
96
96
96
96
96
96
97
95
92
71
HepB3
93
93
93
93
93
93
92
86
73
...
...
Hib3
96
...
...
...
...
...
...
...
...
...
...
MCV
94
94
94
94
94
94
93
91
89
87
63
Pol3
96
96
96
96
96
96
96
97
94
90
46
PAB
92
92
92
85
84
84
83
80
72
59
...

2011 2010


below 50%
24
24
100
100
29
71
92
75
58

75
75
at 80% or above

...
year
2009
target age group
coverage (%)
9-59 m
115
BCG birth
OPV
DT
18 months; 7 years
Pneumo_conj subnational
DTwP
2, 3, 4 months
Rotavirus subnational
DTwPHibHep
2, 3, 4 months
TT

HepB birth
Measles
9, 18 months
1st contact pregnancy; +4 weeks;

+6 months; +1, +1 year
Vitamin A
6-11, 12-59 months
23
Brazil
2011
Births............................................................................................................................... 2,996

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
99
99
99
99
99
99
99
79
56
DTP1
99
99
99
99
98
98
97
99
85
86
62
DTP3
96
98
98
98
97
97
96
98
81
66
37
HepB3
96
96
99
96
99
99
92
94
10
...
...
Hib3
97
96
98
99
98
97
96
90
...
...
...
MCV
97
99
99
99
99
99
99
99
87
78
57
Pol3
97
99
99
99
99
99
98
99
79
58
69
PAB
92
92
92
92
92
92
67
92
78
63
...

2011 2010
5,565 5,565
100
100
11
11
89
89
70
71

80
83
below 50%
at 80% or above

71

year
target age group
coverage (%)
2011
1-<7 y
98
BCG
birth; high-risk groups
Cholera
2 years; military
DT
2, 4, 6 months (pertussis contraindication)
DTwP
DTwPHib
2, 4, 6 months
DTwPHibHep
2, 4, 6 months; high-risk groups

(subnational)
HepA
12, 18 months; high-risk groups
HepB
birth; 1, 6 months; 20-29 years (3 doses)
Hib
2, 4, 6, 15 months; high-risk groups
Influenza
6, 7 months; 60 years; pregnancy
IPV 2, 4, 6, 15 months; high-risk groups (subnational)
24
MenAC
2 years; high-risk groups
MenC_conj
3, 5, 15 months
MMR
1, 4 years
OPV
2, 4, 6, 15 months
Pneumo_conj
2, 4, 6, 12 months
Pneumo_ps
>5 years; high-risk groups
Rabies
post-injury (5 doses)
Rotavirus
35, 97 days
Td
>7 years (3 doses); 11 years
Typhoid
2 years (2 doses); high-risk groups
Varicella
1 year; high-risk groups
Yellow fever
9 months; 10 years (if indicated;
subnational)
Brunei Darussalam
2011
Births...................................................................................................................................... 8

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
96
95
99
99
96
99
96
99
99
91
99
DTP1
99
98
99
99
99
99
99
99
99
97
96
DTP3
97
95
99
98
99
97
94
99
99
93
89
HepB3
93
96
96
96
97
99
99
99
99
96
...
Hib3
96
95
99
98
99
97
94
...
...
...
...
MCV
91
94
99
99
97
97
98
99
99
99
73
Pol3
99
99
99
98
95
94
93
99
99
92
89
PAB
95
95
65
65
64
64
64
77
69
40
...

2011 2010
...
100
below 50%
...
...
...
100
...
100

...
75
at 80% or above

93
year
...
target age group
...
coverage (%)
...
BCG birth
HPV
DTapIPV
Influenza
DTwPHib
HepB
5 years
2, 3, 4 months
birth; 1, 6 months
MMR
OPV
11-12 years; +1, +6 months

2 years (2 doses)
1, 3 years
2, 3, 4 months
25
Bulgaria
2011
Births.................................................................................................................................... 75

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
98
98
98
98
98
98
98
98
99
99
99
DTP1
96
96
96
97
96
97
97
95
98
99
98
DTP3
95
94
94
95
95
95
96
93
96
99
98
HepB3
96
95
96
96
95
96
96
94
95
...
...
Hib3
95
91
...
...
...
...
...
...
...
...
...
MCV
95
97
96
96
96
96
96
89
94
99
98
Pol3
95
94
94
96
95
96
97
94
97
99
99
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
...
28
...
100
...
...
...
96
...
100

...
82
below 50%
at 80% or above

...

year
2009
target age group
coverage (%)
13 m-20 y
...
BCG
birth; 7 months; 7, 11, 17 years
DTaPHibIPV
DTaPIPV
HepB
Influenza
MMR
26
2, 3, 4, 16 months
6 years
birth; 1, 6 months

13 months; 12 years
OPV
only as reserve at national level
Pneumo_conj
2, 3, 4, 12 months
Rabies post-exposure
Td
Typhoid
12, 17, 25, 35, 45, 55 years

>65 years
Burkina Faso
2011
Births.................................................................................................................................. 730

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
99
99
99
99
99
80
72
95
...
DTP1
93
93
93
97
92
91
91
97
79
92
...
DTP3
91
91
92
93
89
86
82
63
34
66
...
HepB3
91
91
92
93
89
76
...
...
...
...
...
Hib3
91
91
92
93
89
76
...
...
...
...
...
MCV
63
63
94
94
94
88
84
59
43
79
...
Pol3
90
90
91
92
93
94
94
64
35
66
...
PAB
88
85
85
79
80
76
72
57
64
55
...

2011 2010


below 50%

at 80% or above

63
63
100
100
98
100
89
100
100
100

...
year
2011
target age group
coverage (%)
9-59 m
113
BCG birth
OPV
DTwPHibHep
TT
Measles
8, 12, 16 weeks
9 months

1st contact pregnancy; +1 month
Yellow fever
9 months
27
Burundi
2011
Births.................................................................................................................................. 288
Gross national income per capita (PPP, US$)................................................................ 610

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
90
93
98
99
97
98
89
85
92
97
...
DTP1
99
99
99
98
99
99
96
88
86
95
...
DTP3
96
96
94
92
99
92
87
80
73
86
...
HepB3
96
96
94
92
99
92
87
...
...
...
...
Hib3
96
96
94
92
99
92
87
...
...
...
...
MCV
92
92
91
84
88
92
87
76
80
74
...
Pol3
94
94
96
89
93
88
82
71
73
97
...
PAB
80
94
94
78
76
66
65
51
61
67
...

2011 2010

45
45
100
100
98
91
78
56

93
93
below 50%

at 80% or above

...

year
2010
target age group
coverage (%)
99
BCG birth
Pneumo_conj
6, 10, 14 weeks
DTwPHibHep
TT

6 m-14 y
Measles
OPV
28
6, 10, 14 weeks
9 months
Vitamin A

+1, +1 year
6-59 months
Cambodia
2011
Births.................................................................................................................................. 317

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
94
94
96
98
90
87
87
81
69
52
...
DTP1
96
93
99
95
87
85
85
78
55
63
...
DTP3
94
92
94
91
82
80
82
59
39
38
...
HepB3
94
92
92
91
82
80
...
...
...
...
...
Hib3
94
92
...
...
...
...
...
...
...
...
...
MCV
93
93
92
89
79
78
79
65
62
34
...
Pol3
94
92
95
91
82
80
82
62
39
38
...
PAB
91
91
91
87
87
84
81
58
45
11
...

2011 2010


below 50%
77
77
100
100
18
14
82
86
53
51

97
96
at 80% or above

...
year
2011
target age group
coverage (%)
9-59 m
100
BCG birth
OPV
DTwPHibHep
TT

6, 10, 14 weeks
HepB birth
JE
Measles
10 months (subnational)
Vitamin A
6, 10, 14 weeks
+1, +6 month; +1, +1 year
6-59 months (2 doses)
9 months
29
Cameroon
2011
Births.................................................................................................................................. 716

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
80
83
81
91
89
96
90
78
62
76
...
DTP1
90
92
88
93
90
87
85
66
71
70
...
DTP3
66
68
67
75
75
78
80
62
46
48
...
HepB3
66
68
67
71
69
68
66
...
...
...
...
Hib3
66
68
67
...
...
...
...
...
...
...
...
MCV
76
79
74
80
74
73
68
49
46
56
...
Pol3
67
70
69
75
75
75
79
57
46
54
...
PAB
75
91
91
86
83
81
76
54
20
19
...

2011 2010
179
179
100
100
below 50%
33
31
66
65
26
28

66
68
at 80% or above

...

year
2012
target age group
coverage (%)
9-59 m
100
BCG birth
DTwPHibHep
TT

Measles
OPV
Pneumo_conj
30
6, 10, 14 weeks
9 months
6, 10, 14 weeks

+1, +2 years
Vitamin A 59 years (every 6 months);

post-partum
Yellow fever
9 months
Canada
2011
Births.................................................................................................................................. 388

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
98
98
98
98
98
98
98
97
97
96
...
DTP3
95
95
95
94
94
94
94
92
87
88
...
HepB3
70
56
42
28
14
14
14
...
...
...
...
Hib3
95
95
95
94
94
94
90
86
...
...
...
MCV
98
97
96
95
94
94
94
96
96
89
...
Pol3
99
97
95
92
90
94
92
88
89
88
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
...
...
...
...
below 50%
...
...
...
...
...
...
...
...

...
...
at 80% or above

...
year
...
target age group
...
coverage (%)
...
BCG
high-risk groups
DTaPIPV
2, 4, 6, 18 months
DTPHibIPV
4-6 years
HepA
high-risk groups
HepB

1st contact; +1, >+2 months

(3 doses); pre-teen (2-3 doses)
HPV
1st contact; +2, +6 months
Influenza <9 years (2 doses); >18 years
MenC_conj

MMR
2, 4, 6 months
(or 2, 4, 12 months)
12, 18 months; or 4-6 years
Pneumo_conj
Pneumo_ps
Td
TdaP
Varicella
2, 4, 6, 12-15 months
65 years
every 10 years
14-16 years
31
Cape Verde
2011
Births.................................................................................................................................... 10

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
99
99
99
99
99
96
94
97
...
DTP1
99
99
99
99
99
98
97
94
90
96
...
DTP3
90
99
99
99
98
96
95
90
88
88
...
HepB3
90
98
98
98
96
95
93
...
...
...
...
Hib3
90
...
...
...
...
...
...
...
...
...
...
MCV
96
97
97
96
95
94
92
86
85
79
...
Pol3
90
99
99
99
98
97
95
90
89
87
...
PAB
92
92
78
78
77
74
70
60
30
75
...

2011 2010
22
22
...
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above

104

year
2009
target age group
coverage (%)
9-59 m
87
BCG birth
MMR
DTwPHibHep
OPV
2, 4, 6 months
HepB birth
Measles
32
9 months
TT

15 months
birth; 2, 4, 6, 18 months
+1, +6 months; +1, +1 year
Central African Republic

2011
Births.................................................................................................................................. 156
Infant mortality rate (per 1,000 live births).................................................................... 108

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
74
74
74
74
74
74
74
66
94
96
17
DTP1
64
64
64
64
64
64
64
60
77
95
35
DTP3
54
54
54
54
54
54
54
37
53
82
13
HepB3
54
54
54
...
...
...
...
...
...
...
...
Hib3
54
54
54
...
...
...
...
...
...
...
...
MCV
62
62
62
62
62
62
62
36
46
82
12
Pol3
47
47
47
47
47
47
47
38
51
82
13
PAB
80
86
86
86
54
52
48
36
34
69

2011 2010


below 50%
24
24
100
100
17
21
50
67
33
13
42
at 80% or above


...
year
2011
target age group
coverage (%)
9-47 m
84
BCG birth
Rotavirus
DTwPHibHep
TT

Measles
6, 10, 14 weeks
9 months
OPV
6, 10, 14 weeks
Pneumo_conj
6, 10, 14 weeks
6, 10 weeks (subnational)
+1, +1 year
Vitamin A
Yellow fever
6 months; 1 year
9 months
33
Chad
2011
Births.................................................................................................................................. 511

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
53
58
46
30
44
56
41
49
43
59
...
DTP1
45
51
46
48
51
59
46
45
41
44
...
DTP3
22
35
27
19
30
41
26
36
18
20
...
HepB3
22
35
27
17
...
...
...
...
...
...
...
Hib3
22
35
27
17
...
...
...
...
...
...
...
MCV
28
33
36
27
31
39
27
28
26
32
...
Pol3
31
39
32
30
38
49
37
30
18
20
...
PAB
60
60
60
58
60
60
61
39
65
14
...

2011 2010

61
61
100
100
23
11
46
34
31
54
28
41

13
26
below 50%
at 80% or above

...

year
2012
target age group
coverage (%)
6-59 m
111
BCG birth
DTwPHibHep
Measles
OPV
34
6, 10, 14 weeks
9 months
6, 10, 14 weeks
TT


+1, +6 months; +1, +1 year
Yellow fever
9 months
Chile
2011
Births.................................................................................................................................. 245

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
91
95
95
99
98
98
95
93
97
94
96
DTP1
98
93
94
96
98
95
92
98
97
98
97
DTP3
94
92
94
95
96
94
91
91
94
95
93
HepB3
94
92
94
95
92
95
...
...
...
...
...
Hib3
94
92
94
95
96
94
91
91
...
...
...
MCV
91
93
93
96
92
91
90
97
97
97
94
Pol3
93
92
94
95
95
94
92
91
94
95
93
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
346
340
100
100
below 50%
27
12
69
86
40
62

...
90
at 80% or above

...
year
target age group
coverage (%)
2007
19-29 y
92.3
BCG birth
MMR
12 months; 6 years
DT
7 years
OPV
2, 4, 6, 18 months
DTwP
4 years
Pneumo_conj

DTwPHibHep
Influenza

2, 4, 6 months
6-23 months; >60 years;
high-risk groups
Pneumo_ps
2, 4, 6 months;
high-risk groups
65 years
35
China
2011
Births............................................................................................................................. 16,364
Surviving infants......................................................................................................... 16,032
Total population..................................................................................................... 1,347,565

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
99
97
94
92
86
84
79
99
...
DTP1
99
99
99
99
99
99
95
94
93
98
...
DTP3
99
99
99
97
93
93
87
85
80
97
...
HepB3
99
99
99
95
92
91
84
60
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
99
99
99
97
94
93
86
84
80
98
...
Pol3
99
99
99
99
94
94
87
86
82
98
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
3,092 3,092
99
98
99
98
98
97

88
88
below 50%

at 80% or above

99

year
2010
target age group
coverage (%)
8 m-4 y
95
BCG birth
MenA
DT
MenAC
6 years
DTaP
3, 4, 5, 18 months
HepA
18 months
HepB
birth; 1, 6 months
JE
8 months; 2 years
36
MMR
MR
OPV

3, 6 years
18 months
8 months
Colombia
2011
Births.................................................................................................................................. 910

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
83
84
90
93
93
96
94
91
99
95
45
DTP1
95
96
97
97
97
97
97
91
95
96
39
DTP3
85
88
92
92
93
93
93
79
85
88
16
HepB3
85
88
92
92
93
93
93
78
71
...
...
Hib3
85
88
92
92
93
93
93
65
...
...
...
MCV
88
88
95
92
95
95
94
80
82
82
13
Pol3
85
88
92
92
93
94
93
82
87
93
16
PAB
79
79
78
78
78
77
77
70
64
45

2011 2010
1,123 1,123
100

below 50%
100
15
10
43
41
42
49
32
32

87
91
at 80% or above

82
year
2010
target age group
1-8 y
coverage (%)
94
BCG birth
DT
DTwP
18 months; 5 years
DTwPHibHep
2, 4, 6 months
HepA subnational
HepB birth
Influenza
6-23 months; +4 weeks;

18-23 months; >60 years
IPV
2, 4, 6, 18 months;

5 years (immunocompromised)
MMR
1, 5 years
MR
10-19 years (subnational)
OPV
Pneumo_conj
2, 4, 12 months
Rotavirus
2, 4 months
Td

+1, +1 year (CBAW and pregnancy)
Yellow fever
1 year; 60; travellers;

high-risk areas
37
Comoros
2011
Births.................................................................................................................................... 28

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
76
76
80
81
77
84
80
90
95
99
...
DTP1
94
81
89
85
79
78
77
85
91
97
...
DTP3
83
74
83
81
75
69
68
70
75
94
...
HepB3
83
74
83
81
75
69
68
...
...
...
...
Hib3
83
74
38
...
...
...
...
...
...
...
...
MCV
72
72
79
76
65
66
67
70
69
87
...
Pol3
85
82
84
81
75
69
67
70
78
94
...
PAB
85
85
83
83
89
88
91
57
67
78
...

2011 2010

17
17
100
100
24
59
71
35
53
18

71
53
below 50%
at 80% or above

...

year
2010
target age group
coverage (%)
6-47 m
84
BCG birth
DTwPHibHep
Measles
OPV
38
6, 10, 14 weeks
9 months
TT


+1, +6 months; +1, +1 year
Vitamin A 6, 12, 18, 24, 30, 36 months
Congo
2011
Births.................................................................................................................................. 145

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
95
95
90
93
86
84
73
50
58
90
92
DTP1
90
90
92
93
80
81
73
45
74
92
67
DTP3
90
90
91
89
80
79
65
33
50
79
42
HepB3
90
90
91
89
80
...
...
...
...
...
...
Hib3
90
90
91
...
...
...
...
...
...
...
...
MCV
90
90
76
79
67
66
56
34
38
75
49
Pol3
90
90
91
89
80
79
65
31
50
80
42
PAB
83
83
82
82
82
81
75
67
73
60
...

2011 2010


below 50%
30
30
100
100
23
33
73
63
37
17

63
93
at 80% or above

...
year
2011
target age group
coverage (%)
9 m-2 y
78
BCG birth
Rotavirus
DTwPHibHep
TT
Measles
OPV
Pneumo_conj

2, 3, 4 months
36 weeks
1st contact pregnancy; +4 weeks
Vitamin A
36 weeks
Yellow fever
36 weeks
8, 12, 16 weeks
(subnational)
39
Congo, Democratic Republic of the

2011
Births............................................................................................................................... 2,912

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
67
86
85
78
80
72
72
57
34
65
57
DTP1
79
68
82
73
78
71
68
49
47
60
...
DTP3
70
58
72
65
70
62
60
40
23
35
...
HepB3
70
58
72
65
70
...
...
...
...
...
...
Hib3
70
58
72
...
...
...
...
...
...
...
...
MCV
71
73
72
64
68
63
61
46
27
38
18
Pol3
78
76
78
64
72
62
60
42
24
34
15
PAB
70
77
85
75
70
66
67
45
42
53
...

2011 2010
509
508
100
100
below 50%
27
42
69
48
39
44

67
44
at 80% or above

...

year
2010
target age group
coverage (%)
6-59 m
103
BCG birth
Rotavirus 6, 10, 14 weeks (subnational)
DTwPHibHep
TT

Measles
OPV
Pneumo_conj
40
6, 10, 14 weeks
9 months
6, 10, 14 weeks

+1, +6 months; +1, +1 year
Vitamin A

Yellow fever
6, +6 months; every
6 months to 59 months
9 months
Cook Islands
2011
Births.................................................................................................................................... ...

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
98
99
99
99
99
99
99
99
96
99
29
DTP1
98
99
99
99
99
99
99
99
97
97
65
DTP3
93
99
82
99
99
99
99
92
93
93
40
HepB3
93
99
82
99
99
99
99
98
85
71
...
Hib3
93
99
82
...
...
...
...
...
...
...
...
MCV
89
99
78
95
98
99
99
76
96
67
...
Pol3
93
99
82
99
99
99
99
92
93
83
39
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010


below 50%
28
100
100
100
100
100

...
100

at 80% or above

96
year
2006
target age group
coverage (%)
1-35 y
90
BCG birth
MR
DTwP
OPV
DTwPHibHep
4 years
9 years; +2, +6 months

15 months; 4 years
6 weeks; 3, 5 months
Td
6 weeks; 3, 5, months
HepB birth
TT
11 years
41
Costa Rica
2011
Births.................................................................................................................................... 73

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
78
79
81
90
91
87
88
92
99
92
80
DTP1
87
97
91
90
90
89
97
90
95
98
95
DTP3
85
91
86
90
89
89
91
88
85
95
86
HepB3
84
89
87
89
89
88
90
89
...
...
...
Hib3
81
93
87
87
88
88
89
92
...
...
...
MCV
83
85
81
89
90
90
89
82
91
90
60
Pol3
82
96
80
89
89
89
91
80
86
95
86
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010

81
81
100
100
28
14
67
86
46
59

...
100
below 50%
at 80% or above

...

year
2002
target age group
1-4 y
coverage (%)
86
BCG birth
Pneumo_conj
2, 4, 15 months
DTaPHibIPV
Pneumo_ps 65 years; high-risk groups
DTaPIPV
2, 4, 6, 15 months
4 years
Td
HepB birth; 2, 6 months; high-risk areas
TdaP post-partum
Influenza
Varicella
MMR
42

15 months; 7 years
15 months
Cte dIvoire
2011
Births.................................................................................................................................. 679

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
74
91
95
91
94
77
85
80
69
62
...
DTP1
75
95
95
89
93
95
83
85
64
77
...
DTP3
62
85
81
74
76
77
76
65
52
54
...
HepB3
62
85
81
74
76
77
76
...
...
...
...
Hib3
62
85
81
...
...
...
...
...
...
...
...
MCV
49
70
67
63
67
73
84
68
57
56
...
Pol3
58
81
77
58
75
76
87
66
46
56
...
PAB
82
82
92
92
74
75
75
76
36
36
...

2011 2010
102
83
100
100
below 50%
28
58
35
14
64
26
47
at 80% or above


...
year
2011
target age group
coverage (%)
9-59 m
95
BCG birth
DTwPHibHep
Measles
OPV
6, 10, 14 weeks
9 months
TT

pregnancy; 1st contact;

+1, +6 months; +1, +1 year
Vitamin A 6, 12, 18, 24, 30, 36 months

Yellow fever
9 months
43
Croatia
2011
Births.................................................................................................................................... 43

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
98
99
99
99
99
98
98
99
...
...
DTP1
97
97
97
97
96
96
96
95
96
...
...
DTP3
96
97
96
96
96
96
96
93
90
...
...
HepB3
97
97
97
97
95
...
...
...
...
...
...
Hib3
96
97
96
96
96
96
96
...
...
...
...
MCV
96
96
95
98
96
95
96
93
92
...
...
Pol3
96
97
96
96
96
96
96
94
90
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010

113
...
19
...
...
...
19
...
19
...

...
...
below 50%

at 80% or above

...
year
...
target age group
...
coverage (%)
...
BCG birth
IPV
DTaP
MMR
4 years
DTaPHibIPV
HepB
44
7, 14 years
1, 6 years
Td
7, 14, 18 years
birth; 2, 6 months; catch up
TT
60 years
Cuba
2011
Births.................................................................................................................................. 110

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
99
99
99
99
99
99
99
98
99
DTP1
96
96
98
96
97
98
99
98
99
97
86
DTP3
96
96
96
95
93
89
89
95
99
92
67
HepB3
96
96
96
95
93
89
95
98
99
...
...
Hib3
96
96
96
97
97
97
94
99
...
...
...
MCV
99
99
99
98
97
96
98
94
99
94
48
Pol3
99
99
99
99
99
99
99
98
95
94
99
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
168
169
100
100
below 50%

at 80% or above

12
100
85
94
88
100
...

95
year
target age group
coverage (%)
2007
12-24 y
96.7
BCG birth
DT
DTwP
DTwPHibHep
6 years
18 months
2, 4, 6 months
HepB birth
Hib
MenBC
MMR
OPV
TT
Typhoid
3, 5 months
1, 6 years
<1, 1, 2, 9 years
15 years
10, 13, 16 years
18 months
45
Cyprus
2011
Births.................................................................................................................................... 13

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
DTP1
99
99
99
98
98
98
98
98
98
97
59
DTP3
99
99
99
97
97
97
98
97
96
93
34
HepB3
96
96
96
93
93
93
88
89
68
...
...
Hib3
96
96
96
90
90
90
58
32
...
...
...
MCV
87
87
87
87
87
87
86
86
83
77
29
Pol3
99
99
99
97
97
97
98
97
96
94
35
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010

83
83
83
83
33
33

...
100
below 50%

at 80% or above

...

year
2011
target age group
coverage (%)
school-age
2
BCG
DTaPHibHepIPV
children of carriers
Hib
2, 4, 6, 12-18 months
2, 4 months
IPV
2, 4, 6, 15-18 months; 4-6 years
DTaPHibIPV
2, 4, 6, 15-18 months
MMR
DTaPIPV

2, 4, 6, 15-18 months;
4-6 years
Pneumo_conj
HepA

HepB
46
24, 32-36 months; high-risk

groups (public sector)
2, 4, 8-12 months
13-15 months; 4-6 years

2, 4, 6, 12-15 months
Pneumo_ps national
Rabies
Td
(if indicated)
14-16 years; +every 10 years
Czech Republic
2011
Births.................................................................................................................................. 116

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
...
...
98
99
99
99
99
98
95
...
...
DTP1
99
99
99
99
99
99
99
99
98
...
...
DTP3
99
99
99
99
99
98
97
98
96
...
...
HepB3
99
99
99
99
99
98
99
...
...
...
...
Hib3
99
99
99
99
99
97
97
...
...
...
...
MCV
98
98
98
97
98
98
97
98
96
...
...
Pol3
99
99
99
99
99
98
96
98
98
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
86
86
...
100
below 50%
...
...
...
100
...
100

...
100
at 80% or above

98
year
...
target age group
...
coverage (%)
...
DTaP
DTaPHibHepIPV

DTaPIPV
HepB
Influenza
5 years
9, 13, 17 weeks;
18 months
10 years
12 years (3 doses)
MMR
Pneumo_conj
Pneumo_ps
TT
15, 21 months
4, 5, 6, 11-18 months
3, 4, 5 months
25 years
>65 years
47
Denmark
2011
Births.................................................................................................................................... 64

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
94
93
90
89
87
93
93
98
97
98
97
DTP3
91
90
89
88
87
93
93
97
90
90
88
HepB3
...
...
...
...
...
...
...
...
...
...
...
Hib3
91
90
89
88
87
93
93
95
78
...
...
MCV
87
85
84
87
89
90
95
99
88
84
...
Pol3
91
90
89
88
87
93
93
97
97
99
99
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010

11
11
100
100
100
100
64

...
...
below 50%

at 80% or above

86

year
...
target age group
...
coverage (%)
...
DTaPHibIPV
DTaPIPV
3, 5, 12 months
5 years
HepB birth; 1, 2, 12 months (neonates

of HBsAg positive mothers)
48
HPV

MMR
12 years; +2, +6 months;

12-15 (females)
15 months; 4 years; 12 years
Pneumo_conj
3, 5, 12 months
Djibouti
2011
Births.................................................................................................................................... 26

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
89
90
90
90
90
88
80
34
51
81
...
DTP1
89
90
90
90
92
76
73
66
66
95
...
DTP3
87
88
89
89
88
72
71
46
41
85
...
HepB3
87
88
89
88
25
...
...
...
...
...
...
Hib3
87
88
89
89
25
...
...
...
...
...
...
MCV
84
85
84
73
74
67
65
50
41
85
...
Pol3
87
88
89
89
88
72
71
46
41
85
...
PAB
79
79
77
79
79
77
71
46
62
80
...

2011 2010


below 50%
100
100
17
33
83
67
17

83
83
at 80% or above

85
year
2011
target age group
coverage (%)
9-24 m
86
BCG birth
OPV
DT subnational
Pneumo_ps subnational
DTwP
DTwPHibHep
HepB
Measles
15 months
6, 10, 14 weeks
9, 15 months
TT

Vitamin A

+1, +1 year
6, 12, 15 months
49
Dominica
2011
Births.................................................................................................................................... ...

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
99
98
90
99
98
99
99
99
65
DTP1
99
99
99
96
98
98
99
99
99
97
84
DTP3
98
98
99
96
96
95
98
99
99
92
63
HepB3
98
98
99
96
93
...
...
...
...
...
Hib3
98
98
99
96
93
...
...
...
...
...
MCV
99
99
99
99
96
97
98
99
99
88
...
Pol3
99
99
99
95
93
96
98
99
99
94
53
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010


below 50%

at 80% or above

100
100
100
100
86
100
100
100

105

year
...
target age group
...
coverage (%)
...
BCG
DT

birth-2 months
2, 4, 6 months; infants with
seizure disorders
DTwP
DTwPHibHep
HepB
50

2, 4, 6 months
Influenza

MMR
OPV
Td
6 months to 5 years;
1, 3 years
2, 4, 6, 18 months; 3-5, 11 years

11 years
Dominican Republic
2011
Births.................................................................................................................................. 216

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
98
98
96
92
92
95
96
90
90
70
29
DTP1
91
96
85
90
87
93
92
91
89
87
61
DTP3
84
88
82
85
87
89
87
78
72
69
36
HepB3
80
84
85
88
81
84
87
68
...
...
...
Hib3
71
81
77
79
65
77
87
...
...
...
...
MCV
79
79
79
79
79
79
81
84
78
70
30
Pol3
84
86
85
87
80
88
86
74
70
90
46
PAB
90
87
86
86
85
85
75
48
82
60
23

2011 2010
155
155
100
100
below 50%
10
46
34
44
60
36
32

63
80
at 80% or above

...
year
2010
target age group
1-8 y
coverage (%)
97
BCG birth
DTwP
18 months; 4 years
DTwPHibHep
2, 4, 6 months
HepB birth; +1, +6 months; high-risk groups
HPV
adolescents (subnational)
Influenza
pregnancy; 6, 12, 24 months;

MenAC
2 years
MenACWY
high-risk groups
MenC_conj
2 years
MMR
1 year
MR subnational (in case of MMR stock-outs)

OPV
Pneumo_conj
2, 4, 6, 12 months;

high-risk groups
Pneumo_ps
65 years
Td
CBAW and pregnancy; 7, 10, 20, 30,

40, 50 years
Typhoid
Vitamin A
6, 12, 18, 24 months
Yellow fever
travellers
51
Ecuador
2011
Births.................................................................................................................................. 298

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
99
99
99
99
99
99
99
89
76
DTP1
99
99
99
99
99
99
98
93
94
87
31
DTP3
99
99
99
99
99
98
94
88
83
68
10
HepB3
98
98
98
98
98
98
94
38
...
...
...
Hib3
99
99
99
99
99
98
94
...
...
...
...
MCV
98
98
98
98
98
97
93
99
81
60
24
Pol3
99
99
99
99
99
97
93
84
82
67
19
PAB
85
74
73
73
72
72
65
42
33
82

2011 2010

171
170
99
100
16
14
83
86
47
77

77
98
below 50%
at 80% or above

92

year
2011
target age group
7y
coverage (%)
107
OPV
Pneumo_conj
Pneumo_ps
Rotavirus
Td
Varicella
Yellow fever

2, 4, 6, 18 months
2, 4 months; 1 year
65 years
2, 4 months
CBAW and pregnancy
6, 10 years
12-23 months;
+every 10 years
DTwPHibHep
2, 4, 6 months
HepB
11 years (3 doses);

high-risk groups
Influenza 6 months-4 years; 65 years;

high-risk groups
MenBC
1st contact; +30 days;

high-risk groups
MMR
1, 6 years
MR
52
Egypt
2011
Births............................................................................................................................... 1,886

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
98
98
98
98
98
99
98
98
93
89
50
DTP1
97
97
97
98
98
98
98
98
96
95
80
DTP3
96
97
97
97
98
98
98
98
88
87
57
HepB3
96
97
97
97
98
98
98
98
74
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
96
96
95
92
97
98
98
98
89
86
41
Pol3
96
97
97
97
98
98
98
98
90
87
67
PAB
86
86
85
85
85
86
85
80
76
74
...

2011 2010
273
273
100
100
below 50%

at 80% or above

97
98
94
95
100
100

97
year
2009
target age group
coverage (%)
2-11 y
104
BCG
DT
DTwP
1 week
2, 4, 6, 18 months
18 months
MenAC
3, 6, 12, 15 years
MMR
OPV
12, 18 months
birth; 2, 4, 6, 9,12, 18 months
DTwPHep
2, 4, 6 months
Td
6, 10 years
HepB
2, 4, 6 months
TT
CBAW, +2, +6 months; +1, +1 year
Influenza
high-risk groups
Vitamin A
9, 18 months
53
El Salvador
2011
Births.................................................................................................................................. 126

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
91
91
87
99
99
93
84
99
99
75
56
DTP1
90
97
97
99
99
98
96
99
99
93
69
DTP3
89
92
91
98
99
96
89
99
99
80
44
HepB3
90
92
91
98
99
96
89
99
...
...
...
Hib3
90
92
91
98
99
96
89
...
...
...
...
MCV
89
92
95
95
99
98
99
97
93
98
45
Pol3
89
92
91
98
99
96
89
98
94
80
42
PAB
88
88
87
87
87
91
92
83
67
37
23

2011 2010
262
262
100
100
21
27
77
71
55
50

86
90
below 50%
at 80% or above

81

year
2008
target age group
coverage (%)
12-18 y
98.1
BCG birth
MMR
DT
OPV
DTwP
DTwPHibHep
DT contraindication
1, 4 years
2, 4, 6, 15-18 months
Pneumo_conj
Rotavirus
Influenza

Td
IPV

54
2, 4, 6, 12 months;
4 years (HIV-exposed)
2, 4, 12 months
Pneumo_ps 60 years; health workers
HepB health workers; high-risk groups

6-59 months; pregnancy;
elderly; high-risk groups
1, 4 years
2, 4 months
CBAW and pregnancy
Equatorial Guinea
2011
Births.................................................................................................................................... 26

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
73
73
73
73
73
73
73
73
99
94
...
DTP1
65
65
65
65
65
65
65
65
94
96
...
DTP3
33
33
33
33
33
33
33
33
79
77
...
HepB3
...
...
...
...
...
...
...
...
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
51
51
51
51
51
51
51
51
81
88
...
Pol3
39
39
39
39
39
39
39
39
79
75
...
PAB
75
75
75
69
62
59
59
61
75
58
...

2011 2010


below 50%
18
18
100
94
67
78
17
17
17
11
at 80% or above


...
year
target age group
coverage (%)
2011
9-47 m
50
BCG birth
OPV birth; 6, 10, 14 weeks; 15 months
DTwP
TT
1, 2, 6 months; 1, 2 years;
pregnancy
Measles
6, 10, 14 weeks; 15 months

9 months
55
Eritrea
2011
Births.................................................................................................................................. 193

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
99
99
99
99
99
89
68
...
...
DTP1
99
99
99
99
99
99
99
88
68
...
...
DTP3
99
99
99
99
96
96
96
81
58
...
...
HepB3
99
99
99
99
96
96
96
...
...
...
...
Hib3
99
99
99
99
...
...
...
...
...
...
...
MCV
99
99
95
95
95
95
95
76
58
...
...
Pol3
99
99
99
99
96
96
96
82
58
...
...
PAB
93
93
86
86
85
85
84
80
17
...
...

2011 2010

58
58
100
100
12
34
33
53
55
12
28

71
97
below 50%
at 80% or above

...

year
2009
target age group
coverage (%)
9-47 m
82
BCG birth
DTwPHibHep
Measles
OPV
56
6, 10, 14 weeks
9 months
TT


+1, +6 months; +1, +1 year
Vitamin A 6, 12, 18, 24, 30, 36 months
Estonia
2011
Births.................................................................................................................................... 16

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
97
97
98
98
99
99
99
99
...
...
DTP1
96
96
97
97
98
98
99
96
94
...
...
DTP3
93
94
95
95
95
95
96
93
82
...
...
HepB3
94
94
95
94
95
95
95
...
...
...
...
Hib3
93
94
95
95
95
88
37
...
...
...
...
MCV
94
95
95
95
96
96
96
93
81
...
...
Pol3
93
94
95
95
95
95
96
93
80
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
15

below 50%
16
100
...
...
100
...
100
...

100
...
at 80% or above

95
year
...
target age group
...
coverage (%)
...
BCG
1-5 days
DT

3, 4.5, 6 months; 2, 6-7 years

DTaPHibIPV
DTaPIPV
HepB

Hib

3, 4.5, 6 months; 2 years

6-7 years
birth; 1, 6 months; or 12 years;

+1, +6 months
IPV

MMR
3, 4.5, 6 months; 2, 6-7 years

1, 13 years
Td
TdaP

15-17 years; subnational
3, 4.5, 6 months; 2 years

57
Ethiopia
2011
Births............................................................................................................................... 2,613

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
69
69
76
81
72
72
67
51
61
64
...
DTP1
61
64
61
64
59
60
59
47
80
73
...
DTP3
51
50
44
49
42
42
42
27
57
49
...
HepB3
51
50
44
49
42
...
...
...
...
...
...
Hib3
51
50
44
49
42
...
...
...
...
...
...
MCV
57
56
51
50
42
41
38
33
38
38
Pol3
62
61
52
54
51
51
50
53
65
49
PAB
88
88
88
84
83
82
80
54
34
24
...

2011 2010

97
98
100
100
23
12
26
33
52
55
30
26

68
58
below 50%
at 80% or above

...

year
2011
target age group
coverage (%)
96
BCG birth
Pneumo_conj
6, 10, 14 weeks
DTwPHibHep
TT

6 m-14 y
Measles
OPV
58
6, 10, 14 weeks
9 months
6, 10, 14 weeks

+1, +6 months; +1, +2, +3 year
Vitamin A
9 months
Fiji
2011
Births.................................................................................................................................... 18

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
99
99
99
99
98
96
99
99
95
DTP1
99
99
99
99
99
99
99
97
98
98
87
DTP3
99
99
99
99
99
98
96
90
97
97
68
HepB3
99
99
99
99
99
99
99
98
82
...
...
Hib3
99
99
99
99
99
99
99
98
...
...
...
MCV
94
94
94
94
94
92
90
81
94
84
32
Pol3
99
99
99
99
99
98
97
91
99
96
55
PAB
94
94
94
94
94
93
93
84
76
...

2011 2010
19
20
...
100
below 50%
...
...
15
...
85
...
75

...
at 80% or above

...
year
target age group
coverage (%)
2012
6-59 m
67
BCG birth
OPV
DTwPHibHep
6, 10, 14 weeks
HepB birth
HPV subnational
TT
MR
6, 12 years
12 months; 6 years
59
Finland
2011
Births.................................................................................................................................... 61

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
...
...
...
...
...
98
98
99
99
91
90
DTP1
99
99
99
99
99
99
99
99
99
96
97
DTP3
99
99
99
99
99
97
97
99
99
90
92
HepB3
...
...
...
...
...
...
...
...
...
...
...
Hib3
99
99
98
98
97
98
98
96
94
...
...
MCV
97
98
98
97
98
97
97
96
98
97
...
Pol3
99
99
99
97
97
97
97
96
99
90
90
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
...
...
...
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above

...
year
...
target age group
...
coverage (%)
...
BCG
>7 years (high-risk groups)
DTaPHibIPV
3, 5, 12 months
DTaPIPV
4 years
HepA
high-risk groups
HepAHepB
high-risk groups
HepB
high-risk groups
Influenza
6-35 months; 65 years;

pregnancy; health workers;

high-risk groups
IPV travellers
60
MenACWY
military; outbreaks
MMR
14-18 months; 6 years
Pneumo_conj
3, 5, 12 months;

<5 years (high-risk groups)
Pneumo_ps
2-4 years; high-risk groups
Rotavirus
2, 3, 5 months
TBE
>3 years (subnational)
Td
every 10 years
TdaP
14-15 years
France
2011
Births.................................................................................................................................. 792

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
...
...
...
...
78
83
81
83
83
74
80
DTP1
99
99
99
99
99
99
99
99
98
97
92
DTP3
99
99
98
98
98
99
98
97
96
94
79
HepB3
65
65
51
47
42
39
35
26
...
...
...
Hib3
97
97
97
97
97
97
97
86
...
...
...
MCV
89
89
89
89
90
89
87
84
83
71
...
Pol3
99
99
98
98
99
99
98
98
97
95
80
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
101
100
...
...
...
...
...
...
...
...
...

...
...

below 50%
at 80% or above

...
year
...
target age group
...
coverage (%)
...
BCG
birth; infants (high-risk groups)
DT
DTaPHibHepIPV
DTaPHibIPV
DTaPIPV
6 years
2, 4, 16-18 months
3 months
11-13, 26-28 years
HPV

MenC_conj
14 years + 2 months,
+ 6 months (females)
1 year
MMR
12, >13 months
Pneumo_conj
2, 4, 12 months
Yellow fever
1 year (subnational)
61
Gabon
2011
Births.................................................................................................................................... 42

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
89
89
89
89
89
89
89
89
90
96
...
DTP1
69
69
69
69
69
69
69
69
81
96
...
DTP3
45
45
45
45
45
45
45
45
70
78
...
HepB3
45
45
45
45
45
45
45
...
...
...
...
Hib3
45
45
...
...
...
...
...
...
...
...
...
MCV
55
55
55
55
55
55
55
55
57
76
...
Pol3
44
44
44
44
44
44
44
44
70
78
...
PAB
75
75
75
73
67
63
58
39
53
84
...

2011 2010

51
51
100
100
35
33
37
45
27
22
47
below 50%
at 80% or above


...

year
2007
target age group
coverage (%)
9-59 m
83
BCG birth
DTwPHibHep
Measles
OPV
62
6, 10, 14 weeks
9 months
TT


+1, +6 months; +1, +1 year
Vitamin A
6 months
Yellow fever
9 months
Gambia
2011
Births.................................................................................................................................... 67

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
90
92
94
95
97
97
99
99
99
98
85
DTP1
99
99
98
97
98
95
95
97
99
98
89
DTP3
96
97
98
96
95
95
95
80
96
92
63
HepB3
96
97
98
98
98
96
95
91
87
...
...
Hib3
96
97
98
96
95
95
95
90
...
...
...
MCV
91
92
96
92
88
89
91
89
91
86
69
Pol3
95
97
97
96
94
94
94
84
98
94
53
PAB
91
91
91
91
90
94
89
92
92
85
...

2011 2010


below 50%

at 80% or above

100
100
100
100
67
83
100
...

...
year
2011
target age group
coverage (%)
9-59 m
95
BCG birth
OPV
DTwP
Pneumo_conj
DTwPHibHep
1 year (after 3rd dose)

2, 3, 4 months
HepB birth
Measles
9 months
TT

birth; 2, 3, 4, 9, 18 months
2, 3, 4 months

+1, +2 year
Yellow fever
9 months
63
Georgia
2011
Births.................................................................................................................................... 51

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
96
96
95
95
96
95
95
95
70
...
...
DTP1
95
99
99
99
99
99
94
89
91
...
...
DTP3
94
91
88
92
98
87
84
80
79
...
...
HepB3
92
95
54
89
94
83
74
55
...
...
...
Hib3
92
67
...
...
...
...
...
...
...
...
...
MCV
94
94
83
96
97
95
92
73
61
...
...
Pol3
90
88
93
90
88
88
84
81
82
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010


below 50%
65
65
100
97
12
95
85
74
75

80
60

at 80% or above

77

year
2008
target age group
coverage (%)
6-27 y
50
BCG
DT
DTwP
DTwPHibHep
0-5 days
MMR
5 years
OPV
18 months
2, 3, 4, months
HepB birth
64
1, 5 years
Td
14 years
Germany
2011
Births.................................................................................................................................. 699

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
99
99
99
99
99
99
99
96
92
93
...
DTP3
99
99
99
99
99
99
99
90
78
80
...
HepB3
93
96
96
96
93
92
90
84
45
...
...
Hib3
93
94
94
93
94
94
94
94
85
...
...
MCV
99
99
99
98
97
97
96
92
92
75
25
Pol3
95
96
96
97
98
97
95
94
95
80
80
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
412
412
...
...
...
...
...
...
...
...

...
...

below 50%
at 80% or above

92
year
...
target age group
...
coverage (%)
...
DTaP
2, 3, 4, 11-14 months
MMR 11-14, 15-23 months (subnational)
DTaPHibHepIPV
2, 3, 4, 11-14 months
MMRV
11-14, 15-23 months
DTaPHibIPV
2, 3, 4, 11-14 months
Pneumo_conj
2, 3, 4, 11-14 months
HepB
HPV
2, 4, 11-14 months
12-17 years (3 doses, females)
Influenza
MenC_conj
>60 years annually

11-14 months
Pneumo_ps
TdaP
>60 years
5-6, 9-17 years; +every 10 years
TdaPIPV 9-17 years (acellular pertussis)

Varicella
11-14, 15-23 months
65
Ghana
2011
Births.................................................................................................................................. 776

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
98
99
99
99
99
99
99
99
87
71
...
DTP1
94
96
96
96
96
87
88
96
88
80
27
DTP3
91
94
94
93
94
84
84
88
70
58
HepB3
91
94
94
93
94
84
84
...
...
...
...
Hib3
91
94
94
93
94
84
84
...
...
...
...
MCV
91
93
93
86
95
85
83
90
70
61
16
Pol3
91
94
94
92
94
84
85
88
71
57
PAB
88
86
86
86
86
85
83
69
68
60

2011 2010
170
170
100
100
15
21
85
79
60
54

87
82
below 50%
at 80% or above

...

year
2010
target age group
coverage (%)
9-59 m
93
BCG birth
DTwPHibHep
Measles
OPV
66
6, 10, 14 weeks
9 months
6, 10, 14 weeks
TT


+1, +6 months; +1, +1 year
Vitamin A 6, 12, 18, 24, 30, 36 months

Yellow fever
9 months
Greece
2011
Births.................................................................................................................................. 117

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
91
91
91
91
91
91
90
88
50
86
95
DTP1
99
99
99
99
99
99
96
96
96
77
89
DTP3
99
99
99
99
99
98
96
89
90
54
72
HepB3
95
95
95
95
95
94
93
89
12
...
...
Hib3
83
83
83
83
83
84
84
87
19
...
...
MCV
99
99
99
99
99
98
96
89
70
76
...
Pol3
99
99
99
99
99
98
96
89
95
96
90
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
54
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above
54

...
year
...
target age group
...
coverage (%)
...
BCG
6 years
DTaP

2, 4, 6, 15-18 months; 4-6 years

(or vaccine combination)
HepA
>12 months; +6 months
HepB
Hib
HPV
IPV
MenACWY
2, 4, 6-18 months
MenC_conj
MMR
Pneumo_conj

Pneumo_ps
2, 4, 6, 12-15 months
Td
TdaP
2, 4, 6-18 months; 4-6 years
2, 4, 6-71 months
2, 4, 6, 12-15 months;
2-3 years
10 years after TdaP; +every 10 years
Varicella
11-12 years
11-18 years
67
Grenada
2011
Births...................................................................................................................................... 2

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
98
99
99
99
98
97
99
99
98
93
50
DTP3
94
97
99
99
96
91
99
97
95
80
25
HepB3
94
97
99
99
96
91
99
...
...
...
...
Hib3
94
97
99
99
96
91
99
33
...
...
...
MCV
95
95
98
99
98
98
99
92
88
85
...
Pol3
95
94
99
99
96
91
99
97
77
69
32
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010

100
100
14
86
100
71
57

...
...
below 50%
at 80% or above

85

year
...
target age group
...
coverage (%)
...
DT
DTwP
DTwPHibHep
HepB

4-5 years
18 months
6-8, 16-20, 24-28 weeks
>18 years (3 doses);
high-risk groups
Influenza

MMR
OPV

Td
68
6 months; 7 months;
high-risk groups
12, 18 months; adults
6-8, 16-20, 24-28 weeks;
18 months; 4-5, >14 years
>7 years (2 doses)
Guatemala
2011
Births.................................................................................................................................. 473

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
89
99
93
99
88
96
96
95
79
62
36
DTP1
91
96
94
99
88
95
97
94
91
86
68
DTP3
85
94
92
95
85
89
87
81
77
66
43
HepB3
85
94
92
95
85
89
87
...
...
...
...
Hib3
85
94
92
95
85
89
87
...
...
...
...
MCV
87
93
92
96
86
95
93
86
83
68
23
Pol3
86
94
92
96
85
90
87
80
80
74
43
PAB
85
85
71
71
71
70
70
67
55
44

2011 2010
335
332
100
100
below 50%
25
19
73
80
26
64

68
83
at 80% or above

...
year
2008
target age group
1-7 y
coverage (%)
89
BCG birth
OPV
DTwP
Pneumo_conj

DTwPHibHep
18 months; 4 years
2, 4, 6 months
HepB birth
Influenza
MMR
MR
high-risk groups
1 year
Rotavirus
Td

Vitamin A
2, 4 months; 1 year
(subnational)
2, 4 months
+1, +1 year or +10, +10 years
6-59, 12-59 months
>14 years
69
Guinea
2011
Births.................................................................................................................................. 394

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
93
93
91
87
84
81
80
81
78
50
...
DTP1
86
86
76
64
76
75
75
61
77
40
...
DTP3
59
64
57
60
63
57
59
47
54
17
...
HepB3
59
64
57
57
57
...
...
...
...
...
...
Hib3
59
64
57
...
...
...
...
...
...
...
...
MCV
58
58
53
55
57
51
51
42
61
35
...
Pol3
57
62
60
59
46
53
59
47
54
18
...
PAB
80
90
96
96
95
95
90
79
68
27
...

2011 2010

38
38
100
97
13
26
87
71
71
39

68
...
below 50%
at 80% or above

0

year
2009
target age group
coverage (%)
9-59 m
101
BCG birth
TT
DTwPHibHep
Vitamin A
Measles
OPV
70
6, 10, 14 weeks
9 months
Yellow fever
1st contact; +1 month

6, 12 weeks; 6-59 months
9 months
Guinea-Bissau
2011
Births.................................................................................................................................... 59

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
93
93
93
92
91
90
89
77
92
90
...
DTP1
92
92
92
91
89
88
86
71
70
82
...
DTP3
76
76
76
74
72
70
68
49
45
61
...
HepB3
76
76
76
...
...
...
...
...
...
...
...
Hib3
76
76
76
...
...
...
...
...
...
...
...
MCV
61
61
61
65
69
72
76
71
45
53
...
Pol3
73
73
73
73
73
72
72
52
45
60
...
PAB
80
78
94
94
92
69
65
49
68
40
...

2011 2010
11
11
82
100
below 50%
18
64
91
45
36

27
at 80% or above

...
year
2009
target age group
coverage (%)
9-59 m
101
BCG birth
DTwPHibHep
Measles
OPV
6, 10, 14 weeks
9 months
TT


+1, +1 year
Vitamin A
Yellow fever
6 months (2 doses)
9 months
71
Guyana
2011
Births.................................................................................................................................... 13

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
97
98
98
96
97
96
96
93
93
85
68
DTP1
97
99
99
94
96
95
93
97
95
94
60
DTP3
93
95
98
93
94
93
93
88
86
83
35
HepB3
93
95
98
93
94
93
93
...
...
...
...
Hib3
93
95
98
93
94
93
93
...
...
...
...
MCV
98
95
97
95
96
90
92
86
77
73
...
Pol3
93
95
97
93
94
92
93
79
87
79
42
PAB
90
97
90
90
91
92
91
82
71
56
...

2011 2010
13

below 50%
13
100
...
...
92
...
92
...

92
...
at 80% or above

...

year
2007
target age group
coverage (%)
0-59 m
95
BCG
2 months
DTP
18, 45 months
DTwPHibHep
HepB
HIB
2, 4, 6 months

2, 4, 6 months
HPV


high-risk groups (subnational)
IPV

2, 4, 6, 18 months; 3 years;
72
MMR
12, 45 months
OPV
Pneumo_conj
2, 4, 6 months
Rotavirus
2, 4, 6 months
Td
15 years; pregnancy; adults
Yellow fever
1, 10 years
Haiti
2011
Births.................................................................................................................................. 266

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
75
75
75
75
75
75
75
72
74
72
...
DTP1
83
83
83
83
83
83
83
77
75
66
21
DTP3
59
59
59
59
59
59
59
49
42
41
HepB3
...
...
...
...
...
...
...
...
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
59
59
59
59
59
59
59
55
49
31
...
Pol3
59
59
59
59
59
59
59
50
42
40
PAB
70
70
70
50
43
31
37
41
41
39
14

2011 2010
141
133
100
100
below 50%
18
12
33
20
50
68
16
46

...
...
at 80% or above

...
year
target age group
coverage (%)
2008
1-19 y
103
BCG birth
DTwP
6, 10, 14 weeks
DTwPHibHep subnational
MR
OPV
9 months
Td

1st contact; +4 weeks; +6 months;

+1, +1 years
Vitamin A
6 months; 1 year
73
Honduras
2011
Births.................................................................................................................................. 205

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
99
99
99
97
98
99
97
70
25
DTP1
99
99
99
96
94
95
99
98
97
94
53
DTP3
98
98
98
93
94
95
98
94
94
84
28
HepB3
98
98
98
93
94
95
98
94
...
...
...
Hib3
98
98
98
93
94
95
98
94
...
...
...
MCV
99
99
99
95
96
97
96
98
89
90
31
Pol3
98
98
98
93
94
94
98
88
94
87
31
PAB
94
94
94
94
94
94
90
93
77
60

2011 2010
298
298
100
100
97
94
91
82

85
84
below 50%

at 80% or above

...

year
2008
target age group
1-4 y
coverage (%)
97
BCG birth
DT
2, 4, 6, 18 months; 4 years;

high-risk groups
DTwP
18 months; 4 years
DTwPHibHep
2, 4, 6 months
HepB birth; 1st contact; +1 +6 months;

high-risk groups
Influenza

IPV 2, 4, 6, 18, months; high-risk groups
74
MMR
12 months
MR
OPV
2, 4, 6, 18 months
Pneumo_conj 2, 4, 6, months; 1 year
Rotavirus
2, 4 months
Td
11 years; pregnancy
Vitamin A 6, 12, 18, 24, 30, 36 months
Yellow fever
>1 year
Hungary
2011
Births.................................................................................................................................. 100

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
99
99
99
99
99
99
99
99
99
DTP1
99
99
99
99
99
99
99
99
99
99
99
DTP3
99
99
99
99
99
99
99
99
99
99
99
HepB3
...
...
...
...
...
...
...
...
...
...
...
Hib3
99
99
99
99
99
99
99
99
...
...
...
MCV
99
99
99
99
99
99
99
99
99
99
99
Pol3
99
99
99
99
99
99
99
99
99
99
98
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010


below 50%
81
81
100
100
100
100
100
100

100
100

at 80% or above

100
year
...
target age group
...
coverage (%)
...
BCG birth
MMR
DTaPHibIPV
Pneumo_conj
DTaPIPV
HepB
2, 3, 4, months
6 years
TdaP
15 months; 11 years
2, 4, 15 months
11 years
13 years (2 doses)
75
Iceland
2011
Births...................................................................................................................................... 5

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
98
98
99
99
97
97
95
99
99
99
99
DTP3
96
96
96
98
97
97
95
98
99
99
99
HepB3
...
...
...
...
...
...
...
...
...
...
...
Hib3
96
96
96
98
97
97
95
98
99
...
...
MCV
93
93
92
96
95
95
90
91
99
99
...
Pol3
96
96
96
98
97
97
95
98
99
99
99
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
...
59
...
100
...
...
...
100
...
100

...
...
below 50%
at 80% or above

...
year
...
target age group
...
coverage (%)
...
DTaP
DTaPHibIPV
5 years
3, 5, months; 1 year
DTaPIPV
14 years
Influenza
60 years
76
MenC_conj
MMR
Pneumo_ps
6, 8 months
18 months; 12 years
60 years
India
2011
Births............................................................................................................................. 27,098
Surviving infants......................................................................................................... 25,767
Total population..................................................................................................... 1,241,492

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
87
87
87
87
86
87
81
74
81
66
...
DTP1
83
83
83
83
83
83
78
69
88
88
25
DTP3
72
72
72
72
71
66
67
62
71
70
HepB3
47
37
34
21
...
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
74
74
74
74
74
70
64
55
72
56
...
Pol3
70
70
70
70
69
67
55
64
71
66
PAB
87
87
86
86
86
86
86
85
83
81
20

2011 2010
645

below 50%
644
96
...
...
87
...
76
...

...
...
at 80% or above

16
year
2011
target age group
coverage (%)
9 m-10 y
89
BCG birth
JE
DTwP

Measles
6, 10, 14 weeks; 16-24 months;

5 years
DTwPHibHep

HepB
6, 10, 14 weeks
(subnational)
16-24 months (subnational)

9-12, 16-24 months
OPV birth; 6, 10, 14 weeks; 16-24 months

TT
10, 16 years; pregnancy
Vitamin A 9, 18, 24, 30, 36, 42 months
77
Indonesia
2011
Births............................................................................................................................... 4,331

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
82
82
78
77
84
88
85
80
77
74
61
DTP1
86
87
82
79
86
86
85
85
87
82
...
DTP3
63
63
62
58
72
72
72
71
69
60
...
HepB3
63
63
62
62
74
66
65
65
50
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
89
89
82
80
82
79
77
74
63
58
...
Pol3
70
71
67
75
72
78
79
75
71
60
...
PAB
85
85
85
79
83
83
83
82
74
64

2011 2010


below 50%
497
495
99
100
15
17
80
79
55
56

90
86
at 80% or above

106

year
2007
target age group
coverage (%)
6-59 m
92.5
BCG
DT
1 month
school entrance
IPV
Measles
DTwPHep
2, 3, 4 months
OPV
DTwPHibHep

2, 3, 4 months
(subnational)
Td
HepB
78
0-7 days
2, 3, 4, 9 months (subnational)
9 months; 7 years
1, 2, 3, 4 months
schoolchildren grades 2 and 3
Vitamin A
6-11, 12-59 months
Iran (Islamic Republic of)

2011
Births............................................................................................................................... 1,255

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
99
99
99
99
99
99
96
95
DTP1
99
99
99
99
99
98
97
99
98
97
57
DTP3
99
99
99
99
99
98
95
99
98
91
32
HepB3
99
99
99
99
97
98
94
99
59
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
99
99
99
98
97
99
94
99
95
85
39
Pol3
99
99
99
99
98
99
95
99
97
90
38
PAB
95
95
83
83
83
83
83
82
66
71

2011 2010
392
360
100
100
below 50%
100
100
100
100

100
100

at 80% or above

99
year
2003
target age group
coverage (%)
5-25 y
102
BCG birth
OPV
DTwP
Rubella
HepB

birth; 2, 6 months;
high-risk groups
MenAC military
MMR

CBAW (rubella test negative)
Td every 10 years (military, pregnancy)

Varicella high-risk groups (subnational)
12, 18 months
79
Iraq
2011
Births............................................................................................................................... 1,144

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
92
92
89
85
91
89
92
93
97
96
76
DTP1
90
86
92
84
70
77
84
92
86
93
36
DTP3
77
72
73
65
54
58
65
78
74
83
14
HepB3
76
71
71
63
53
57
62
67
57
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
MCV
76
74
81
76
64
62
69
87
80
75
Pol3
78
72
74
68
72
63
69
84
73
83
16
PAB
85
80
69
69
69
70
71
75
81
70

2011 2010
129
125
100
100
23
42
76
58
40
42

57
50
below 50%
at 80% or above

91

year
target age group
coverage (%)
2011
18-24 y
40
BCG birth
DT
2, 4, 6, 18 months; 4-6 years
DTwP
2, 4, 6, 18 months; 4-6 years
DTwPHib
4, 18 months (subnational)
DTwPHibHep
HepA
2, 2.5 years; high-risk groups
HepB
birth; 2, 6 months
IPV
Measles
9 months
MenACWY 7, 12 years; travellers, high-risk

groups (subnational)
80
MMR
OPV
Pneumo_ps
Rotavirus
Td
>6 years
TT
CBAW and pregnancy; 1st contact;

+1, +6 months; +1, +2 years
Typhoid
Vitamin A
9, 15 months; 4-6 years
Yellow fever
4 years; travellers
Ireland
2011
Births.................................................................................................................................... 72

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
41
30
30
34
33
31
31
89
87
84
...
DTP1
98
98
98
97
97
97
96
95
90
85
59
DTP3
95
94
94
93
92
91
90
86
73
65
34
HepB3
95
46
...
...
...
...
...
...
...
...
...
Hib3
95
94
94
93
92
91
90
85
...
...
...
MCV
92
90
90
89
87
86
84
79
77
78
...
Pol3
95
94
94
93
92
91
90
86
77
81
72
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010


below 50%

at 80% or above

100
100
100
100
100
63
...
...

...
year
2009
target age group
coverage (%)
15-18 y
100
BCG
birth (subnational)
DTaPHibHepIPV
DTaPIPV
2, 4, 6 months
4-5 years
MenC_conj
MMR

4, 6, 13 months
1, 4-5 years; health workers
(during outbreaks)
HepB 0, +1, +5 months; high-risk groups
Pneumo_conj
2, 6 months; 1 year
HIB
Pneumo_ps

65 years; 2 years
(high-risk groups)
HPV

Influenza
13 months
12-13 years; +2, +4-6 months
(subnational)
high-risk groups
Td
TdaP
81
Israel
2011
Births.................................................................................................................................. 156

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
...
...
...
...
...
...
...
...
...
...
75
DTP1
96
96
96
96
96
96
93
96
98
97
94
DTP3
94
95
95
96
96
96
93
96
96
93
84
HepB3
99
98
97
96
97
94
96
97
93
...
...
Hib3
93
93
93
93
93
93
93
94
93
...
...
MCV
98
98
98
98
97
96
94
97
93
91
81
Pol3
94
94
94
94
96
94
95
92
96
93
85
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010

15
15
100
100
100
100
100
100

100
100
below 50%

at 80% or above

88

year
...
target age group
...
coverage (%)
...
BCG
high-risk groups
DT 2, 4, 6, 12 months (if pertussis contraindication)
DTaP
2, 4, 6, 12 months
DTaPHibIPV
2, 4, 6, 12 months
HepA
HepB
birth; 1, 6 months; high-risk groups
Hib
2, 4, 6, 12 months; high-risk groups
HPV
9-45 years; +2, +6 months (10-45 years;

+1, +6 months if CERVARIX)
Influenza
high-risk groups
IPV
high-risk groups; catch up
JE
0, 7 (depending on presentation),

28 days; travellers
82
MenACWY
high-risk groups
MMR
1, 6 years; 13 years
MMRV
12 months; 6 years; high-risk groups
Pneumo_conj
2, 4, 12 months
Pneumo_ps
Rotavirus
2, 4, 6 months
TBE travellers
Td
every 10 years, post-injury
TdaP
14 years
TdaPIPV
7 years
Typhoid travellers
TyphoidHepA travellers
Varicella
1, 6 years; high-risk groups
Yellow fever
travellers
Italy
2011
Births.................................................................................................................................. 557

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
98
98
98
98
99
98
98
95
98
94
...
DTP3
96
96
96
96
97
96
95
87
95
83
...
HepB3
96
96
96
96
97
96
96
94
95
95
...
Hib3
96
95
96
96
96
96
95
55
...
...
...
MCV
90
91
90
90
90
88
87
74
50
43
...
Pol3
96
96
96
96
97
97
97
97
98
98
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
...
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above
21

...
year
...
target age group
...
coverage (%)
...
aP
3, 5, 11-12 months; 5-6 years, 11-12 years
BCG
Dip
3, 5, 11-12 months; 5-6, 11-15 years
DT
3, 5, 11-12 months; 5-6 years
DTaP
3, 5, 11-12 months; 5-6 years
DTaPHep
3, 5, 11-12 months
DTaPHepIPV
3, 5, 11-12 months
DTaPHib
3, 5, 11-12 months
DTaPHibHep
3, 5, 11-12 months
DTaPHibHepIPV
3, 5, 11-12 months
DTaPHibIPV
3, 5, 11-12 months
DTaPIPV
3, 5, 11-12 months; 5-6 years
HepA
high-risk groups
HepB
3, 5, 11-12 months; high-risk groups
Hib
3, 5, 11-12 months
HPV
12 years; +1, +6 months (females)
Influenza
high-risk groups
IPV
3, 5, 11-12 months; 5-6 years
Measles
12-15 months; 5 or 12 years
MenC_conj
3, 5, 11-12 months (if indicated)
MMR
12-15 months, 5-12 years; health workers
Pneumo_conj
3, 5, 11-12 months (if indicated)
Pneumo_ps
high-risk groups
Rubella females
Td
11-15 years
TdaP
11-15 years
TT
83
Jamaica
2011
Births.................................................................................................................................... 50

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
95
94
92
87
90
95
94
98
98
38
DTP1
99
99
99
99
99
99
99
97
96
95
48
DTP3
99
99
99
99
99
99
99
93
90
86
24
HepB3
99
99
99
99
99
99
99
...
...
...
...
Hib3
99
99
99
99
99
99
99
...
...
...
...
MCV
88
89
88
88
76
87
84
88
90
74
...
Pol3
99
99
99
99
99
99
99
95
91
87
34
PAB
80
80
62
58
54
53
51
51
...
...
...

2011 2010

13
13
100
100
15
15
85
85
46
46
100
100
below 50%
at 80% or above


60

year
target age group
coverage (%)
2006
12-72 m
21
BCG birth
DT 6 weeks; 3, 5-6, 18 months; 4-6 years

DTwP
DTwPHibHep
6 weeks; 3, 5-6 months
HepB 6 weeks; 3, 6 months; or 1st contact,

+1, +6, months (high-risk groups)
HIB

Influenza health workers; high-risk groups
84
IPV 6 weeks; 3, 5-6, 18 months; 4-6 years

(immunocompromised)
MMR
OPV 6 weeks; 3, 5-6, 18 months; 4-6 years
Pneumo_conj 2, 4, 6, 18 months; children

with sickle cell disease
(subnational)
Td
4-6 years; pregnancy; adults
Yellow fever
travellers
Japan
2011
Births............................................................................................................................... 1,073

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
94
99
94
90
94
...
...
...
...
85
...
DTP1
99
99
99
99
99
99
99
88
90
96
82
DTP3
98
98
98
98
98
98
98
85
74
90
60
HepB3
...
...
...
...
...
...
...
...
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
94
94
94
95
96
97
98
96
93
73
69
Pol3
96
98
99
98
97
95
95
98
97
90
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
1,725 1,724
...
...
...
...
...
...
...
...
...

...
...

below 50%
at 80% or above

92
year
...
target age group
...
coverage (%)
...
BCG
DT
DTaP
HIB
HPV
Influenza
6 months
11 years
3, 4.5, 6, 18 months
13 years (3 doses)
65 years
JE
Measles
1-2, 5-7 years
MR
1-2, 5-7 years
OPV
Pneumo_conj
Rubella
6 months; 1 year
1-2, 5-7 years
85
Jordan
2011
Births.................................................................................................................................. 154

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
95
95
95
95
90
95
89
...
...
...
...
DTP1
98
98
98
98
99
99
98
91
99
97
55
DTP3
98
98
98
97
98
98
95
91
95
92
30
HepB3
98
98
98
97
98
98
95
93
54
...
...
Hib3
98
98
98
97
98
98
95
...
...
...
...
MCV
98
98
95
95
95
99
95
94
92
87
29
Pol3
98
98
98
98
98
98
95
94
95
92
32
PAB
90
87
87
87
87
86
67
44
47
49
...

2011 2010


below 50%

at 80% or above

12
12
100
100
100
100
100
100
...
100

90

year
2005
target age group
coverage (%)
8-16 y
87.1
BCG
DT
DTaPHibIPV
0-6 years
3, 4, 5, 18 months
3, 4, 5 months
Measles
9 months
MenACWY
>2 years; pilgrims
MMR
12, 18 months
DTwP
18 months
HepB
3, 4, 5 months
Pneumo_conj
HIB
3, 4, 5 months
Td
6, 16 years
health workers, pilgrims,

high-risk groups
TT


+1, +1 year
Influenza

86
OPV
3, 5 months
Kazakhstan
2011
Births.................................................................................................................................. 345

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
96
96
96
97
99
99
69
98
90
...
...
DTP1
99
99
98
99
97
99
99
98
97
...
...
DTP3
99
99
98
99
93
99
98
97
93
...
...
HepB3
99
99
99
99
94
99
94
99
...
...
...
Hib3
95
96
97
49
...
...
...
...
...
...
...
MCV
99
99
99
99
99
99
99
99
95
...
...
Pol3
99
98
99
99
94
99
99
96
94
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
205
204
100
100
below 50%

at 80% or above

100
100
100
100
...
96

99
year
2005
target age group
coverage (%)
15-25 y
99.3
BCG
birth; 6 years
Influenza
Dip
12 years
MMR
DT
6 years
OPV
DTwPHib
DTwPHibHep
HepA
3, 18 months
2, 4 months
2 years
high-risk groups
1, 6 years
Pneumo_conj
Td
Typhoid
2, 4 months; 1 year

high-risk groups
HepB birth
87
Kenya
2011
Births............................................................................................................................... 1,560

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
92
99
97
95
92
92
85
91
97
92
...
DTP1
95
93
92
90
89
90
85
83
96
92
...
DTP3
88
83
84
85
81
80
76
82
94
84
...
HepB3
88
83
84
85
81
80
76
...
...
...
...
Hib3
88
83
84
85
81
80
76
...
...
...
...
MCV
87
86
88
90
80
77
69
78
83
78
...
Pol3
88
83
84
85
76
77
70
80
94
84
...
PAB
73
78
78
78
74
74
73
68
61
60
...

2011 2010
153
149
100
100
below 50%
29
34
68
59
43
44

73
58
at 80% or above

0

year
2009
target age group
coverage (%)
9-59 m
82
BCG birth
DTwPHibHep
TT 1st contact pregnancy; +1 months;

2nd, 3rd, 4th pregnancies
Measles
OPV
Pneumo_conj
88
6, 10, 14 weeks
9 months
6, 10, 14 weeks
Vitamin A 6, 12, 18, 24, 30, 36 months

Yellow fever
Kiribati
2011
Births.................................................................................................................................... ...

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
86
87
76
83
90
91
93
80
47
93
66
DTP1
99
97
90
97
99
98
93
95
82
98
68
DTP3
99
91
86
82
94
86
79
90
60
97
43
HepB3
95
91
86
83
96
88
50
90
36
73
...
Hib3
95
91
86
83
...
...
...
...
...
...
...
MCV
90
89
82
72
93
61
85
80
47
75
...
Pol3
95
95
84
74
93
86
74
90
58
97
10
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010


below 50%

at 80% or above

100
100
17
17
83
83
33
33
...

61
year
2009
target age group
coverage (%)
12-59 m
106.7
BCG birth
MR
DTwP
OPV
DTwPHibHep
6 years
6, 10, 14 weeks
HepB birth
HPV
TT
Vitamin A

1, 6 years
6, 10, 14 weeks
13 years
6-12 months; 13 months
to 6 years
89
Korea, Democratic Peoples Republic of

2011
Births.................................................................................................................................. 348

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
98
98
98
97
96
96
94
78
82
99
50
DTP1
95
94
94
93
93
91
83
61
84
98
74
DTP3
94
93
93
92
92
89
79
56
64
98
50
HepB3
94
93
93
92
92
96
92
...
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
99
99
98
98
99
96
96
78
67
98
29
Pol3
99
99
98
98
99
98
97
93
88
99
50
PAB
93
91
91
91
91
90
90
81
90
90
...

2011 2010
208
208
100
100
100
100
100
100

100
...
below 50%

at 80% or above

99

year
target age group
coverage (%)
2007
6 m-45 y
100
BCG birth
Measles
DTwPHep
OPV
6, 10, 14 weeks
TT
HepB birth
Vitamin A
90
9, 15 months
6, 10, 14 weeks
3, 4 months
6-11, 12-59 months
Korea, Republic of
2011
Births.................................................................................................................................. 479

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
96
96
96
96
98
97
73
93
72
...
DTP1
99
96
96
95
95
98
98
97
99
90
...
DTP3
99
94
94
94
91
98
96
97
99
74
...
HepB3
99
94
94
94
91
99
99
93
99
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
99
98
93
92
92
99
99
95
93
93
Pol3
98
95
95
92
91
98
96
99
99
74
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
...
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above
230

98
year
2009
target age group
coverage (%)
school-age
100
BCG
DTaP
birth-4 weeks
2, 4, 6, 15-18 months; 4-6 years
DTaPIPV
HepB
birth; 1, 6 months
HFRS

1st contact, +1 month;

+1 year; high-risk groups
Influenza
IPV
high-risk groups
JE

MMR
Td
TdaP
12-24 months; +1-4 weeks;

+1 year; 6, 12 years
11-12 years
11-12 years
Typhoid
high-risk groups
Varicella
12-15 months
91
Kuwait
2011
Births.................................................................................................................................... 50

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
98
99
99
94
84
...
...
...
...
...
DTP1
99
98
99
99
99
99
99
98
99
88
86
DTP3
99
98
99
99
99
99
99
98
99
71
67
HepB3
99
99
99
99
99
99
99
95
99
...
...
Hib3
99
98
99
99
99
99
99
98
...
...
...
MCV
99
98
99
99
99
99
99
99
98
66
48
Pol3
99
98
99
99
99
99
99
94
99
71
70
PAB
95
95
84
84
83
82
81
77
37
51

2011 2010
109
100
...
...
...
...
...
...
...
...
100
100
below 50%
at 80% or above

109

99

year
2010
target age group
1-7 y
coverage (%)
...
BCG
3 months
DT
pertussis contraindication

(subnational)
DTwP
3.5 years
DTwPHibHep
2, 4, 6, 18 months
HepB birth
Influenza high-risk groups (subnational)
IPV
2 months
MenAC
expatriates (subnational)
MenACWY 2 years; pilgrims; travellers
92
MMR
1, 2, 12 years (females)
OPV
4, 6, 12, 18 months
Pneumo_conj
2, 4, 6, 18 months
Pneumo_ps
pilgrims; high-risk

Td
10, 18 years
TT
pregnancy; high-risk groups

(subnational)
Typhoid food handlers (subnational)
Yellow fever
travellers
Kyrgyzstan
2011
Births.................................................................................................................................. 131

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
98
98
98
99
98
99
96
96
96
...
...
DTP1
97
99
98
99
98
96
98
99
97
...
...
DTP3
96
96
95
95
94
92
98
99
93
...
...
HepB3
96
96
96
97
94
90
97
44
...
...
...
Hib3
96
96
...
...
...
...
...
...
...
...
...
MCV
97
99
99
99
99
97
99
98
97
...
...
Pol3
94
88
96
95
94
93
98
99
96
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010


below 50%
40
42
100
100
...
...
100
...
100
100

100
100

at 80% or above

98
year
2002
target age group
coverage (%)
26-36 y
97.1
BCG birth
MMR
DT
6 years
MR
DTwP
2 years
OPV
DTwPHibHep
2, 3.5, 5 months
Td
1 year
6 years
birth; 2, 3.5, 5 months
11, 16, 26, 36, 46, 56 years
HepB birth
93
Lao Peoples Democratic Republic

2011
Births.................................................................................................................................. 140

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
77
72
67
68
56
61
65
69
62
26
...
DTP1
83
81
76
73
59
68
68
83
77
41
...
DTP3
78
74
67
61
50
57
49
51
54
18
...
HepB3
78
74
67
61
50
57
49
...
...
...
...
Hib3
78
74
...
...
...
...
...
...
...
...
...
MCV
69
64
59
52
40
48
41
42
68
32
...
Pol3
79
76
67
60
46
56
50
57
64
26
...
PAB
80
80
47
47
47
52
50
58
44
12
...

2011 2010
143
143
100
100
10
50
51
45
38
15
10

66
56
below 50%
at 80% or above

...

year
2011
target age group
coverage (%)
9 m-19 y
97
BCG birth
OPV
DTwPHibHep
TT

HepB
Measles
MR
94
6, 10, 14 weeks
birth (subnational)
9 months
6, 10, 14 weeks
+1, +1 year
Vitamin A 6, 12, 18, 24, 30, 36 months
Latvia
2011
Births.................................................................................................................................... 24

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
95
92
99
99
99
99
99
99
99
...
...
DTP1
97
97
97
98
98
99
99
99
99
...
...
DTP3
94
89
95
97
98
98
99
96
98
...
...
HepB3
91
89
94
96
97
97
98
95
...
...
...
Hib3
93
88
95
96
97
99
94
79
58
...
...
MCV
99
93
96
97
97
95
95
97
81
...
...
Pol3
94
89
96
97
98
98
99
96
98
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010


below 50%
119
33
...
100
...
...
18
...
82
...
70
100
88
at 80% or above


91
year
...
target age group
...
coverage (%)
...
BCG
DTaPHibHepIPV
DTaPHibIPV
DTaPIPV
2-5 days
2, 4, 6, 12-15 months
2, 4, 6 months
7 years
HepB
birth; 1, 2, 12-15 months;
14 years (catch up); high-risk groups
HPV
MMR
7 years
MMRV
12-15 months
Pneumo_conj
2, 4, 6 months
TdIPV
14 years
12 years (3 doses)
95
Lebanon
2011
Births.................................................................................................................................... 65

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
84
84
84
84
84
84
83
90
97
94
17
DTP3
81
81
81
81
80
78
77
83
93
82
HepB3
81
81
81
81
80
78
77
83
...
...
...
Hib3
81
81
81
81
80
78
77
...
...
...
...
MCV
79
79
79
79
74
69
63
71
85
61
Pol3
75
75
75
75
75
75
74
83
93
82
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010


below 50%
26
26
100
100
100
96
81
77

42
...

at 80% or above

86

year
2000
target age group
coverage (%)
1-15 y
93
DT
DTwP
DTwPHib
DTwPHibHep
10-12, 16-18 years

4-5 years
18 months
2, 4, 6 months
HepB birth
IPV
Measles
MMR
OPV

9 months
1, 4-5 years
4, 6, 18 months; 4-5, 10-12,
16-18 years
96
Lesotho
2011
Births.................................................................................................................................... 60

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
95
95
95
95
95
95
96
88
96
89
81
DTP1
93
93
93
93
93
94
94
87
95
91
75
DTP3
83
83
83
83
84
86
87
83
88
82
56
HepB3
83
83
83
83
86
90
87
...
...
...
...
Hib3
83
83
83
...
...
...
...
...
...
...
...
MCV
85
85
85
85
85
85
85
74
83
80
49
Pol3
91
91
91
91
91
91
90
82
88
82
56
PAB
83
83
83
83
82
80
79
73
61
...
...

2011 2010


below 50%
10
10
100
100
10
80
80
10
20
10
100
70
at 80% or above


...
year
2010
target age group
coverage (%)
6 m-15 y
91
BCG birth
OPV
DT
DTwPHibHep
HPV

Measles
18 months
6, 10, 14 weeks
9-13 years (females,
3 doses, subnational)
TT
6, 10, 14 weeks
1st contact; +4 weeks; +1 year
Vitamin A 6, 12, 18, 24, 30, 36 months
9, 18 months
97
Liberia
2011
Births.................................................................................................................................. 157

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
73
64
80
80
74
77
76
78
...
...
...
DTP1
61
60
75
75
75
75
75
80
...
...
...
DTP3
49
47
64
64
60
60
60
46
...
...
...
HepB3
49
47
64
64
...
...
...
...
...
...
...
Hib3
49
47
64
64
...
...
...
...
...
...
...
MCV
40
41
64
64
64
63
62
63
...
...
...
Pol3
56
54
71
71
63
66
66
56
...
...
...
PAB
91
91
91
91
90
73
60
51
55
33
...

2011 2010

15
15
100
100
47
53
53
47
13
13

73
27
below 50%
at 80% or above

0

year
2010
target age group
coverage (%)
unknown
100
BCG birth
DTwPHibHep
Measles
OPV
Pneumo_conj

98
6, 10, 14 weeks
9 months
6, 10, 14 weeks
(subnational)
TT


+1, +6 months; +1, +1 year
Vitamin A
Yellow fever
6 months; 1 year
9 months
Libya
2011
Births.................................................................................................................................. 144

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
99
99
99
99
99
98
99
90
88
DTP1
98
98
98
98
98
98
98
97
98
94
82
DTP3
98
98
98
98
98
98
98
94
95
84
60
HepB3
98
98
98
98
98
98
97
92
92
...
...
Hib3
98
98
98
98
56
...
...
...
...
...
...
MCV
98
98
98
98
98
98
97
93
92
89
61
Pol3
98
98
98
98
98
98
98
94
95
84
60
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
...
...
...
...
below 50%
...
...
...
...
...
...
...
...

...
...
at 80% or above

...
year
2009
target age group
coverage (%)
12 m-6 y
98
BCG birth
MenACWY 6 years; travellers; pilgrims
DT
MMR
DTwP
DTwPHibHep
6 years
18 months
OPV
12, 18 months
2, 4, 6 months
Td
HepB birth
TT
Influenza
Yellow fever
high-risk groups
15 years
15 years
travellers
99
Lithuania
2011
Births.................................................................................................................................... 35

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
98
99
99
99
99
99
99
99
97
...
...
DTP1
95
98
98
96
99
98
98
99
96
...
...
DTP3
92
95
98
96
95
94
94
94
90
...
...
HepB3
95
94
95
96
96
95
95
98
...
...
...
Hib3
92
95
98
96
95
94
61
...
...
...
MCV
94
96
96
97
97
97
97
97
94
...
...
Pol3
92
95
98
96
95
94
93
92
89
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
56
52
93
100
below 50%
91
100
84
94

96
94

at 80% or above

94

year
...
target age group
...
coverage (%)
...
Pneumo_conj

2, 3, 4, 12-14 months
(subnational)
BCG birth
DTaPHibIPV
DTaPIPV
2, 4, 6, 18 months
6 years
HepB
birth; 1, 6 months
MMR
100
Rabies

Td
post-exposure; +3, +7,

+14, +28 days
15 years
Luxembourg
2011
Births...................................................................................................................................... 6

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
99
99
99
99
99
99
99
98
98
96
...
DTP3
99
99
99
99
99
99
99
98
97
90
...
HepB3
95
94
95
94
87
91
95
49
...
...
...
Hib3
99
98
99
98
99
99
98
91
...
...
...
MCV
96
96
96
96
96
96
95
91
88
80
...
Pol3
99
99
99
99
99
99
99
98
96
90
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
...
...
...
...
below 50%
...
...
...
...
...
...
...
...

...
...
at 80% or above

...
year
...
target age group
...
coverage (%)
...
DTaPHibHepIPV
2, 3, 13 months
DTaPHibIPV
4 months
DTaPIPV
5-6 years; 15-16 years;

+every 10 years
HepB

(catch up)
HPV
12-18 years
Influenza
65 years
IPV
every 10 years (if indicated)
MenC_conj
13 months
MMR
12, 15-23 months
MMRV 12, 15-23 months (subnational)
Mumps
12, 15-23 months
Pneumo_conj
2, 4, 12 months
Pneumo_ps
60 years
Rotavirus
2, 3 months
Typhoid travellers
Varicella
13 years
Yellow fever
travellers
101
Madagascar
2011
Births.................................................................................................................................. 747

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
82
81
80
83
94
90
80
72
72
67
21
DTP1
96
94
88
84
92
91
82
72
80
71
...
DTP3
89
85
83
77
84
83
82
57
57
46
...
HepB3
89
85
86
80
84
82
81
...
...
...
...
Hib3
89
85
78
52
...
...
...
...
...
...
...
MCV
70
73
67
70
81
66
62
56
55
47
...
Pol3
88
85
82
77
83
79
72
60
56
46
...
PAB
78
76
76
76
72
71
66
58
38
45
...

2011 2010
112
111
100
100
21
37
77
59
34
58

56
47
below 50%
at 80% or above

...

year
2010
target age group
coverage (%)
9-47 m
93
BCG birth
Rotavirus
DTwPHibHep
TT

Measles
OPV
6, 10, 14 weeks
9 months
Pneumo_conj
6, 10, 14 weeks
(subnational)
102
Vitamin A
+1, +6 months; +1, +1 year
6 months; 1 year
Malawi
2011
Births.................................................................................................................................. 686

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
97
95
97
95
99
99
83
97
97
...
DTP1
98
97
97
97
96
99
99
98
96
95
80
DTP3
97
93
93
91
87
99
93
75
89
87
58
HepB3
97
93
93
91
87
99
93
...
...
...
...
Hib3
97
93
93
91
87
99
93
...
...
...
...
MCV
96
93
92
88
83
85
82
73
90
81
49
Pol3
86
86
93
92
88
99
94
73
90
93
28
PAB
87
87
87
87
86
88
86
84
87
81
...

2011 2010


below 50%

at 80% or above

28
28
100
100
100
100
68
68
100
82

...
year
2010
target age group
coverage (%)
9 m-15 y
107
BCG birth
Rotavirus
DTwPHibHep
TT

Measles
6, 10, 14 weeks
9 months
OPV
6, 10, 14 weeks
Pneumo_conj
6, 10, 14 weeks
+1, +1 year
Vitamin A 6, 12, 18, 24, 30, 36 months;

post-partum
103
Malaysia
2011
Births.................................................................................................................................. 579

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
98
98
90
99
99
99
99
99
94
DTP1
99
98
95
96
90
96
96
95
93
95
86
DTP3
99
94
95
96
90
90
95
95
94
90
67
HepB3
97
96
95
95
90
87
92
94
91
86
...
Hib3
99
94
95
95
90
89
85
...
...
...
...
MCV
95
96
95
94
95
90
90
88
86
70
...
Pol3
99
94
95
96
90
96
94
95
94
90
67
PAB
90
87
87
87
87
88
88
88
84
82
20

2011 2010
141
141
100
100
below 50%
11
89
91
65
63

...
...
at 80% or above

...

year
target age group
coverage (%)
2004
7-15 y
96
BCG birth
DT
7 years
DTaPHibIPV
2, 3, 5, 18 months
DTwP
HepB
birth; 1, 6 months
HPV
13 years (3 doses)
Influenza
high-risk groups
JE
9, 10, 18 months; 5, 8,

104
Measles
MenACWY pilgrims
MMR
1, 7 years
OPV
18 months; 7 years
Rubella
females; post-partum
TdaP
15 years
Typhoid
food handlers
Maldives
2011
Births...................................................................................................................................... 5

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
98
97
99
99
99
99
99
99
99
99
DTP1
97
97
99
99
99
99
99
98
99
97
22
DTP3
96
96
98
98
98
98
98
98
94
94
HepB3
96
97
98
98
98
98
98
96
80
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
96
97
98
97
97
97
97
99
96
96
...
Pol3
96
97
98
98
98
98
98
98
97
94
PAB
95
95
95
95
94
94
94
95
92
86

2011 2010
20
20
...
100
below 50%
100
100
100
100

100
100

at 80% or above

96
year
2007
target age group
4-6 y
coverage (%)
56
BCG birth
MenACWY
DT
MMR
DTwP
HepB
Influenza

Measles
5 years (catch up)

6, 10, 14 weeks
birth; 6, 10 weeks
>15 years; pilgrims
(subnational)
9 months
18 months
OPV
TT


+1, +1 year
Vitamin A
Yellow fever

9, 18 months
>18 years; travellers
(subnational)
105
Mali
2011
Births.................................................................................................................................. 728

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
89
86
86
86
86
86
83
69
76
82
...
DTP1
85
85
85
85
86
86
87
61
73
67
...
DTP3
72
76
73
74
74
78
77
43
49
42
...
HepB3
72
76
73
74
74
90
83
...
...
...
...
Hib3
72
76
73
74
44
16
...
...
...
...
MCV
56
63
60
71
66
68
73
49
52
43
...
Pol3
71
73
70
74
76
79
78
53
49
42
...
PAB
89
85
92
92
90
89
86
50
36
45
...

2011 2010

60
59
100
100
23
22
72
71
27
41

23
25
below 50%
at 80% or above

...

year
2011
target age group
coverage (%)
92
BCG birth
Pneumo_conj
6, 10, 14 weeks
DTwPHibHep
TT

9-59 m
Measles
OPV
106
6, 10, 14 weeks
9 months

+1, +6 months; +1, +1 year
Yellow fever
9 months
Malta
2011
Births...................................................................................................................................... 4

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
...
...
...
...
...
...
...
...
92
77
...
DTP1
99
97
91
88
84
85
94
97
97
84
...
DTP3
96
76
73
72
74
85
92
94
92
63
...
HepB3
82
75
86
86
82
86
85
...
...
...
...
Hib3
96
76
73
72
72
83
83
93
...
...
...
MCV
84
73
82
78
79
94
86
74
51
80
...
Pol3
96
76
73
72
76
83
94
94
92
86
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010


below 50%

at 80% or above

...
100
...
...
...
100
...
...
100
...

85
year
...
target age group
...
coverage (%)
...
BCG
DTaPHibIPV
12 years
6 weeks; 3, 4, 18 months
HepA
high-risk groups
HepB
12, 13, 18 months
MMR 13 months; 3 years (subnational)

Pneumo_conj

TdIPV
(subnational)
16 years
107
Marshall Islands
2011
Births.................................................................................................................................... ...

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
98
95
92
92
93
89
71
49
...
DTP1
99
99
99
99
99
90
89
64
88
97
...
DTP3
94
94
96
95
93
74
77
39
70
92
...
HepB3
97
97
99
97
93
97
89
38
47
10
...
Hib3
92
92
99
92
83
60
69
45
...
...
...
MCV
97
97
78
86
94
96
86
94
57
52
...
Pol3
95
95
99
96
91
95
88
36
64
89
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
100
33
...
33
...
33
...
33
...
100
...

below 50%
at 80% or above


...

year
2003
target age group
coverage (%)
6 m-40 y
...
BCG birth
MMR
DTaP
2, 4, 6, 12 months; 4-6 years
OPV
HepB
birth; 2, 6 months; adolescents
Hib
HPV
Influenza
IPV
MenA
108
2, 4, 12 months
high-risk groups
2, 4, 6 months
Pneumo_conj
12, 13 months
2, 4, 6, 12 months
Rotavirus
2, 4, 6 months
Td
every 10 years
TdaP
Vitamin A
11-12 years
6-59 months
Mauritania
2011
Births.................................................................................................................................. 118

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
86
85
81
89
92
86
87
75
80
79
...
DTP1
91
82
79
88
92
85
85
70
93
69
...
DTP3
75
64
64
74
75
68
71
53
55
33
...
HepB3
75
64
64
74
74
68
42
...
...
...
...
Hib3
75
64
64
...
...
...
...
...
...
...
...
MCV
67
67
59
65
67
62
61
62
67
38
...
Pol3
73
52
63
73
75
68
71
61
56
33
...
PAB
80
87
87
77
77
62
59
44
43
24
...

2011 2010


below 50%
53
53
100
100
15
32
57
51
28
17
11

68
26
at 80% or above

...
year
2011
target age group
coverage (%)
9-59 m
96
BCG birth
Pneumo_ps subnational
DTwPHibHep
TT

Measles
OPV
6, 10, 14 weeks
9 months
1st contact or pregnancy;

+1, +6 months;+1, +1 year
109
Mauritius
2011
Births.................................................................................................................................... 16

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
95
96
98
97
99
88
86
87
89
DTP1
99
99
99
99
97
99
99
88
97
95
96
DTP3
98
99
99
99
97
97
97
88
93
85
89
HepB3
98
99
99
99
97
97
97
88
...
...
...
Hib3
98
99
99
99
96
96
...
...
...
...
...
MCV
99
99
99
98
98
99
98
84
89
76
...
Pol3
98
99
99
99
96
98
97
88
93
86
90
PAB
95
95
87
87
86
85
86
79
78
61

2011 2010

10
10
100
100
100
100
40
50

...
100
below 50%

at 80% or above

88

year
...
target age group
...
coverage (%)
...
BCG
DT
DTaPHib

HepB

Influenza

110
1 month
18 months; 5 years
(subnational)
6, 10, 14 weeks; travellers;
high-risk groups
1.5-2 years; 60 years;
high-risk groups
MenACWY travellers
MMR
OPV
12 months; 5 years
TT
post-injury; pregnancy
Typhoid travellers
Yellow fever
travellers
Mexico
2011
Births............................................................................................................................... 2,195

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
98
99
99
99
99
99
99
98
67
48
DTP1
99
96
98
98
99
99
99
99
97
77
69
DTP3
97
95
95
96
98
98
98
97
91
53
44
HepB3
98
93
95
97
98
98
98
97
...
...
...
Hib3
97
95
95
96
98
98
98
97
...
...
...
MCV
98
95
96
96
96
96
96
96
90
75
35
Pol3
97
95
95
96
98
98
98
97
92
66
91
PAB
88
88
87
87
87
87
86
81
71
59

2011 2010
2,456 2,438
...
...
...
...
...
...
...
...
...

...
...

below 50%
at 80% or above

97
year
2011
target age group
6-7 y
coverage (%)
96
BCG birth
DTwP
4 years
DTwPHibIPV
2, 4, 6, 18 months
HepB
birth; 2, 6 months;

>12 years (2 doses)
HPV
9, 12, 15 years
Influenza

>60 years; pregnancy;

high-risk groups
MMR
1, 6 years
MR
>12 years; 13-39 years (6 doses)
OPV
>6 months; <5 years
Pneumo_conj
2, 4 months; 1 year
Pneumo_ps
65 years; high-risk

Rotavirus
2, 4 months
Td
11-12 years (2 doses);

>12 years (4 doses); pregnancy
Vitamin A
111
Micronesia (Federated States of)

2011
Births...................................................................................................................................... 3

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
75
70
75
79
82
55
70
24
50
12
...
DTP1
96
90
97
87
86
83
98
92
94
95
...
DTP3
84
85
91
85
79
67
94
85
83
85
...
HepB3
83
88
89
89
90
84
91
87
82
56
...
Hib3
72
70
73
73
79
59
74
75
...
...
...
MCV
92
80
86
86
92
83
96
85
90
81
...
Pol3
83
85
81
88
79
81
94
85
81
85
...
PAB
...
....
...
...
...
...
...
...
...
...
...

2011 2010

100
100
25
75
100
75
50

...
...
below 50%
at 80% or above

75

year
...
target age group
...
coverage (%)
...
BCG birth
OPV
DTaP
Pneumo_conj
DTaPHepIPV 2, 6 months (subnational)
Rotavirus
HepB
Td
Hib
HPV
IPV
MMR
112
birth; 2, 6 months
2, 4 months; 1 year
11 years
4 months, 4 years (subnational)
12, 13 months
TdaP
TT
2, 4, 6, months; 1, 4 years
2, 4, 6, months; 1 year
2, 4, 6 months
>11 years
11 years
adults; +every 10 years
Vitamin A 6, 12, 18, 24, 30, 36 months
Moldova
2011
Births.................................................................................................................................... 44

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
98
98
96
99
99
99
99
99
95
...
...
DTP1
96
93
88
96
97
97
98
98
98
...
...
DTP3
93
90
85
95
96
97
98
95
96
...
...
HepB3
96
98
89
98
98
99
99
92
19
...
...
Hib3
78
63
47
...
...
...
...
...
...
...
...
MCV
91
97
90
94
95
97
97
89
91
...
...
Pol3
96
97
87
97
97
98
99
97
97
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010


below 50%
44
44
100
100
95
95
91
77
93

93
95
at 80% or above

89
year
2002
target age group
coverage (%)
8-19 y
92.8
BCG
DT
DTwP
DTwPHibHep
2 days; 7 years
7 years
MMR
OPV
12 months; 7, 15 years
2, 4, 6, 22 months; 7, 15 years
22 months
2, 4, 6 months
HepB birth
113
Monaco
2011
Births.................................................................................................................................... ...

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
89
89
89
89
89
89
89
97
90
99
...
DTP1
99
99
99
99
99
99
99
99
99
99
...
DTP3
99
99
99
99
99
99
99
99
99
99
...
HepB3
99
99
99
99
99
99
99
99
...
...
...
Hib3
99
99
99
99
99
99
99
99
...
...
...
MCV
99
99
99
99
99
99
99
99
99
99
...
Pol3
99
99
99
99
99
99
99
99
99
99
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
...
...
...
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above

...
year
...
target age group
...
coverage (%)
...
DTaPHibHepIPV
2 months
HepA

5 months; 1 year;
high-risk groups
HepB
5 months; 1 year
MenC_conj
114
2 years
MMR
1, 3-6 years
Pneumo_ps
Td
2 months
15, 20, 25, 30, 35, 40, 50, 60 years
Mongolia
2011
Births.................................................................................................................................... 65

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
98
98
99
98
99
97
94
81
51
DTP1
99
98
95
98
95
99
99
95
96
94
91
DTP3
99
96
95
96
95
99
99
94
88
84
76
HepB3
99
96
97
96
98
98
98
93
88
...
...
Hib3
99
96
97
96
78
56
28
...
...
...
...
MCV
98
97
94
97
98
99
97
92
85
92
17
Pol3
99
96
96
95
99
98
99
94
86
87
86
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
338
340
100
100
below 50%
100
100
99
98

86
91

at 80% or above

93
year
target age group
coverage (%)
2007
2-10 y
97
BCG birth
HepB birth
DT
MMR
DTwPHibHep
7, 15 years
2, 3, 4 months
OPV
9 months: 2 years
birth; 2, 3, 4 months
115
Montenegro
2011
Births...................................................................................................................................... 8

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
97
95
95
98
98
98
...
...
...
...
...
DTP1
98
97
96
98
98
95
...
...
...
...
...
DTP3
95
94
92
95
92
90
...
...
...
...
...
HepB3
91
90
87
93
90
90
...
...
...
...
...
Hib3
90
90
87
93
89
90
...
...
...
...
...
MCV
91
90
86
89
90
90
...
...
...
...
...
Pol3
95
93
91
95
92
90
...
...
...
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010


below 50%

at 80% or above

21
21
100
100
100
100
76
71
100
100

97

year
...
target age group
...
coverage (%)
...
BCG birth
HIB
DT
Influenza seasonal
DTaP
DTaPHibIPV
HepB
116
6 years
18 months
9, 17, 23 weeks
12, 16 weeks; 9 months
MMR
OPV
Td
18 months
1, 6 years
18 months; 6, 14 years
14 years
Morocco
2011
Births.................................................................................................................................. 620

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
99
99
96
95
95
97
96
96
...
DTP1
99
99
99
99
98
99
99
98
94
93
...
DTP3
99
99
99
99
95
97
98
95
90
81
...
HepB3
98
98
98
97
95
95
96
43
...
...
...
Hib3
99
99
99
99
91
...
...
...
...
...
...
MCV
95
98
98
96
95
95
97
93
88
79
...
Pol3
98
99
99
99
95
97
98
95
90
81
...
PAB
89
89
87
90
88
87
89
86
80
66
...

2011 2010


below 50%

at 80% or above

81
68
100
100
98
100
72
94
100
100

80
year
2008
target age group
coverage (%)
9 m-14 y
99
BCG birth
OPV
DTwP
Pneumo_conj
DTwPHiB
HepB
Measles
MR
18 months; 5 years
2, 3, 4 months
birth; 2, 9 months
9 months
18 months
Rotavirus
TT

Vitamin A
2, 4, 12 months
2, 3 months

+1, +1 year
6, 12, 18 months
117
Mozambique
2011
Births.................................................................................................................................. 889

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
91
90
90
90
90
89
89
84
78
59
...
DTP1
90
90
88
87
85
86
86
84
75
71
...
DTP3
76
74
74
75
75
75
75
70
57
46
...
HepB3
76
74
74
75
75
75
75
...
...
...
...
Hib3
76
74
74
...
...
...
...
...
...
...
...
MCV
82
82
80
77
75
75
76
71
71
59
...
Pol3
73
73
74
74
75
75
75
69
57
46
...
PAB
83
83
83
83
82
81
77
75
53
37
...

2011 2010
144
144
100
44
31
68
30
36
58

46
...
below 50%
at 80% or above

...

year
2011
target age group
coverage (%)
6-59 m
105
BCG birth
DTwPHibHep
TT

Measles
OPV
6, 10, 14 weeks
9 months
118

+1, +1 year
Vitamin A 6, 12, 18, 24, 30, 36 months
Myanmar
2011
Births.................................................................................................................................. 824

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
93
93
93
88
89
85
76
88
90
95
DTP1
99
99
99
99
99
97
92
87
94
96
22
DTP3
99
99
99
98
97
91
80
82
84
88
HepB3
52
99
99
98
99
89
76
...
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
99
99
99
98
95
89
80
84
82
68
...
Pol3
99
99
99
98
96
92
82
87
84
88
...
PAB
93
93
93
93
93
92
89
79
80
62

2011 2010


below 50%
330
325
95
98
15
10
76
87
51
54

92
94
at 80% or above

80
year
2007
target age group
coverage (%)
9 m-5 y
94
BCG
6 weeks
DTwP
6, 10, 14 weeks
HepB
Measles
OPV
TT
6-59 weeks, 13-59 months

6, 10, 14 weeks
1st contact pregnancy; +4 weeks
119
Namibia
2011
Births.................................................................................................................................... 60

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
89
88
85
88
95
88
95
77
92
...
...
DTP1
88
87
87
88
88
91
93
90
90
...
...
DTP3
82
83
83
83
86
86
86
79
74
...
...
HepB3
82
83
...
...
...
...
...
...
...
...
...
Hib3
82
83
...
...
...
...
...
...
...
...
...
MCV
74
75
76
73
69
63
73
69
68
...
...
Pol3
85
83
83
83
81
74
86
80
73
...
...
PAB
83
83
82
82
82
81
80
74
40
...
...

2011 2010

34
34
100
100
32
32
68
68
21
21

47
...
below 50%
at 80% or above

...

year
target age group
coverage (%)
2009
9-59 m
104
BCG birth
DT
Vitamin A
DTwPHibHep
Measles
5, 10 years
6, 10, 14 weeks
9 months
OPV birth; 6, 10, 14 weeks; 5, 10 years
120
Yellow fever

9 months
travellers; high-risk
Nauru
2011
Births.................................................................................................................................... ...

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
99
99
99
99
90
93
78
93
...
DTP1
99
99
99
99
99
98
90
85
79
90
...
DTP3
99
99
99
99
99
72
80
44
56
74
...
HepB3
99
99
99
99
99
99
80
58
57
...
...
Hib3
99
99
99
...
...
...
...
...
...
...
...
MCV
99
99
99
99
99
99
79
...
...
...
Pol3
99
99
99
99
99
90
80
27
56
74
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010

below 50%
14
100
...
...
100
...
100
...

100
...
at 80% or above

100
year
2001
target age group
coverage (%)
12-59 m
...
BCG birth
MR
DTwP
OPV

DTwPHibHep
18 months; 4 years
6, 10, 14 weeks
HepB birth
TT
12, 15 months
6, 10, 14 week; 18 months;
4 years
1st visit; +4 weeks; pregnancy
121
Nepal
2011
Births.................................................................................................................................. 722

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
97
94
94
87
89
93
87
84
76
74
22
DTP1
96
85
94
84
85
93
81
84
77
68
28
DTP3
92
82
89
82
82
89
75
74
54
43
HepB3
92
82
89
82
82
69
41
...
...
...
...
Hib3
92
...
...
...
...
...
...
...
...
...
...
MCV
88
86
90
79
81
85
74
71
56
57
...
Pol3
92
83
93
82
82
91
78
74
50
42
...
PAB
82
81
81
81
84
86
88
67
48
35

2011 2010

75
75
100
100
23
53
76
44
41
40

99
79
below 50%
at 80% or above

...

year
target age group
coverage (%)
2008
9 m-5 y
93.5
BCG birth
OPV
DTwPHibHep
TT pregnancy
JE
Measles
122
6, 10, 14 weeks
1 year
9 months
Vitamin A
6, 10, 14 weeks
6-59 months
Netherlands
2011
Births.................................................................................................................................. 181

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
99
99
99
99
98
98
99
99
98
98
98
DTP3
97
97
97
97
96
96
98
97
97
97
96
HepB3
...
...
...
...
...
...
...
...
...
...
...
Hib3
97
97
97
97
96
96
97
96
...
...
...
MCV
96
96
96
96
96
95
96
96
94
94
91
Pol3
97
97
97
97
96
96
98
97
97
97
96
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
415
100
...
below 50%
12
...
98
...
92
...

...
...
at 80% or above

93
year
...
target age group
...
coverage (%)
...
DTaPHibHepIPV

2, 3, 4, 11 months
(high-risk groups)
HPV

DTaPHibIPV

2, 3, 4, 11 months
(high-risk groups)
MenC_conj
DTaPIPV
4 years
DTIPV
9 years
HepB

12 years, +1 month,
+6 months (females only)
MMR
Pneumo_conj
14 months
14 months; 9 years
2, 3, 4, 11 months
birth; <2 days after birth

(children of carriers)
123
New Zealand
2011
Births.................................................................................................................................... 64

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
DTP1
95
95
94
91
91
92
92
96
96
96
91
DTP3
95
93
92
89
88
89
89
90
89
90
76
HepB3
95
90
93
90
88
87
87
90
88
...
...
Hib3
94
89
98
86
78
80
80
90
...
...
...
MCV
93
91
89
86
79
82
82
85
84
90
80
Pol3
95
93
92
89
88
89
89
82
87
90
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
...
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above
20

86

year
...
target age group
...
coverage (%)
...
BCG
high-risk groups
IPV
high-risk groups
DTaPHibHepIPV 6 weeks; 3, 5 months
MenACWY
DTaPIPV
MMR
HepB
Hib
HPV
4 years
high-risk groups
15 months
12 years
Influenza
<5 years; >64 years;

124
high-risk groups
15 months; 4 years; outbreaks
Pneumo_conj 6 weeks; 3, 5, 15 months

Pneumo_ps
Td
TdaP
high-risk groups
45, 65 years; high-risk groups

11 years
Nicaragua
2011
Births.................................................................................................................................. 138

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
98
98
98
98
98
98
96
96
93
84
34
DTP1
99
99
99
99
94
94
92
97
93
88
39
DTP3
98
98
98
97
93
88
86
83
80
70
16
HepB3
98
98
98
97
93
88
86
83
...
...
...
Hib3
98
98
98
97
93
88
86
83
...
...
...
MCV
99
99
99
99
99
99
97
86
85
82
15
Pol3
99
99
99
97
93
88
87
85
83
90
21
PAB
81
81
80
80
80
85
87
83
68
39
...

2011 2010


below 50%
153
153
88
100
10
88
91
78
74

78
86
at 80% or above

...
year
2011
target age group
coverage (%)
1-39 y
116
BCG birth
OPV
2, 4, 6 months
DTwP
Pneumo_conj
2, 4, 6 months
18 months; 6 years
DTwPHibHep
HepB

Influenza
MMR
2, 4, 6 months

health workers
1 year
Pneumo_ps
Rotavirus
Td
Vitamin A
50 years
2, 4, 6 months
10, 20 years
6 months; 2, 3, 4 years
125
Niger
2011
Births.................................................................................................................................. 777

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
61
85
86
78
73
69
64
50
53
50
...
DTP1
80
80
81
76
68
63
58
46
42
46
...
DTP3
75
70
71
67
57
51
45
34
23
22
...
HepB3
75
70
71
...
...
...
...
...
...
...
...
Hib3
75
70
71
...
...
...
...
...
...
...
...
MCV
76
71
69
66
60
53
47
37
40
25
...
Pol3
44
75
71
68
57
52
46
41
23
22
...
PAB
84
84
84
84
79
73
69
63
57
17
...

2011 2010

42
42
100
100
10
10
90
90
67
45

71
79
below 50%
at 80% or above

0

year
2010
target age group
coverage (%)
9-47 m
102
BCG birth
DTwPHibHep
Measles
OPV
126
6, 10, 14 weeks
9 months
TT

1st contact or pregnancy,

+4 weeks; +6 months; +1, +1 year
Vitamin A
Yellow fever
6, 11 months
9 months
Nigeria
2011
Births............................................................................................................................... 6,458

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
64
77
76
65
53
52
49
41
42
80
...
DTP1
53
77
73
63
52
49
48
42
59
79
...
DTP3
47
69
63
53
42
40
36
29
34
56
...
HepB3
50
66
63
41
42
27
18
...
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
71
71
64
53
41
44
41
33
44
54
...
Pol3
73
75
66
60
54
46
45
26
31
55
...
PAB
60
69
67
64
63
63
62
57
44
32
...

2011 2010
774
774
100
100
below 50%
33
10
51
50
16
40
38
38

...
52
at 80% or above

year
2011
target age group
coverage (%)
9-59 m
100
BCG birth
Measles
DTwP
6, 10, 14 weeks
OPV
DTwPHibHep

6, 10, 14 weeks
(subnational)
TT

1st contact pregnancy; +1,

Vitamin A
6-59 months (subnational)
HepB
birth; 6, 14 weeks
HPV subnational
Yellow fever
9 months
9 months
127
Niue
2011
Births.................................................................................................................................... ...

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
99
99
98
99
96
99
92
99
85
DTP1
99
99
99
99
99
99
94
99
99
99
27
DTP3
98
99
99
99
98
99
84
99
99
99
HepB3
98
99
99
99
98
99
85
99
90
...
...
Hib3
99
99
99
99
99
99
99
99
...
...
...
MCV
99
99
99
99
98
99
99
99
34
99
77
Pol3
98
99
99
99
98
99
85
99
99
99
76
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010

100
100
100
100
100
100

100
100
below 50%

at 80% or above

100

year
target age group
coverage (%)
2001
12-59 m
...
BCG birth
MMR
DTaPHibHepIPV

Pneumo_conj

6 weeks;
3, 5 months
HepB birth
HIB
128
15 months
Td
15 months; 4 years
6 weeks; 3, 5,
15 months
11 years
Norway
2011
Births.................................................................................................................................... 61
Total population............................................................................................................. 4925

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
99
99
99
99
99
99
99
99
98
95
...
DTP3
94
93
94
94
93
94
91
90
97
86
...
HepB3
...
...
...
...
...
...
...
...
...
...
...
Hib3
95
94
95
94
95
95
90
93
...
...
...
MCV
93
93
93
93
92
92
89
88
92
87
...
Pol3
94
93
94
94
93
94
91
91
92
84
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010


below 50%

at 80% or above

19
19
100
100
100
100
100
95
...
...

94
year
...
target age group
...
coverage (%)
...
BCG
high-risk groups
DTaPHibIPV
DTaPIPV
HepB

HPV
3, 5, 12 months
7 years
birth; 1, 6 months;
high-risk groups
Influenza
IPV
MMR
Pneumo_conj
high-risk groups
15 years
15 months; 11 years
3, 5, 12 months
12 years (3 doses, females)
129
occupied Palestinian territory

2011
Births.................................................................................................................................. 137

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
98
98
99
99
99
99
99
92
91
...
...
DTP1
99
99
99
99
99
99
99
95
99
...
...
DTP3
99
99
97
96
99
96
96
93
99
...
...
HepB3
98
97
96
95
98
96
99
94
93
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
99
98
97
96
98
99
98
93
73
...
...
Pol3
99
99
98
97
99
97
99
93
96
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010


below 50%

at 80% or above

17
17
100
100
100
100
100
100
...
100

95

year
...
target age group
...
coverage (%)
...
BCG birth
IPV
DTwP 7-8 weeks; 3-4, 5-6, 16-18 months
MMR
HepB

OPV
Hib
130
birth; 2, 6 months; and

14 years; +1; +6 months
(if not previously vaccinated)
2, 3-4, 5-6, 16-18 months
Td
TdaP
3-4, 5-6, 16-18 months

6 years
14, 19 years
6 years
Oman
2011
Births.................................................................................................................................... 50

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
99
99
99
99
98
98
96
96
51
DTP1
99
99
99
99
99
98
99
99
99
98
41
DTP3
99
99
98
99
99
98
99
99
99
98
18
HepB3
99
98
97
98
99
98
98
99
99
...
...
Hib3
99
99
98
99
99
98
99
...
...
...
...
MCV
99
99
99
98
97
96
98
99
98
98
22
Pol3
99
99
96
97
97
98
99
99
99
98
18
PAB
91
91
91
91
95
94
94
94
80
93
35

2011 2010


below 50%
61
61
100
100
100
100
100
100

100
100

at 80% or above

99
year
...
target age group
...
coverage (%)
...
BCG birth
DT
6 years
DTwP
18 months
DTwPHibHep
2, 4, 6 months
HepB birth
Influenza seasonal
IPV
9 weeks
MenACWY pilgrims
MMR
12, 18 months
OPV
4, 6, 18 months; 6, 18 years
Pneumo_conj
2, 4, 6 months
Rabies
post-exposure; high-risk groups
Rubella
15-49 years; post-partum
Td
12, 17 years
TT
pregnancy; post-injury
Typhoid
food handlers
Varicella
1 year
Vitamin A
9, 18 months; post-partum
Yellow fever
travellers
131
Pakistan
2011
Births............................................................................................................................... 4,764

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
85
88
82
86
89
89
82
74
73
80
DTP1
88
88
89
84
90
90
82
72
73
77
20
DTP3
80
86
76
69
83
83
80
62
58
54
HepB3
80
86
76
69
83
83
73
...
...
...
...
Hib3
80
86
76
...
...
...
...
...
...
...
...
MCV
80
82
70
81
80
80
78
59
47
50
Pol3
75
80
72
74
83
83
81
65
58
54
PAB
75
84
84
80
78
80
78
71
63
50
...

2011 2010
142
139
100
100
15
22
77
72
53
49

63
59
below 50%
at 80% or above

56

year
2008
target age group
coverage (%)
103
Pneumo_conj

6, 10, 14 weeks
(subnational)
9 m-13 y
BCG birth
DTwPHibHep
Measles
OPV
132
6, 10, 14 weeks
9, 15 months
TT


+1, +6 months; +1, +1 year
Palau
2011
Births.................................................................................................................................... ...

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
99
99
99
99
99
98
98
98
99
99
...
DTP3
84
69
49
92
94
98
98
96
99
99
...
HepB3
91
80
69
92
91
98
98
96
99
...
...
Hib3
85
66
48
92
95
98
98
96
...
...
...
MCV
85
39
75
97
91
98
98
83
99
98
...
Pol3
98
68
48
92
94
98
98
96
99
99
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010


below 50%
...
100
...
...
...
100
...
...
...

...
...

at 80% or above

83
year
...
target age group
...
coverage (%)
...
DTaP
IPV
DTaPHepIPV
6 week; 4, 6 months
MMR
HepB birth
Pneumo_conj
Hib
6 weeks; 4, 6, 12 months
Rotavirus
HPV
Td
4-6 years
12, 15 months
3, 5, 7, 15 months
5-10 years
133
Panama
2011
Births.................................................................................................................................... 70

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
97
97
97
97
97
98
99
99
99
97
99
DTP1
95
95
95
93
97
96
95
99
95
95
72
DTP3
87
94
85
86
85
88
92
98
86
86
47
HepB3
87
94
85
86
85
88
92
...
...
...
...
Hib3
87
94
85
86
85
88
92
...
...
...
...
MCV
97
97
96
96
95
95
99
97
84
73
71
Pol3
91
95
85
86
84
98
88
99
86
86
70
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010

77
76
100
100
25
75
100
78
99

...
84
below 50%
at 80% or above

83

year
2010
target age group
<5 y
coverage (%)
16
BCG birth
DT
<5 years (pertussis contraindication)
DTwP
5 years
DTwPHib
18 months
DTwPHibHep
2, 4, 6 months
HepA
12, 18 month
HepB
birth; 11 years; health workers; high-risk groups
HPV
10 years; +1, +6 months (females)
Influenza
6, 7 months; >60 years; health workers;

high-risk groups
IPV
2, 4, 6, 15-18 months;

4-5 years (immunocompromised)
MMR
1, 5 years
134
MR >19 years; CBAW; health workers; high-risk groups

OPV
Pneumo_conj
2, 4, 6, 12-15 months; high-risk groups
Pneumo_ps
Rotavirus
2, 4 months
Td
>6 years; CBAW; health workers
TdaP
11 years; health workers; post-partum;

high-risk groups
Varicella
15, 18 months; outbreaks
Vitamin A
6, 12, 18 months
Yellow fever
1 year; +every 10 years;

high-risk areas (subnational)
Papua New Guinea

2011
Births.................................................................................................................................. 208

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
83
79
79
68
67
75
73
81
91
92
62
DTP1
83
80
80
70
76
85
80
84
97
97
57
DTP3
61
56
62
52
60
61
61
59
62
68
32
HepB3
62
56
62
56
59
70
63
57
23
20
...
Hib3
61
56
62
...
...
...
...
...
...
...
...
MCV
60
55
55
54
58
65
63
62
42
67
...
Pol3
58
61
68
65
61
56
50
47
68
68
29
PAB
61
61
61
61
60
57
53
24
60
78
45

2011 2010
89
89
98
98
below 50%
34
44
30
31
34
22
21
12

16
21
at 80% or above

...
year
2010
target age group
coverage (%)
6 m-2 y
42
BCG birth
OPV
DTwPHibHep
TT
1, 2, 3 months
HepB birth
Measles
Vitamin A
1, 2, 3 months
7, 13 years; pregnancy
6, 12 months
6, 9 months
135
Paraguay
2011
Births.................................................................................................................................. 158

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
94
92
91
94
96
98
97
85
82
75
31
DTP1
97
96
94
96
98
99
97
95
87
86
40
DTP3
90
90
86
90
92
96
94
86
68
67
17
HepB3
90
90
86
88
87
92
92
...
...
...
...
Hib3
90
90
86
87
87
90
90
...
...
...
...
MCV
93
94
91
91
91
91
91
92
75
69
19
Pol3
87
88
83
88
90
94
93
86
68
64
14
PAB
85
85
74
74
74
81
78
47
75
66
26

2011 2010
238
241
100
99
13
13
51
50
37
36
24
22

89
88
below 50%
at 80% or above

65

year
2009
target age group
1-4 y
coverage (%)
79
BCG birth
DTwP
18 months; 4 years
DTwPHibHep
2, 4, 6 months
HepA 1st contact; +1 month; travellers (subnational)
HepB 1st contact; +1, +6 months; high-risk groups
HIB
1st contact (immunocompromised;

subnational)
Influenza
6-35 (2 doses) and >60 years;

IPV
2, 4, 6, 18 months; 4 years; high-risk groups
MenAC
MMR
1, 4 years
136
MR
>5 years; travellers
OPV
Pneumo_conj
Pneumo_ps
Rotavirus
2, 4 months
Td
CBAW and 1st contact; +1 month; +1, +1,

+1 year (>7 years and high-risk groups)
TdaP travellers; pertussis outbreaks (subnational)
Typhoid
1st contact; travellers (subnational)
Varicella
1st contact; health workers;

outbreaks (subnational)
Yellow fever
1 year
Peru
2011
Births.................................................................................................................................. 591

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
91
95
97
96
95
94
93
93
94
83
57
DTP1
94
97
99
96
97
97
98
99
96
89
39
DTP3
91
93
93
79
81
83
86
98
90
72
16
HepB3
91
93
93
79
81
83
86
...
...
...
...
Hib3
91
93
93
79
81
83
86
35
...
...
...
MCV
96
94
91
88
86
83
80
97
98
64
23
Pol3
91
92
92
90
89
87
85
93
89
73
16
PAB
85
85
67
67
67
66
65
66
50
19
...

2011 2010
1,834 1,834
100

below 50%
100
17
15
36
33
47
52
43
46

80
79
at 80% or above

70
year
2011
target age group
1-4 y
coverage (%)
87
BCG birth
DT 4, 6 months (pertussis contraindication)
DTwP
18 months; 4 years
DTwPHibHep
2, 4, 6 months
HepB
birth; 1st contact; +2, +6 months
HIB 2, 4 months (pertussis contraindication)
HPV

(subnational)
Influenza 7-24, +1 months; high-risk groups
IPV
2, 4, 6 months (HIV-exposed)
MMR
1, 4 years
MR <5 years; high-risk groups (subnational)
OPV
2, 4, 6 months
Pneumo_conj
2. 4, 12 months
Rotavirus
2, 4 months
Td
CBAW and 1st contact; +1 month;

+1, +1, +1 year (>7 years

and high-risk groups)
Vitamin A
>6 months (high-risk areas)
Yellow fever
15 months; high-risk areas
137
Philippines
2011
Births............................................................................................................................... 2,358

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
84
83
90
93
90
91
91
92
82
96
56
DTP1
85
81
89
94
90
90
91
92
76
96
72
DTP3
80
79
87
91
87
88
89
78
70
88
47
HepB3
76
77
85
88
87
77
49
38
...
...
Hib3
14
...
...
...
...
...
...
...
...
...
MCV
79
80
88
92
92
92
92
78
72
85
...
Pol3
80
78
86
91
87
88
90
74
67
88
50
PAB
76
75
68
58
58
61
57
55
54
57

2011 2010

217
217
85
81
36
40
47
37
25
18

...
92
below 50%
at 80% or above

28

year
target age group
coverage (%)
2011
9 m-8 y
84
BCG birth
Measles
DTwP
6, 10, 14 weeks
MMR
DTwPHibHep
6, 10, 14 weeks
OPV
HepB
138
birth; 6, 14 weeks
Vitamin A
9 months
1 year
6, 10, 14 weeks
6, 12 weeks
Poland
2011
Births.................................................................................................................................. 410

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
93
93
94
94
93
94
94
96
98
97
93
DTP1
99
99
99
99
99
99
99
99
98
98
98
DTP3
99
99
99
99
99
99
99
98
96
96
96
HepB3
98
98
98
98
98
98
98
99
23
...
...
Hib3
99
99
99
94
88
31
22
...
...
...
...
MCV
98
98
98
98
98
99
98
97
96
95
92
Pol3
96
96
96
98
99
99
99
98
96
96
96
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
...
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above
379

...
year
...
target age group
...
coverage (%)
...
BCG birth
IPV
DTwP

7-8 weeks; 3-4, 5-6,

16-18 months
MMR
HepB

birth; 2, 6 months; 14 years,

+1, +6 months (catch up)
Hib
2, 3-4, 5-6, 16-18 months
OPV
Td
TdaP
3-4, 5-6, 16-18 months

6 years
14, 19 years
6 years
139
Portugal
2011
Births.................................................................................................................................... 97

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
96
96
98
98
98
99
89
82
94
88
...
DTP1
99
99
97
99
99
99
94
99
97
96
90
DTP3
98
98
96
97
97
97
93
96
93
89
73
HepB3
97
97
96
97
97
97
94
58
...
...
Hib3
97
97
96
97
97
97
93
86
...
...
...
MCV
96
96
95
97
95
97
93
87
94
85
54
Pol3
97
97
96
97
96
97
93
96
96
89
18
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010


below 50%
100
100
100
100
100
100

100
100

at 80% or above

...

year
2010
target age group
coverage (%)
travellers
...
BCG birth
HPV
DTaPHib
MenC_conj
DTaPHibIPV
DTaPIPV
HepB
140
18 months
2, 4, 6 months
5-6 years
birth; 2, 4 months
MMR
Td
13 years, +2, +6 months

3, 5, 15 months
Qatar
2011
Births.................................................................................................................................... 21

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
97
99
98
97
96
99
99
99
96
97
DTP1
94
98
99
97
96
99
99
92
97
94
82
DTP3
93
97
99
97
94
96
97
80
92
82
61
HepB3
93
97
99
97
94
96
97
89
90
...
...
Hib3
93
97
99
97
94
96
97
80
...
...
...
MCV
99
99
99
96
92
99
99
91
87
79
26
Pol3
93
98
98
98
97
95
98
91
92
82
61
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
...
...
...
...
below 50%
...
...
...
...
...
...
...
...

...
...
at 80% or above

100
year
target age group
coverage (%)
2007
12-59 m
93
BCG birth
DTaP
4-6 years
DTaPHib
DTaPHibHepIPV 2 months (subnational)
DTwPHibHep 4, 6 months (subnational)
HepA
HepB birth
IPV
2 months
MenACWY
>2 years; every 3 years
MMR
OPV
Pneumo_conj
2, 4, 6, 15 months
Pneumo_ps
elderly; high-risk groups
Rotavirus
2, 4 months
TdaP
13-16 years
TT
0, 1, 6 months; post-injury
Typhoid
food handlers; travellers
Varicella
12 months; 46 years
Yellow fever
travellers
141
Romania
2011
Births.................................................................................................................................. 221

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
99
99
99
99
98
99
99
90
...
DTP1
96
98
98
98
98
99
99
99
98
98
...
DTP3
89
94
95
96
96
97
97
99
98
96
...
HepB3
96
98
95
97
99
99
98
98
...
...
...
Hib3
89
...
...
...
...
...
...
...
...
...
...
MCV
93
95
96
96
97
95
97
98
93
92
...
Pol3
89
94
95
95
96
97
97
99
94
92
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010

42
42
100
...
...
10
...
90
...
76
...

88
...
below 50%
at 80% or above

91

year
...
target age group
...
coverage (%)
...
BCG birth
IPV
DTaP
MMR
DTaPHibIPV
4 years
2, 4, 6, 12 months
Td
9 years
12 months; 7 years
HepA outbreaks
TT post-injury
HepB
Typhoid travellers; flooding (subnational)
Influenza
142
birth; 2, 6 months
seasonal; chronic diseases
Yellow fever
travellers (subnational)
Russian Federation
2011
Births............................................................................................................................... 1,689

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
95
96
96
98
96
97
97
96
92
...
...
DTP1
97
97
99
99
99
99
99
97
92
...
...
DTP3
97
97
98
98
98
99
98
96
78
...
...
HepB3
97
97
98
98
98
98
97
...
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
98
98
98
99
99
99
99
97
85
...
...
Pol3
97
98
98
98
99
99
98
97
77
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010


below 50%

at 80% or above

83
83
100
100
100
100
100
100
...
...

97
year
2010
target age group
coverage (%)
18-35 y
...
BCG
3 days; 7, 14 years
Dip
every 10 years (subnational)
DT
3, 4.5 months; 1 year
DTwP
DTwPHep
HepB
HIB
3, 4.5, 6, 18 months
6 months
1st day; 1, 6 months
Influenza seasonal
IPV
Measles
MM
MMR
Mumps
OPV
Rubella
Td
3, 4.5 months
1, 6 years
1, 6 years
1, 6 years (subnational)
1, 6 years
1, 6 years
6-7, 14 years; +every 10 years
143
Rwanda
2011
Births.................................................................................................................................. 449

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
99
93
89
98
91
81
89
92
...
DTP1
98
98
98
97
99
99
95
93
94
94
...
DTP3
97
97
97
97
97
99
95
90
83
84
...
HepB3
97
97
97
97
97
99
95
...
...
...
...
Hib3
97
97
97
97
97
99
95
...
...
...
...
MCV
95
95
95
92
94
95
89
74
84
83
...
Pol3
93
93
93
97
98
99
95
90
84
83
...
PAB
85
85
85
85
82
82
79
81
89
85
...

2011 2010
30
30
100
...
40
...
60
...
...
97
...

below 50%
at 80% or above


...

year
2009
target age group
coverage (%)
9-59 m
101
BCG birth
OPV
DTwPHibHep
Pneumo_conj
HPV
Measles
144
6, 10, 14 weeks

9 months

6, 10, 14 weeks
TT

1st contact pregnancy; +4 week;

Saint Kitts and Nevis

2011
Births.................................................................................................................................... ...

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
91
93
95
97
99
99
99
94
80
...
DTP1
99
98
99
99
99
99
99
99
99
99
79
DTP3
97
95
97
98
99
99
99
98
99
99
56
HepB3
98
96
97
98
99
99
99
99
...
...
...
Hib3
98
96
97
97
99
99
99
12
...
...
...
MCV
99
99
99
99
99
99
99
99
99
99
...
Pol3
98
90
94
97
99
98
99
98
99
99
76
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010


below 50%
17
17
100
100
100
100
100
100

100
...

at 80% or above

101
year
...
target age group
...
coverage (%)
...
BCG
DTwP
DTwPHibHep
HepB
IPV

0-4 weeks
2, 4, 6 months
high-risk groups
MMR
1, 2 years
OPV
Td
2, 4, 6 months
11, 16 years; +every 10 years
Yellow fever
travellers
2, 4, 6 months; high-risk
145
Saint Lucia
2011
Births...................................................................................................................................... 3

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
97
97
97
99
99
94
97
91
98
94
27
DTP1
98
98
99
99
99
94
99
76
98
96
79
DTP3
97
97
95
96
99
85
95
70
98
89
56
HepB3
97
97
95
96
99
85
95
...
...
...
...
Hib3
97
97
95
96
99
85
95
...
...
...
...
MCV
95
95
99
99
94
94
94
88
94
82
...
Pol3
97
97
95
96
99
85
95
70
98
90
58
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010


below 50%
100
100
11
22
89
78
44
56

67
89
at 80% or above

...
year
...
target age group
...
coverage (%)
...
BCG
DT
DTwP
DTwPHibHep
6 weeks
MMR
4-5 years
OPV
18 months
3, 5, 7 months
HepB
high-risk groups
Influenza
high-risk groups
IPV
3, 5, 7, 18 months; 5, 11 years
(immunocompromised)
146
1, 4-5, 11-12 years

3, 5, 7, 18 months; 5, 11 years
Td
Varicella
Yellow fever
11 years
high-risk groups
travellers
Saint Vincent and the Grenadines

2011
Births...................................................................................................................................... 2

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
90
80
87
93
99
95
99
99
99
...
DTP1
98
99
99
99
99
99
99
99
98
98
51
DTP3
95
99
99
99
99
99
98
97
97
98
26
HepB3
96
99
99
99
99
99
99
...
...
...
...
Hib3
96
99
99
99
99
99
99
...
...
...
...
MCV
99
99
99
99
99
99
96
95
99
96
...
Pol3
95
99
99
99
98
98
92
99
97
92
26
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010


below 50%

at 80% or above

100
100
100
100
100
67
67
100

103
year
...
target age group
...
coverage (%)
...
BCG
birth-1 year
DT
4-5, 10-15 years
DTwP
18 months
DTwPHibHep
2, 4, 6 months
HepB birth; 1st contact; +1, +2 months;

adults (high-risk groups)
HIB

IPV

2, 4, 6, 18 months; 4-5 years

(HIV-exposed)
MMR
OPV
1, 4-5 years
2, 4, 6, 18 months; 4-5 years
Td
Yellow fever
>10 years
6 months (children of carriers;

subnational)
147
Samoa
2011
Births...................................................................................................................................... 4

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
91
94
99
91
84
86
97
96
97
72
DTP1
99
97
91
50
85
80
87
99
97
96
54
DTP3
91
87
72
46
71
56
64
99
94
90
29
HepB3
91
87
72
38
69
56
60
96
96
...
...
Hib3
91
87
72
32
...
...
...
...
...
...
...
MCV
67
61
49
45
63
54
57
93
96
89
...
Pol3
91
86
72
78
71
57
73
99
94
88
29
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010

100
100
11
11
33
89
56
67
22

...
67
below 50%
at 80% or above

65

year
2009
target age group
coverage (%)
6-59 m
76
BCG birth
MMR
12, 15 months
DTaP
OPV
6, 10, 14 weeks
DTwPHibHep
5 years
6, 10, 14 weeks
HepB birth
148
Td


+1, +6 months; +1, +1 year
San Marino
2011
Births.................................................................................................................................... ...

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
90
80
95
89
92
98
98
97
99
99
...
DTP3
86
79
92
87
92
95
95
96
99
99
...
HepB3
86
78
92
87
92
95
95
94
98
...
...
Hib3
85
78
92
87
92
95
94
92
80
...
...
MCV
83
68
93
73
92
94
94
74
97
...
...
Pol3
86
75
92
87
92
95
95
96
98
99
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
...
...
...
...
below 50%
...
...
...
...
...
...
...
...

...
...
at 80% or above

84
year
...
target age group
...
coverage (%)
...
DTaPHibHepIPV
DTaPIPV
HPV
3, 5, 11-12 months
11 years (3 doses)
MMR
15 months; 10 years
Td
TdaP
149
Sao Tome and Principe

2011
Births...................................................................................................................................... 5

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
99
99
98
98
98
81
95
99
...
DTP1
98
98
99
99
99
99
99
89
92
97
...
DTP3
96
98
98
99
97
97
97
82
79
92
...
HepB3
96
98
98
99
87
75
96
...
...
...
...
Hib3
96
98
...
...
...
...
...
...
...
...
...
MCV
91
92
90
93
86
85
88
69
74
71
...
Pol3
96
98
99
99
98
97
97
87
79
90
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010


below 50%

at 80% or above

100
100
100
100
71
57
100
100

...

year
2007
target age group
coverage (%)
9 m-14 y
101
BCG birth
DTwPHibHep
6, 10, 14 weeks
HepB birth
Measles
9 months
OPV birth; 6, 10, 14 weeks; 17 months

Pneumo_conj

150
6, 10, 14 weeks
(subnational)
Td


+1, +2 years (subnational)
TT


+1, +2 years
Vitamin A 6, 12, 18, 24, 30, 36 months

Yellow fever
9 months
Saudi Arabia
2011
Births.................................................................................................................................. 605

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
98
98
98
98
96
95
96
94
94
90
33
DTP1
99
98
98
98
97
97
97
95
98
97
66
DTP3
98
98
98
98
96
96
96
95
96
92
41
HepB3
98
98
98
98
96
96
97
93
93
66
...
Hib3
98
98
98
98
96
96
96
...
...
...
...
MCV
98
98
98
97
96
95
97
94
94
88
Pol3
98
98
98
98
96
96
96
95
96
92
41
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010


below 50%

at 80% or above

20
20
100
100
100
100
100
100
...
100

97
year
target age group
coverage (%)
2011
9 m-6 y
97
BCG birth
DT <7 years (pertussis contraindication)
DTwP
4-6 years
DTwPHib
18 months
DTwPHibHep
2, 4, 6 months
HepA
18 months; 2 years (subnational)
HepB birth
HIB
2, 4, 6 months (pertussis

contraindication; subnational)
IPV
2 months
Measles
9 months
MMR
1 year; 4-6 years
OPV
4, 6, 12, 18 months; 4-6 years
Pneumo_conj
Pneumo_ps
high-risk groups
Td
7 years
Varicella
(subnational)
Yellow fever
151
Senegal
2011
Births.................................................................................................................................. 471

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
95
96
97
98
96
94
92
89
91
90
...
DTP1
94
94
94
94
97
99
97
79
93
75
...
DTP3
83
85
86
88
94
89
84
52
80
51
...
HepB3
83
85
86
88
94
89
84
...
...
...
...
Hib3
83
85
86
88
94
89
18
...
...
...
...
MCV
82
81
79
77
84
80
74
48
80
51
...
Pol3
73
70
83
87
93
89
84
49
80
53
...
PAB
88
88
88
88
85
86
80
62
54
45
...

2011 2010
75
...
95
...
62
...
29
...
...

...
80
below 50%
at 80% or above
65

...

year
target age group
coverage (%)
2010
6-59 m
81
BCG birth
TT
DTwPHibHep
Vitamin A
6-11, 12-59 months;
post-partum
Measles
OPV
152
6, 10, 14 weeks
9 months
Yellow fever
pregnancy (2 doses)
9 months
Serbia
2011
Births.................................................................................................................................. 110

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
98
99
98
99
98
85
97
...
...
DTP1
91
91
98
98
98
97
99
97
96
...
...
DTP3
91
91
95
95
94
92
98
95
89
...
...
HepB3
89
89
93
93
99
93
65
...
...
...
...
Hib3
91
91
94
98
89
42
...
...
...
...
...
MCV
95
95
95
92
95
88
96
89
86
...
...
Pol3
91
91
97
95
93
97
98
98
90
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
...
25
...
100
below 50%
...
...
...
100
...
100

...
...
at 80% or above

...
year
...
target age group
...
coverage (%)
...
BCG birth
DT
7 years
DTwP
HepA
HepB
birth; 4 weeks; 5 months
HIB
8, 14, 20 weeks (subnational)
Influenza >65 years; high-risk groups
IPV >12 months (immunocompromised)
MenAC
travellers; high-risk groups

(subnational)
MMR
1, 7 years
OPV

7, 14 years
Pneumo_ps
high-risk groups
(subnational)
Td
14 years
Typhoid
Yellow fever
*All data prior to 2006 pertain to the pre-cession Serbia and Montenegro.
153
Seychelles
2011
Births.................................................................................................................................... ...

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
96
99
99
99
99
99
99
98
...
DTP1
99
99
99
99
99
99
99
99
98
99
...
DTP3
99
99
99
99
99
99
99
98
97
99
...
HepB3
99
99
99
99
99
99
99
98
99
...
...
Hib3
99
99
...
...
...
...
...
...
...
...
...
MCV
99
99
97
99
99
99
99
97
97
86
...
Pol3
99
99
99
99
99
99
99
98
97
99
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010


below 50%

at 80% or above

16
16
100
100
100
100
100
100
...
100

101

year
...
target age group
...
coverage (%)
...
BCG
DT
DTwP
DTwPHibHep
154
birth; 6 years
6 years
18 months
3, 4, 5 months
MMR
OPV
15 months; 6 years
3, 4, 5, 18 months; 6, 15 years
TT
Yellow fever
15, 25 years
1 year
Sierra Leone
2011
Births.................................................................................................................................. 227

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
96
96
96
92
82
83
85
74
...
...
...
DTP1
94
94
94
84
77
79
80
64
...
...
...
DTP3
84
84
84
78
64
64
65
44
...
...
...
HepB3
84
84
84
78
63
...
...
...
...
...
...
Hib3
84
84
84
78
63
...
...
...
...
...
...
MCV
80
80
80
73
60
65
71
37
...
...
...
Pol3
81
81
81
75
63
65
67
46
...
...
...
PAB
85
85
97
97
94
85
83
53
76
85

2011 2010


below 50%
14
14
100
100
21
93
79
29
36

29
14

at 80% or above

...
year
2009
target age group
coverage (%)
9-59 m
101
BCG birth
Rotavirus
DTwPHibHep
TT

Measles
OPV
Pneumo_conj
6, 10, 14 weeks
9 months
6, 10, 14 weeks
+1, +1 year
Vitamin A
9 months
Yellow fever
9 months
155
Singapore
2011
Births.................................................................................................................................... 47

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
99
99
98
98
98
99
98
99
85
DTP1
98
98
98
98
97
96
96
98
98
95
94
DTP3
96
97
97
97
96
95
96
98
98
85
84
HepB3
96
96
97
96
95
94
96
97
96
74
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
95
95
95
95
95
93
96
96
97
84
47
Pol3
96
97
97
97
96
95
96
98
98
85
83
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
...
...
...
...
below 50%
...
...
...
...
...
...
...
...

...
...
at 80% or above

94

year
...
target age group
...
coverage (%)
...
BCG birth
MMR
DTaP 3, 4, 5, 18 months (subnational)
OPV 3, 4, 5, 18 months; 6-7, 10-11 years
HepB
Pneumo_conj
HPV
Influenza

156
birth; 1, 5-6 months

9-26 (3 doses; females)
6 months-5 years
(recommended)
Pneumo_ps
TdaP
1-2, 6-7 years

high-risk groups
10-11 years
Slovakia
2011
Births.................................................................................................................................... 58

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
97
98
97
98
98
98
98
94
92
...
...
DTP1
99
99
99
99
99
99
99
99
99
...
...
DTP3
99
99
99
99
99
99
99
99
99
...
...
HepB3
99
99
99
99
99
99
99
98
...
...
...
Hib3
99
99
99
99
99
99
99
59
...
...
...
MCV
98
98
99
99
99
98
98
98
99
...
...
Pol3
99
99
99
99
99
99
99
98
98
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010


below 50%

at 80% or above

79
79
100
100
100
100
100
100
...
...

99
year
target age group
coverage (%)
2002
unknown
...
BCG

3 days; 10 years (if tuberculin

negative)
DTaPHibHepIPV

DTaPIPV
HepB
2, 4, 10 months
(subnational)
5, 12 years
Influenza
MMR
Pneumo_conj
Td
high-risk groups
14 months; 10 years
2, 4, 10 months
every 15 years
birth (children of carriers)
157
Slovenia
2011
Births.................................................................................................................................... 20

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
...
...
...
...
...
...
...
98
99
...
...
DTP1
98
98
98
99
99
99
98
96
98
...
...
DTP3
96
96
96
97
97
97
95
91
98
...
...
HepB3
...
...
...
...
...
...
...
...
...
...
...
Hib3
96
96
96
97
97
97
95
...
...
...
...
MCV
95
95
95
96
96
96
94
95
93
...
...
Pol3
96
96
96
97
97
97
95
93
98
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
...
...
100
...
...
...
100
...
100

...
...
below 50%
at 80% or above

...
year
...
target age group
...
coverage (%)
...
BCG
Dip
DTaPHibIPV
HepA
HepB
Hib
HPV
Influenza
IPV
Measles
MenACWY
158

(if indicated)
3, 4.5, 6, 18 months
(if indicated)
5 (2 doses), 6 years
high-risk groups
12 years (3 doses)
(if indicated)
(if indicated)
high-risk groups
MenC_conj high-risk groups (subnational)

MMR
1, 5 years
Pneumo_conj
high-risk groups
Pneumo_ps
high-risk groups
Rubella
(if indicated)
Td
9 years
TdaP
9 years
TT
18 years
Typhoid
(if indicated)
Varicella
high-risk groups
Solomon Islands
2011
Births.................................................................................................................................... 17

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
89
85
83
81
84
84
78
92
77
87
65
DTP1
94
85
82
78
84
96
81
85
87
91
71
DTP3
88
79
81
78
79
91
78
82
69
77
46
HepB3
88
79
81
77
79
93
73
77
68
...
...
Hib3
88
79
77
77
...
...
...
...
...
...
...
MCV
73
68
60
60
78
84
70
85
68
70
...
Pol3
93
78
82
78
77
91
74
82
69
75
43
PAB
85
85
85
85
84
74
74
75
81
71
...

2011 2010


below 50%
10
10
100
100
50
50
50
50
30

90
70
at 80% or above

...
year
2009
target age group
coverage (%)
12-48 m
90
BCG birth
OPV
DTwPHibHep
6, 10, 14 weeks
HepB birth
Td subnational
Measles
TT
1 year
6, 10, 14 weeks; 6 years
1st contact; +1 month; +6 years
MR subnational
159
Somalia
2011
Births.................................................................................................................................. 416

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
41
41
29
36
38
40
50
69
46
31
DTP1
52
55
52
40
59
40
50
57
46
42
...
DTP3
41
45
42
31
40
26
35
33
22
19
...
HepB3
...
...
...
...
...
...
...
...
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
46
46
43
34
35
35
35
24
34
30
Pol3
49
49
41
40
40
26
35
37
22
18
PAB
64
64
64
49
50
51
47
47
48
49
...

2011 2010

20
98
100
100
55
64
15
15
30
20
25
16

10
23
below 50%
at 80% or above

...

year
2010
target age group
coverage (%)
9-59 m
70
BCG birth
OPV
DTwP
TT

6, 10, 14 weeks
Measles
160
9 months
Vitamin A


+1, +1 year; pregnancy
6 months; +every
6 months (5 years)
*Since 2008, Somalia supplements routine services with DTP and MCV administered
through Child Health Days. The estimates are based solely on routine doses.
South Africa
2011
Births................................................................................................................................ 1052
Surviving infants............................................................................................................ 1001

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
78
74
78
60
61
63
70
89
95
57
...
DTP1
77
77
77
76
76
75
75
85
89
89
...
DTP3
72
66
70
73
72
74
72
73
72
72
...
HepB3
76
74
70
65
74
76
74
73
...
...
...
Hib3
72
66
70
73
72
74
72
73
...
...
...
MCV
78
74
78
64
62
64
63
72
76
79
...
Pol3
73
74
74
75
73
75
73
71
72
76
...
PAB
77
77
75
75
72
74
59
68
29
...
...

2011 2010


below 50%
52
52
100
100
27
90
69
63
48

94
71

at 80% or above

83
year
2010
target age group
coverage (%)
98
BCG birth
Pneumo_conj
6, 14 weeks; 9 months
DTaPHibIPV

6, 10, 14 weeks;
18 months
Rotavirus
HepB
6, 10, 14 weeks
6 m-15 y
Measles
OPV
9, 18 months
Td
Vitamin A

6, 14 weeks
6, 12 years
6, 12, 18, 24, 30,
birth; 6 weeks
161
South Sudan
2011
Births.................................................................................................................................... ...

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
57
...
...
...
...
...
...
...
...
...
...
DTP1
58
...
...
...
...
...
...
...
...
...
...
DTP3
46
...
...
...
...
...
...
...
...
...
...
HepB3
...
...
...
...
...
...
...
...
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
64
...
...
...
...
...
...
...
...
...
...
Pol3
46
...
...
...
...
...
...
...
...
...
...
PAB
44
...
...
...
...
...
...
...
...
...
...

2011 2010

79
...
100
...
25
...
29
...
46
...
62
...

35
...
below 50%
at 80% or above

...
year
...
target age group
...
coverage (%)
...
BCG birth
OPV
DTwP
TT

Measles
162
6, 10, 14 weeks
9 months

1st contact or pregnancy:
+1, +6 months; +1, +1 year
Spain
2011
Births.................................................................................................................................. 499

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
99
99
98
99
98
99
98
98
96
95
...
DTP3
97
97
96
97
96
98
96
95
90
86
...
HepB3
97
97
96
97
96
81
81
77
...
...
...
Hib3
97
97
96
97
96
98
96
92
...
...
...
MCV
95
95
98
98
97
97
97
94
90
99
...
Pol3
97
97
96
97
96
98
96
95
88
94
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
...
19
...
95
below 50%
...
...
...
95
...
89

...
...
at 80% or above

...
year
...
target age group
...
coverage (%)
...
DTaP
4-6 years
DTaPHibHepIPV

2, 4, 6, 15-18 months
(subnational)
DTaPHibIPV
2, 4, 6, 15-18 months
(subnational)
HepB 0, 2, 6 months; or 1, 2, 6 months
(subnational)
HPV
11-14 years (females, 3 doses)
Influenza
>65 years
MenC_conj
MMR
Pneumo_conj

Pneumo_ps

2, 6, 15-18 months
2, 4, 6, 15-18 months;
high-risk groups
> 65 years;
high-risk groups
Td
14-16 years
Varicella
10-14 years
163
Sri Lanka
2011
Births.................................................................................................................................. 373

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
99
99
99
99
99
98
90
84
61
DTP1
99
99
97
99
99
99
99
99
97
95
71
DTP3
99
99
97
98
98
98
99
99
93
86
46
HepB3
99
99
97
98
98
98
99
...
...
...
...
Hib3
99
99
...
...
...
...
...
...
...
...
...
MCV
99
99
97
98
98
99
99
99
87
80
...
Pol3
99
99
97
98
98
98
99
99
92
86
46
PAB
95
86
93
93
91
90
87
92
81
72
45

2011 2010


below 50%

at 80% or above

26
26
100
100
100
100
100
92
...
100

95

year
target age group
coverage (%)
2004
16-20 y
72
BCG birth
MR
DT
OPV
2, 4, 6, 18, 60 months
DTwP
DTwPHibHep
JE
5 years
18 months
12 years
TT pregnancy; 1st pregnancy (2 doses)
9 months
Typhoid high-risk groups (subnational)
Measles
MMR
1, 3 years (subnational)
164
Td
2, 4, 6 months
Vitamin A

6, 12, 18, 30 months;

2, 3 years
Sudan
2011
Births............................................................................................................................... 1,447

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
92
90
82
88
83
77
72
56
63
77
DTP1
98
99
92
96
95
91
88
75
72
83
18
DTP3
93
90
81
86
84
78
78
62
48
62
HepB3
93
75
72
78
78
60
22
...
...
...
...
Hib3
93
75
72
78
...
...
...
...
...
...
...
MCV
87
90
82
79
79
73
69
58
51
57
...
Pol3
93
90
81
85
84
77
78
62
48
62
PAB
74
74
74
70
72
70
68
61
76
72
...

2011 2010
160
157
100
100
below 50%
10
90
89
41
40

71
69

at 80% or above

...
year
2008
target age group
coverage (%)
97
Pneumo_conj

6, 10, 14 weeks
(subnational)
9-59 m
BCG birth
DTwPHibHep
HepB
Measles
OPV
6, 10, 14 weeks
birth (subnational)
Rotavirus
TT

6, 10 weeks
1st contact; +1, +6 month;
+1, +1 years
*All data up to and including 2010 pertain to the pre-cession Republic of Sudan.
165
Suriname
2011
Births.................................................................................................................................... 10

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
90
99
91
95
96
94
93
90
94
94
50
DTP3
86
96
87
85
84
84
83
71
84
83
25
HepB3
86
86
87
84
84
84
83
...
...
...
...
Hib3
86
86
87
84
84
84
83
...
...
...
...
MCV
85
90
88
86
85
83
91
84
85
65
...
Pol3
86
96
85
85
84
84
84
70
81
81
24
PAB
93
93
93
93
93
93
92
92
92
92
...

2011 2010


below 50%
10
10
100
100
10
10
90
90
40
70
100
100
at 80% or above


...

year
2005
target age group
1-5 y
coverage (%)
87
DT
Influenza
DTwP
MMR
DTwPHibHep
2, 4, 6 months
OPV
HepB
birth; 12 years
Td
HPV subnational
166
Yellow fever
6 months; 12 years
1, 5 years
12 years
1 year (subnational)
Swaziland
2011
Births.................................................................................................................................... 35

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
98
98
98
98
99
99
99
90
99
96
...
DTP1
98
95
98
98
98
97
97
95
94
96
...
DTP3
91
89
94
94
95
95
95
87
82
89
...
HepB3
91
89
94
94
95
95
95
83
...
...
...
Hib3
91
89
94
...
...
...
...
...
...
...
...
MCV
98
94
98
97
95
94
92
92
94
85
...
Pol3
85
89
93
94
95
95
96
90
81
89
...
PAB
86
86
86
86
85
85
82
80
77
63
...

2011 2010


below 50%

at 80% or above

100
100
100
100
25
100
100

74
year
target age group
coverage (%)
2010
9-59 m
90
BCG birth
DT
6, 10, 14 weeks
TT CBAW and 1st contact pregnancy;

+1, +6 months; +1, +1 year
(subnational)
9, 18 months
Vitamin A 6, 12, 18, 24, 30, 36 months
5 years
DTwPHibHep
Measles
OPV


5 years
167
Sweden
2011
Births.................................................................................................................................. 113

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
23
23
23
23
23
21
20
16
14
13
DTP1
99
99
99
99
99
99
99
99
99
99
99
DTP3
98
98
98
98
98
98
98
99
99
99
99
HepB3
...
...
...
...
...
...
...
...
...
...
...
Hib3
98
98
98
98
98
98
98
98
99
...
...
MCV
96
96
96
96
96
97
96
91
97
96
88
Pol3
98
98
98
98
98
98
98
99
99
99
97
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
290
290
100
100
100
100
97
99

...
...
below 50%

at 80% or above

...
year
...
target age group
...
coverage (%)
...
BCG birth-6 months; high-risk groups
HPV
DTaP

Influenza

every 10 years (children born

before 2002)
10-12 years (3 doses; females)

65 years; high-risk
DTaPHibHepIPV
3, 5, 12 months;

high-risk groups (HB)
MMR

DTaPHibIPV
Pneumo_conj
DTaPIPV
HepB

168
3, 5, 12 months
5-6 years
(children of carriers)
18 months; 6-8 years;

12 years (if born before 2002)
3, 5, 12 months
Pneumo_ps >65 years; health workers;

high-risk areas (subnational)
TdaP
Switzerland
2011
Births.................................................................................................................................... 77

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
95
98
95
95
95
95
95
95
93
96
...
DTP3
95
96
95
95
94
94
94
88
89
90
...
HepB3
...
...
...
...
...
...
...
...
...
...
...
Hib3
95
94
95
95
92
92
93
86
...
...
...
MCV
92
92
90
90
87
87
87
81
83
90
...
Pol3
95
95
95
95
95
95
95
92
95
98
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
26
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above
26

...
year
...
target age group
...
coverage (%)
...
Pneumo_conj
2, 4, 12 months
DTaPIPV
HepB
HPV
4-7 years
11-15 years; +6 months
11-14 years; +1-2, +6 months
MenC_conj 12-15 months; 11-15 years

MMR
Pneumo_ps
Td
Varicella
>65 years

11 years; +1 month
12, 15-24 months
169
Syrian Arab Republic

2011
Births.................................................................................................................................. 466

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
90
90
90
89
90
90
90
91
91
92
35
DTP1
86
89
89
88
88
88
88
90
96
93
35
DTP3
72
80
80
79
80
80
80
84
89
91
13
HepB3
66
84
84
83
83
83
83
79
74
...
...
Hib3
72
80
80
79
80
80
80
...
...
...
...
MCV
80
82
82
81
81
81
81
84
85
87
13
Pol3
75
83
83
83
83
83
83
86
89
91
13
PAB
94
94
94
94
92
93
92
90
76
63

2011 2010
75
75
...
100
below 50%
...
...
...
100
...
100

...
100
at 80% or above

88

year
2008
target age group
coverage (%)
11-15 y
99.5
BCG birth
MMR
DT
OPV
6 years
DTwPHibIPV
3, 4, 5, 18 months
(subnational)
HepB
MenACWY
170
birth; 3, 7 months
6 years (school entrance)
12, 18 months
7, 12, 18 months
Td
12 years
TT

1st contact ; +1, +6 months;

+1, +1 year
Vitamin A
12, 18 months
Tajikistan
2011
Births.................................................................................................................................. 194

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
97
98
82
89
83
93
97
98
96
...
...
DTP1
98
95
96
92
88
92
92
88
86
...
...
DTP3
96
93
93
86
86
83
84
83
80
...
...
HepB3
96
93
93
86
84
88
81
...
...
...
...
Hib3
96
93
93
46
...
...
...
...
...
...
...
MCV
98
94
89
86
85
82
85
88
70
...
...
Pol3
97
95
93
87
85
76
79
86
69
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010


below 50%
66
65
100
100
100
100
98
94

95
...

at 80% or above

96
year
2009
target age group
coverage (%)
1-14 y
98.4
BCG
DT
3-5 days; 6, 16-17 years

6 years
MR
OPV
1, 6 years
DTwP
16-23 months
Td
DTwPHibHep
2, 3, 4 months
Typhoid subnational; high-risk groups
HepB birth
Vitamin A
16, 26, 36, 46 years
0-59 months
171
Tanzania, United Republic of

2011
Births................................................................................................................................ 1913
Surviving infants............................................................................................................ 1805

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
93
89
89
90
91
86
96
85
72
DTP1
96
98
90
88
89
94
95
92
93
92
81
DTP3
90
91
85
86
83
90
90
79
81
78
59
HepB3
90
91
85
86
83
90
90
...
...
...
...
Hib3
90
91
85
...
...
...
...
...
...
...
...
MCV
93
92
91
88
90
93
91
78
78
80
46
Pol3
88
94
88
89
88
91
91
64
79
78
57
PAB
88
83
90
81
81
81
81
79
85
77
37

2011 2010
129
129
100
100
18
21
82
79
57
54

86
78
below 50%
at 80% or above

...

year
2011
target age group
coverage (%)
9-59 m
96
BCG birth
DTwPHibHep
4, 8, 12 weeks or

6, 10, 12 weeks (Zanzibar)
HPV

9 years; +2, +6 months

(subnational)
Measles
OPV

172
9 months
birth; 4, 8, 12 weeks or 6, 10, 12

weeks (Zanzibar)
Pneumo_conj
6, 10, 14 weeks
(subnational)
Rotavirus
TT

+1, +1 year
Thailand
2011
Births.................................................................................................................................. 824

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
99
99
99
99
99
99
98
99
68
DTP1
99
99
99
99
99
99
99
98
98
97
73
DTP3
99
99
99
99
98
98
98
97
96
92
49
HepB3
98
98
98
98
96
96
96
95
93
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
98
98
98
98
96
96
96
94
91
80
...
Pol3
99
99
99
99
98
98
98
97
96
92
19
PAB
91
91
91
91
89
88
88
85
87
75
25

2011 2010
931
926
...
...
...
...
...
...
...
...
...

...
...

below 50%
at 80% or above

...
year
...
target age group
...
coverage (%)
...
BCG birth
Cholera travellers
DTwP
1.5-2, 4-5 years
DTwPHep
2, 4, 6 months
HepB
birth; 1 month
Influenza
>65 years (subnational);

JE

1.5-2 (2 doses, 1 month apart),

2.5-3 years
MenACWY

MMR
OPV
9 months; school entrance

2, 4, 6 months; 1.5-2, 4-5 years
Rotavirus
Td

pilgrims; travellers
(subnational)

(schoolchilden grade 6; pregnancy)
Yellow fever
173
The former Yugoslav Republic of Macedonia

2011
Births.................................................................................................................................... 22

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
98
98
98
94
95
92
99
97
95
...
...
DTP1
95
95
98
95
95
95
99
98
98
...
...
DTP3
95
95
96
95
95
93
97
95
95
...
...
HepB3
90
90
95
97
96
89
53
...
...
...
...
Hib3
89
89
82
13
...
...
...
...
...
...
...
MCV
98
98
96
98
96
94
96
97
97
...
...
Pol3
95
95
96
96
96
92
98
96
95
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
...
31
...
100
below 50%
...
...
...
100
...
100

...
...
at 80% or above

...

year
2009
target age group
coverage (%)
13 m-26 y
...
BCG
birth; 7 years
MMR
1, 6 years
DTwP
HepB
birth; 2, 6 months
Rubella
HIB
2, 3, 5, 18 months
TdaP
HPV 12 years; +2, +6 months (females)
174
OPV
TT
2, 3.5, 5, 18 months; 7, 14 years

14 years (females)
7, 14 years
18 years
Timor-Leste
2011
Births.................................................................................................................................... 44

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
68
71
71
85
74
74
70
...
...
...
...
DTP1
69
75
76
85
76
71
64
...
...
...
...
DTP3
67
72
72
79
70
63
55
...
...
...
...
HepB3
67
72
72
79
...
...
...
...
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
62
66
70
73
63
61
48
...
...
...
...
Pol3
66
72
78
79
70
62
55
...
...
...
...
PAB
81
81
81
66
59
63
59
...
...
...
...

2011 2010


below 50%
13
13
100
100
77
77
15
23
15
92
...
at 80% or above


...
year
2011
target age group
coverage (%)
6 m-14 y
92
BCG
birth-1 year
DTwPHep
Measles
OPV
6, 10, 14 weeks
9 months
TT


+1, +6 months; +1, +1 year
Vitamin A 6, 12, 18, 24, 30, 36 months
birth-2 weeks; 6, 10, 14 weeks
175
Togo
2011
Births.................................................................................................................................. 195

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
90
94
91
92
91
96
96
84
83
99
...
DTP1
95
97
93
92
94
91
91
80
74
90
...
DTP3
81
81
78
81
82
84
82
64
58
77
...
HepB3
81
81
78
24
...
...
...
...
...
...
...
Hib3
81
81
78
24
...
...
...
...
...
...
...
MCV
67
66
66
63
71
78
70
58
53
73
...
Pol3
81
81
78
80
72
85
80
63
59
76
...
PAB
81
81
81
81
82
81
81
63
52
47
...

2011 2010


below 50%
35
35
100
97
14
11
86
89
43
43
100
97
at 80% or above


0

year
2010
target age group
coverage (%)
9-47 m
97
BCG birth
Rotavirus
DTwPHibHep
TT

Measles
OPV
6, 10, 14 weeks
9 months
Pneumo_conj
6, 10, 14 weeks
(subnational)
176
Vitamin A

Yellow fever
1st contact pregnancy; +1,
6, 10, 14 weeks;
9 months; post-partum
9 months
Tonga
2011
Births...................................................................................................................................... 3

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
99
99
99
99
99
99
99
99
99
DTP1
99
99
99
99
99
99
99
99
98
97
65
DTP3
99
99
99
99
99
99
99
95
95
94
40
HepB3
99
99
99
98
99
99
99
97
91
94
...
Hib3
99
99
99
99
99
99
99
...
...
...
...
MCV
99
99
99
99
99
99
99
95
94
86
...
Pol3
99
99
99
99
99
99
99
95
93
93
20
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010


below 50%
100
100
100
100
100
100

100
100

at 80% or above

99
year
target age group
coverage (%)
2001
12-59 m
...
BCG birth
MR
12, 18 months
DTwP
OPV
6, 10, 14 weeks
DTwPHibHep
18 months; 5 years
6, 10, 14 weeks
Td
16 years
HepB birth
177
Trinidad and Tobago

2011
Births.................................................................................................................................... 20

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
96
96
95
91
90
93
98
90
96
94
51
DTP3
90
90
90
90
88
92
95
90
89
82
26
HepB3
90
90
90
90
89
89
95
...
...
...
...
Hib3
90
90
90
90
88
89
95
74
...
...
...
MCV
92
92
94
91
91
89
93
90
84
70
...
Pol3
91
91
90
91
90
89
95
90
90
87
38
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010

100
100
11
11
89
89
67
67

...
...
below 50%
at 80% or above

107

year
...
target age group
...
coverage (%)
...
Dip
pertussis contraindication
DT
2, 4, 6, 18, 60 months
MenC_conj
MMR
DTwP
18, 60 months
OPV
DTwPHibHep
2, 4, 6 months
HepB >10 years (3 doses); high-risk groups
Pneumo_conj

HIB
Pneumo_ps
Influenza
2, 4, 6 months
6 months; >3 years
IPV
2, 4, 5, 18 months: 4-5 years
(HIV-exposed)
178
Td
Yellow fever
3 years
12, 48 months
2, 4, 6, 18 months; 4-5 years
2, 4, 6 months;
high-risk infants
24 months
10 years
1, 11 years; travellers
Tunisia
2011
Births.................................................................................................................................. 179

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
98
98
98
99
99
99
98
95
97
96
...
DTP1
98
98
99
99
99
99
98
99
97
97
...
DTP3
98
98
99
99
98
99
98
97
94
93
...
HepB3
98
98
99
99
98
99
97
94
...
...
...
Hib3
43
...
...
...
...
...
80
...
...
...
...
MCV
96
97
98
98
98
98
96
95
91
93
...
Pol3
98
98
99
99
98
99
98
97
94
93
...
PAB
96
96
96
96
96
89
90
68
58
40

2011 2010
225
225
100
100
below 50%

at 80% or above

100
100
86
92
100
100

...
year
2005
target age group
coverage (%)
13-18 y
90.5
BCG birth
Measles
DTwP
OPV 2, 3, 6, 18 months; 6, 12, 18 years
DTwPHibHep
HepB
2, 3, 6, 18 months
2, 3, 6 months
birth; 2, 6 months
Rubella
Td
15 months; 6 years
6, 12, 18 years
179
Turkey
2011
Births............................................................................................................................... 1,289

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
97
97
96
96
94
88
88
96
90
93
...
DTP1
98
98
97
97
98
92
92
92
86
94
67
DTP3
97
97
96
96
96
90
90
85
67
84
42
HepB3
96
96
94
92
96
82
85
71
...
...
...
Hib3
97
97
96
96
76
...
...
...
...
...
...
MCV
97
97
97
97
96
98
91
87
65
78
27
Pol3
97
97
96
96
96
90
90
85
67
84
63
PAB
90
90
71
71
70
68
62
50
42
20
...

2011 2010
...
81
...
100
below 50%
...
...
...
100
...
96

...
...
at 80% or above

...

year
target age group
coverage (%)
2005
9 m-6 y
96
BCG
DTaPHibIPV
DTaPIPV
HepB
2 months
2, 4, 6, 18 months
6 years
birth; 1, 6 months
180
MMR
OPV
Pneumo_conj
Td
12 months; 6 years
6, 18 months
2, 4, 6, 12 months
14 years
Turkmenistan
2011
Births.................................................................................................................................. 109

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
98
99
99
99
99
99
99
99
93
...
...
DTP1
98
99
98
98
99
99
99
97
97
...
...
DTP3
97
96
96
96
98
98
99
97
93
...
...
HepB3
97
96
97
96
98
98
99
...
...
...
...
Hib3
71
58
...
...
...
...
...
...
...
...
...
MCV
99
99
99
99
99
99
99
96
92
...
...
Pol3
97
96
97
96
98
98
99
98
96
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010


below 50%
67
64
100
100
100
100
100
100

100
...

at 80% or above

99
year
...
target age group
...
coverage (%)
...
BCG
DT
DTwP
DTwPHibHep
2-3 days; 14 years

6 years
18 months
2, 3, 4 months
HepB birth
MMR
OPV
Td

2-3 days; 2, 3, 4, 18 months
15, 25 years
181
Tuvalu
2011
Births.................................................................................................................................... ...

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
99
99
99
99
99
99
88
96
99
DTP1
99
99
97
99
99
99
99
93
95
99
61
DTP3
96
89
88
99
97
97
93
82
87
99
36
HepB3
96
89
91
99
97
97
79
81
49
...
...
Hib3
96
89
84
...
...
...
...
...
...
...
...
MCV
98
85
90
93
95
84
62
81
94
95
...
Pol3
96
89
85
99
97
97
99
82
85
84
23
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010

100
100
100
100
50
38

...
100
below 50%

at 80% or above

90

year
2010
target age group
coverage (%)
12-71 m
79
BCG birth
MR
12, 18 months
DTwP
OPV
6, 10, 14 weeks
DTwPHibHep
5-6 years
6, 10, 14 weeks
HepB birth
182
TT

1st contact; +4 weeks; +1,

+ 6 months
Uganda
2011
Births............................................................................................................................... 1,545

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
86
86
90
86
87
83
90
82
83
75
...
DTP1
91
87
96
87
93
85
90
80
81
72
...
DTP3
82
80
79
71
73
64
64
52
59
45
...
HepB3
82
80
79
71
73
64
64
...
...
...
...
Hib3
82
80
79
71
73
64
64
...
...
...
...
MCV
75
73
77
70
75
75
68
57
57
52
...
Pol3
82
79
78
69
70
62
59
55
58
45
...
PAB
85
85
89
85
85
83
85
70
82
41
...

2011 2010
112
80
100
100
below 50%
12
...
29
...
59
...
26
18

59
56
at 80% or above

...
year
2009
target age group
coverage (%)
9-47 m
104
BCG birth
OPV
DTwPHibHep
TT

HPV

Measles
6, 10, 14 weeks
10-12 years; +4 weeks;
+5 months (subnational)
9 months
Vitamin A


CBAW (15-49 years);
+1, +6 months; +1, +1 year
6 months; 1, 1.5, 2,
2.5, 3 years
183
Ukraine
2011
Births.................................................................................................................................. 494

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
90
92
94
95
98
97
96
98
95
...
...
DTP1
73
98
86
96
99
98
98
99
98
...
...
DTP3
50
52
71
90
98
98
96
99
98
...
...
HepB3
21
48
66
84
92
96
97
...
...
...
Hib3
26
51
66
81
46
11
...
...
...
...
...
MCV
67
56
75
94
97
98
96
99
97
...
...
Pol3
58
57
74
91
98
99
95
99
97
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
...
...
...
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above

56

year
2008
target age group
coverage (%)
15-29 y
...
BCG
3 days; 7 years
Dip
23 years
DT
6 years
DTwP
DTwPHibIPV
184
5 months
3, 4 months
HepB
HIB
MMR
OPV
Td
birth; 1, 6 months
18 months
1, 6 years
5, 18 months; 6, 14 years
14, 18, 28, 38, 48 years
United Arab Emirates

2011
Births.................................................................................................................................... 94

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
98
98
98
98
98
98
98
98
98
96
15
DTP1
94
94
95
96
97
97
97
96
96
95
32
DTP3
94
94
93
92
92
92
94
94
90
85
11
HepB3
94
94
93
92
92
92
92
92
90
...
...
Hib3
94
94
93
92
92
92
94
92
...
...
...
MCV
94
94
93
92
92
92
92
94
90
80
34
Pol3
94
94
94
94
94
94
94
94
90
85
11
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
...
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above

...
year
2001
target age group
coverage (%)
9 m-18 y
94
BCG birth
DT
5-6 years
DTwPHib
18 months
DTwPHibHep
2, 4, 6 months
HepB birth; high-risk groups (subnational)
Hib
18 months
Influenza
pilgrims; high-risk groups
IPV
MenACWY pilgrims
MMR
OPV
Pneumo_conj
Pneumo_ps
Rubella
Td
Typhoid
Varicella
Yellow fever

2, 4, 6 months
high-risk groups
13-14 years (females)
15-16 years
high-risk groups
high-risk groups
travellers
185
United Kingdom
2011
Births.................................................................................................................................. 761

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
98
98
97
97
97
97
97
97
97
94
66
DTP3
95
94
93
92
92
92
91
91
94
84
41
HepB3
...
...
...
...
...
...
...
...
...
...
...
Hib3
95
94
93
92
92
92
91
91
94
...
...
MCV
90
89
86
86
86
85
82
88
92
87
53
Pol3
95
94
93
92
92
92
91
91
96
92
81
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010

421
177
...
98
...
...
...
100
...
53

...
...
below 50%
at 80% or above

85

year
...
target age group
...
coverage (%)
...
BCG
DTaPHibIPV
DTaPIPV

2, 3, 4 months
3 years, 4 months
HepB birth; 1, 2, 6 months; high-risk groups

HibMenC
HPV

Influenza
186
1 year
12-13 years; +1, +6 months;
females <18 years (catch up)
MenC_conj
MMR
Pneumo_conj
Pneumo_ps

TdIPV
Varicella

3, 4 months
13 months; 3 years & 4 months

2, 4, 12 months
high-risk groups
>2 years; 65 years
13-18 years
(if indicated)
United States
2011
Births............................................................................................................................... 4,322

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
98
98
98
99
99
99
99
99
98
96
98
DTP3
94
94
94
95
95
95
96
94
95
90
96
HepB3
91
91
91
91
92
92
92
90
68
...
...
Hib3
88
88
90
91
93
93
94
93
91
...
...
MCV
90
90
91
91
92
92
93
91
88
90
86
Pol3
94
94
94
93
93
93
92
90
88
85
95
PAB
...
...
...
...
..
...
...
...
...
...
...

2011 2010
...
...
...
...
below 50%
...
...
...
...
...
...
...
...

...
...
at 80% or above

...
year
...
target age group
...
coverage (%)
...
DTaP
2, 4, 6, 15-18 months; 4-6 years

HepA
12-23 months; high-risk groups
HepB
birth; 1-2, 6-18 months

Hib
2, 4, 6, 12-15 months (various

vaccine combinations)
HPV
Influenza
6-23 months; >50 years;

high-risk groups
IPV
2, 4, 6-18 months; 4-6 years
MenC_conj 11-12 years; high-risk groups

MMR
Pneumo_conj
2, 4, 6, 12-15 months;

high-risk groups >15 months
Pneumo_ps
Rotavirus 2, 4, 6 months; (or 2, 4, months

depending on vaccine)
TdaP
11-12 years
Varicella
12-18 months; 4-6 years;

high-risk adults
187
Uruguay
2011
Births.................................................................................................................................... 49

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
99
99
99
99
99
99
99
99
56
DTP1
99
98
99
98
98
99
99
92
97
98
77
DTP3
95
95
95
94
94
95
96
90
91
97
53
HepB3
95
95
95
94
94
95
96
92
...
...
...
Hib3
95
95
95
94
94
95
96
88
...
...
...
MCV
95
95
94
95
96
94
95
89
90
97
50
Pol3
95
95
95
94
94
95
96
92
91
97
59
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010
275
275
100
100
100
100
100
100

100
100
below 50%

at 80% or above

...

year
target age group
coverage (%)
2003
12-48 m
94
BCG birth
DT
2, 4, 6, 15 months

DTwP
5 years
DTwPHibHep
2, 4, 6, 15 months
HepA
HepB
birth (post-exposure); 12 years;

+1, +6 months (females);

high-risk groups
HIB
2, 4, 6, 15 months

188
Influenza
high-risk groups; health

workers; pregnancy
IPV
2, 4, 6, 12 months (OPV
contraindication)
MMR
12 months; 5 years
OPV
2, 4, 6, 12 months
Pneumo_conj
2, 4, 12 months
Pneumo_ps
Td
12 years
Varicella
12 months
Yellow fever
travellers
Uzbekistan
2011
Births.................................................................................................................................. 589

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
99
99
99
96
99
99
93
98
99
...
...
DTP1
99
99
99
99
98
96
99
99
96
...
...
DTP3
99
99
98
98
96
96
99
99
87
...
...
HepB3
99
99
98
91
99
98
99
...
...
...
...
Hib3
99
99
98
...
...
...
...
...
...
...
...
MCV
99
98
95
98
98
98
99
99
91
...
...
Pol3
99
99
99
98
98
94
99
99
99
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2011 2010


below 50%
195
199
100
...
...
...
100
...
100

...
...
at 80% or above

100
year
2011
target age group
coverage (%)
1-14 y
99
BCG birth
MMR
DTwP
OPV
DTwPHibHep
16 months
2, 3, 4 months
Td
12 months; 6 years
7, 16 years
HepB birth
189
Vanuatu
2011
Births...................................................................................................................................... 7

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
81
81
81
81
81
81
81
79
67
96
...
DTP1
78
78
78
78
78
78
79
85
90
91
...
DTP3
68
68
68
68
68
68
68
71
73
76
...
HepB3
59
59
59
59
59
59
61
70
66
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
52
52
52
52
52
52
53
61
60
66
...
Pol3
67
67
67
67
67
67
67
67
74
78
...
PAB
75
73
73
73
73
88
84
86
33
47
...

2011 2010

100
33
33
67
67
67

67
67
below 50%
at 80% or above

...

year
2009
target age group
coverage (%)
12-59 m
97
BCG birth
Td
6, 12 years
HepB birth
TT


+1, +1 years
Measles
OPV
190
1 year
6, 10, 14 weeks; 6, 12 years
Venezuela (Bolivarian Republic of)

2011
Births.................................................................................................................................. 598

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
95
92
91
90
82
83
95
99
91
82
72
DTP1
90
90
86
87
70
79
98
92
87
84
79
DTP3
78
78
84
50
62
71
87
77
68
63
56
HepB3
78
78
84
53
62
71
88
...
...
...
Hib3
78
78
84
51
62
71
87
...
...
...
MCV
86
79
87
93
87
82
76
84
47
61
50
Pol3
78
74
75
76
67
73
80
86
85
72
95
PAB
50
50
50
52
51
49
51
...
...
...
...

2011 2010
367
367
100
100
below 50%
41
46
51
45
38
25

59
52
at 80% or above

26
year
2009
target age group
coverage (%)
6-10 y
50
BCG birth
OPV
DTwP
Pneumo_ps
5 years
DTwPHibHep
HepB

birth; 1st contact; +2,

+6 months; 1st contact; or +2,
+4 months (high-risk groups)
Influenza

MMR
2, 4, 6, 18 months
6, 7 months; >60 years;

high-risk groups
1, 5 years
>60 years; + 5 years
Rotavirus
2, 4 months
Td 1st contact; +1, +6 months; +1, +1

year
TT


+1, +1 year
Yellow fever
1 year
191
Viet Nam
2011
Births............................................................................................................................... 1,458

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
98
94
97
92
94
95
95
98
96
90
...
DTP1
97
93
97
97
92
94
98
97
97
96
...
DTP3
95
93
96
93
92
94
95
96
93
88
...
HepB3
95
88
94
87
67
93
94
...
...
...
...
Hib3
95
63
...
...
...
...
...
...
...
...
...
MCV
96
98
97
92
83
93
95
97
95
88
...
Pol3
96
94
97
93
92
94
94
96
94
88
...
PAB
87
87
87
84
86
87
86
86
80
24
...

2011 2010
696
695
100
100
below 50%
94
95
92
94

88
92

at 80% or above

93

year
target age group
coverage (%)
2010
1-5 yrs
96
BCG birth
Measles
DTwP
OPV
DTwPHibHep
18 months
2, 3, 4 months
9, 18 months
2, 3, 4 months
TT pregnancy; +1, +6 months; +1 year
HepB birth
Typhoid
JE

Vitamin A 6, 12, 18, 24, 30, 36 months
192
12 months; + 2 weeks;
Yemen
2011
Births.................................................................................................................................. 940

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
59
65
58
60
64
67
66
82
60
95
DTP1
89
94
92
93
94
92
93
88
69
94
18
DTP3
81
87
86
87
87
85
85
76
44
84
HepB3
81
87
86
87
87
85
86
15
...
...
...
Hib3
81
87
86
87
87
85
55
...
...
...
...
MCV
71
73
69
73
74
68
76
71
40
69
Pol3
81
88
86
87
87
85
86
76
44
84
PAB
66
66
66
63
52
56
59
54
30
17
...

2011 2010


below 50%
333
333
96
99
32
17
57
75
12
64
69
at 80% or above


54
year
2009
target age group
9-5 y
coverage (%)
96
BCG birth
Pneumo_conj
6, 10, 14 weeks
DTwPHibHep
6, 10, 14 weeks
HepB
6, 10, 14 weeks
TT

Measles
OPV
9, 18 months
Vitamin A

+1, +1 year
9, 18 months
193
Zambia
2011
Births.................................................................................................................................. 622

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
88
92
92
91
91
92
92
94
97
97
...
DTP1
87
92
96
95
93
92
92
94
97
97
...
DTP3
81
83
94
87
80
81
82
85
86
91
...
HepB3
81
83
94
87
80
81
82
...
...
...
...
Hib3
81
83
94
87
80
81
82
...
...
...
...
MCV
83
96
90
87
93
85
85
85
86
90
...
Pol3
83
80
93
90
77
83
84
85
84
90
...
PAB
81
90
90
90
89
90
91
78
85
62
...

2011 2010

72
72
100
100
38
29
63
68
47
68

72
72
below 50%
at 80% or above

...

year
2010
target age group
coverage (%)
9-47 m
115
BCG birth
DTwPHibHep
Measles
OPV
194
6, 10, 14 weeks
9 months
6, 10, 14 weeks
TT


+1, +1, +6 months; +1, +1 year
Vitamin A 6, 12, 18, 24, 30, 36 months
Zimbabwe
2011
Births.................................................................................................................................. 377

2011 2010 2009 2008 2007 2006 2005 2000 1995 1990 1980
BCG
98
94
90
91
86
81
76
85
96
91
...
DTP1
99
98
87
89
85
81
77
85
96
96
...
DTP3
99
94
84
75
72
68
65
79
88
88
...
HepB3
93
83
73
75
72
68
65
79
...
...
Hib3
93
83
73
75
...
...
...
...
...
...
...
MCV
92
84
76
70
69
67
66
75
87
87
...
Pol3
99
97
82
75
72
70
67
79
88
89
...
PAB
66
76
76
76
78
78
77
76
42
57
...

2011 2010
62
60
98
100
below 50%
27
38
71
58
58
47

68
15
at 80% or above

...
year
2010
target age group
coverage (%)
6 m-14 y
97
BCG birth
DT
5 years
DTwP
18 months
DTwPHibHep
Measles
OPV
3, 4, 5 months
9 months
Pneumo_conj
6, 10, 14 weeks
(subnational)
Rotavirus
TT

+1, +1 years
Vitamin A 6, 12, 18, 24, 30, 36 months
195
GLOSSARY OF ACRONYMS
Note: Compound acronyms denote vaccine combinations.
DTPHibHepIPV, for example, denotes DTP, Hib, HepB and IPV
vaccines combined.
196
AMC
advanced market commitment
aP
acellular pertussis vaccine
BCG
bacille Calmette-Gurin (vaccine against

tuberculosis)
CBAW
childbearing-aged women; refers to ages 15-45

unless otherwise noted
Dip
diphtheria toxoid vaccine
DT
diphtheria toxoid
DTaP
diphtheria and tetanus toxoid with acellular

pertussis vaccine
DTP
diphtheria and tetanus toxoid with pertussis vaccine
DTP1
first dose of diphtheria and tetanus toxoid with

pertussis vaccine
DTP3
third dose of diphtheria and tetanus toxoid with

pertussis vaccine
DTwP
diphtheria and tetanus toxoid with whole-cell

pertussis vaccine
EPI
Expanded Programme on Immunization
GAVI
Global Alliance for Vaccines and Immunisation
GNI
gross national income (US)
H1N1
monovalent vaccine against the 2009 influenza A

(H1N1) virus
HepA
hepatitis A vaccine
HepB
hepatitis B vaccine
HepB3
third dose of hepatitis B vaccine
HFRS
hemorrhagic fever with renal syndrome (hantavirus)

vaccine
Hib
Haemophilus infl uenzae type b vaccine
Hib3
third dose of Haemophilus influenzae type b

vaccine
HPV
human papilloma virus vaccine
IPV
inactivated polio vaccine
JE
Japanese encephalitis
MCV
measles-containing vaccine
MCV2
second dose of measles-containing vaccine
MenA
meningococcal A vaccine; this monovalent vaccine

protects against meningitis serogroup A
MenAC
meningococcal AC vaccine; this bivalent vaccine

protects against meningitis serogroups A and C
MenACW
meningococcal ACWY vaccine; this quadrivalent

vaccine protects against meningitis serogroups A,
C and W-135
MenACWY
meningococcal ACWY vaccine; this quadrivalent

vaccine protects against meningitis serogroups A,
C, Y and W-135
MenBC
meningococcal BC vaccine; this bivalent vaccine

protects against meningitis serogroups B and C
MenC
meningococcal C vaccine; this monovalent vaccine

protects against meningitis serogroup C
MenC_conj
meningococcal C conjugate vaccine
MM
measles and mumps vaccine
MMR
measles-mumps-rubella vaccine
MMRV
measles-mumps-rubella-varicella vaccine
MR
measles and rubella vaccine
OPV
oral polio vaccine
PAB
protected at birth against tetanus
Pneumo_conj
pneumococcal conjugate vaccine
Pneumo_ps
pneumococcal polisaccharide vaccine
Pol3
third dose of poliomyelitis vaccine
PPP
purchasing power parity
Pw
whole-cell pertussis vaccine
TBE
tick-borne encephalitis vaccine
TBD
to be determined
Td
tetanus toxoid with reduced amount of diphtheria

toxoid
Tdap
tetanus toxoid vaccine (full dose) with acellular

pertussis vaccine (reduced dose)
TT
tetanus toxoid
UNICEF
United Nations Children's Fund
WHO
World Health Organization
197
Immunization Summary for 2011 data jointly produced

by the United Nations Childrens Fund (UNICEF) and the
World Health Organization (WHO) presents detailed
statistics on the performance of national and local
immunization systems in 195 countries and territories.
The attached CD-ROM complements the print version and
provides such reports and forms as:
Excel worksheets containing WHO/UNICEF coverage estimates with data for all years since 1980, plus
reported data that include district-level performance
indicators, supply and safety indicators, survey data
and national immunization schedules for 2010 - 2011.
Samples of the WHO/UNICEF Joint Reporting Form
on Immunization in English, French and Spanish.
National Immunization Coverage Final Report (PDF)
for each country or territory.
Full-text version of Immunization Summary:
A Statistical Reference containing data through 2011.
Minimum technical requirements:
Microsoft Office (Microsoft Excel and Word)
Adobe Acrobat (for PDF downloads)
Further information on the publication

can be obtained from:
UNICEF Statistics and Monitoring Section

Division of Policy and Practice
3 United Nations Plaza
New York, NY 10017, USA
immunization@unicef.org
www.unicef.org
Tel: +1-212-326-7000
World Health Organization (WHO)

20 Avenue Appia
CH-1211 Geneva 27, Switzerland
info@who.int
www.who.int
Tel: +41-22-791-2111
The United Nations Childrens Fund (UNICEF) November 2012

En ImmSumm 2013

Hochgeladen von

Dokumentinformationen

Copyright

Verfügbare Formate

Dieses Dokument teilen

Dokument teilen oder einbetten

Freigabeoptionen

Stufen Sie dieses Dokument als nützlich ein?

Sind diese Inhalte unangemessen?

Copyright:

Verfügbare Formate

En ImmSumm 2013

Hochgeladen von

Copyright:

Verfügbare Formate

IMMUNIZATION SUMMARY

A statistical reference containing

A statistical reference containing

See inside back cover

Glossary of acronyms............................................... 196

Measles control activities, including coverage

Table 1: Indicative budget prices for

Recommended budget price, 2013

Table 2: Indicative budget price for

Device (box of 100,

BCG autodisable syringe, 0.1 ml

Autodisable syringe, 0.5 ml

Reconstitution syringe, 2 ml, with needle

Re-use prevention feature syringe, 2 ml,

Reconstitution syringe, 5 ml, with needle

Re-use prevention feature syringe, 5 ml,

Re-use prevention feature syringe with SIP,

Re-use prevention feature syringe with SIP, 10

Safety box, 5 l (box of 25)

Note: The list of countries and territories in MDG regions appears

MAPS: GLOBAL INDICATORS

Source: WHO/UNICEF coverage estimates,

80-89% (29 countries or 15%)

50-79% (38 countries or 20%)

<50% (4 countries or 2%)

Map 1: Immunization coverage with measles-containing vaccines in infants, 2011

*156 developing countries and economies

Source: WHO/UNICEF coverage estimates,

Not applicable (38 countries)

(DTP3 estimated coverage for 2011

No data (22 countries or 15%)

No (97 countries or 62%)

Yes (36 countries or 23%)

National coverage rates (WHO/UNICEF estimates)

BCG bacille Calmette-Gurin (vaccine against tuberculosis)

District coverage (as reported)

Measles control activities (as reported)

National coverage rates (%) (WHO/UNICEF estimates, 2011)

District coverage (as reported)

Number of districts in country

DTP3: proportion of districts with coverage (%) between 50-79%

MCV: proportion of districts with coverage at 90% or above (%)

DTP1DTP3 drop-out rate: proportion of districts that

Measles control activities (as reported)

Most recent national measles campaign

target age group

birth; 6, 10, 14 weeks; 9 months

National coverage rates (%) (WHO/UNICEF estimates, 2011)

District coverage (as reported)

Number of districts in country

Percentage of districts reporting

DTP3: proportion of districts with coverage (%) between 50-79%

MCV: proportion of districts with coverage at 90% or above (%)

DTP1DTP3 drop-out rate: proportion of districts that

Measles control activities (as reported)

MCV2 routine coverage in 2011 (%)

Most recent national measles campaign

target age group

1st contact; +1 month

National coverage rates (%) (WHO/UNICEF estimates, 2011)

District coverage (as reported)

Number of districts in country

MCV: proportion of districts with coverage at 90% or above (%)

DTP1DTP3 drop-out rate: proportion of districts that